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ABSTRACT 
 
JUNCTOPHILIN DAMAGE CONTRIBUTES TO EARLY FORCE DEFICITS AND 
EXCITATION-CONTRACTION COUPLING FAILURE AFTER PERFORMING 
ECCENTRIC CONTRACTIONS  
by 
Benjamin T. Corona 
 
Junctophilins (JP1 & JP2) are expressed in skeletal muscle and are the primary proteins 
involved in transverse (T)-tubule and sarcoplasmic reticulum (SR) membrane apposition.  
During the performance of eccentric contractions, the apposition of T-tubule and SR 
membranes may be disrupted, resulting in excitation-contraction (EC) coupling failure 
and thus reduced force-producing capacity.  In this study, we made three primary 
observations: 1) Through the first three days after the performance of 50 eccentric 
contractions in vivo by the left hindlimb anterior crural muscles of female mice, both JP1 
and JP2 were significantly reduced by ~50 and 35%, respectively, while no reductions 
were observed after the performance of non-fatiguing concentric contractions; 2) 
following the performance of a repeated bout 50 eccentric contractions in vivo, only JP1 
was immediately reduced (~30%) but recovered by 3d post-injury in tandem with the 
recovery of strength and EC coupling; and 3) following the performance of 10 eccentric 
contractions at either 15 or 35˚C by isolated mouse EDL muscle,  isometric force, EC 
coupling, and JP1 and JP2 were only reduced after the 35˚C eccentric contractions.  
Regression analysis of JP1 and JP2 content in TA and EDL muscles from each set of 
  
 
 
experiments indicated that JP damage is significantly associated with early (0 – 3d) 
strength deficits after performing eccentric contractions (R = 0.49; P < 0.001).  As a 
whole, the results of this study indicate that JP damage plays in role in early force deficits 
due to EC coupling failure following the performance of eccentric contractions. 
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CHAPTER 1 
THE ROLE OF JUNCTOPHILINS IN EARLY STRENGTH DEFICITS AFTER  
PERFORMING ECCENTRIC CONTRACTIONS 
Introduction 
The general topic of contraction-induced muscle injury has been studied extensively.  
Using the following search parameters, (skeletal muscle) AND (damage OR injury) AND 
(contraction OR exercise), the United States National Library of Medicine database (PubMed) 
yielded over 3,500 research articles.  The abundance of interest and attention this topic has 
received by the research community is likely related to the fact that most everyone, if not all 
people, experience exercise-induced muscle injury at some point in their lives.   
Contraction-induced muscle injury is usually not of a clinical magnitude in healthy 
populations, although there are specific groups of individuals that are prone to debilitating 
chronic muscle injury (e.g., Duchenne muscular dystrophy patients) or acute severe muscle 
damage (i.e., rhabdomyolysis).  For all populations, contraction-induced muscle injury can result 
in a myriad of perturbations to skeletal muscle including muscle damage (Lieber et al., 1996; 
Lowe et al., 1995), sarcoplasmic reticulum (SR) Ca++ dysregulation (Balnave & Allen, 1995; 
Ingalls et al., 1998b; Lynch et al., 1997; Warren et al., 2002a), resting cytosolic Ca++ 
perturbation (Balnave & Allen, 1995; Ingalls et al., 1998b; Lynch et al., 1997; Warren et al., 
2002a), plasmalemma damage (Armstrong et al., 1983; Warren et al., 1993b; Warren et al., 
2002a), and mitochondrial disruption (Duan et al., 1990; Warren et al., 1996).  Ultimately, this 
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type of muscle injury results in immediate and prolonged force deficits (Balnave & Allen, 1995; 
Corona et al., 2008a; Ingalls et al., 1998a; Ingalls et al., 1998b; Ingalls et al., 2004b; Lowe et al., 
1995; McCully & Faulkner, 1986).  Loss of the ability to produce force can have a profound 
impact on sports performance, occupational tasks, and job performance.  For groups prone to 
contraction-induced muscle injury, functional deficits can be life-threatening.  For example, 
decrements in force producing capacity of the respiratory muscles (i.e., diaphragm) consequent 
of chronic muscle injury necessitates ventilation assistance at a young age in Duchenne muscular 
dystrophy patients (Petrof, 1998).   
Immediate and prolonged force deficits that occur after contraction-induced muscle 
injury appear to be of dissimilar etiology (Armstrong et al., 1991; Proske & Morgan, 2001; 
Warren et al., 2002b).  Skeletal muscle force production relies on SR Ca++ release, which under 
normal circumstances is voltage-induced.  The process in which plasmalemma and T tubule 
membrane depolarization directly leads to SR Ca++ release is called excitation-contraction (E-C) 
coupling.  Force deficits immediately and three days after injury are due primarily to E-C 
coupling disruption and to a lesser extent to damage to force-bearing proteins (Balnave & Allen, 
1995; Ingalls et al., 1998b; Warren et al., 1993c).  In contrast, prolonged strength deficits are due 
to loss of contractile protein (Ingalls et al., 1998a; Lowe et al., 1995) mediated by an 
inflammatory response.  It has been shown that E-C coupling disruption is due to a loss of 
communication between the T tubule (dihydropyridine receptor; DHPR) and the SR terminal 
cisternae (SR Ca++ release channel; ryanodine receptor; RYR1) (Balnave & Allen, 1995; Ingalls 
et al., 1998b; Ingalls et al., 2004a; Warren et al., 2000; Warren et al., 1995).  However, it is not 
known how the communication between the DHPR and RYR1 is altered in injured muscle. 
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The following literature review provides general information about contraction-induced 
muscle injury, focusing primarily on the effects of muscle injury on force producing capacity.  
Specifically, the impact of injurious muscle contractions on early strength deficits will be 
highlighted with in-depth discussion of the underlying cause of early strength deficits.  The 
effects of muscle temperature during injury induction, as well as the effect of a repeated bout of 
injurious contractions on the initial force deficits and E-C uncoupling will be discussed.  The 
purpose of this literature review is to support the theory that E-C uncoupling observed 
immediately after injurious contractions are due to alterations of the triadic proteins junctophilin 
1 and 2 (JP1 & JP2). 
Excitation Contraction Coupling 
Structure of the Triad 
 Adult skeletal muscle fibers are designed to rapidly disperse an electrical signal 
throughout the cell.  The electrical stimulus, in turn, prompts the activation of a chemical 2nd 
messenger system (i.e., SR Ca++ release), which then removes inhibition of mechanical force 
production. The process in which an electrical signal, or muscle action potential, elicits SR Ca++ 
release is called excitation contraction (E-C) coupling. 
 Skeletal muscle possesses a transverse (T) tubule system, which is a system of continuous 
intracellular conduits that are extensions of the plasmalemma and whose lumen is continuous 
with the extracellular fluid, that allows an entire muscle fiber to respond rapidly to electrical 
stimuli.  The T tubule membrane is excitable and functions to propagate action potentials from 
the plasmalemma into the depths of the muscle fiber (Stephenson, 2006).  The majority of the T 
tubule system is arranged in perpendicular to the longitudinal axis of the muscle fiber (i.e., 
transverse tubules), which surround the myofibrils.  Additionally, there are longitudinal tubules 
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that connect adjacent transverse tubules making the T tubule system a continuous network 
(Stephenson, 2006). 
 T tubules are intimately associated with specialized endoplasmic reticulum called 
sarcoplasmic reticulum (SR) in striated muscle.  The SR has three distinct regions:  the 
longitudinal reticulum, which is oriented in parallel with the myofibrils, the terminal cisternae, 
which comprise the ends of the SR and therefore “cap” the longitudinal reticulum, and the 
lumen, which is the space encapsulated by the SR membrane.  Electron micrographs illustrate 
that a T tubule associates with two terminal cisternae of adjacent SR, forming structures called 
triads (Flucher et al., 1993; Franzini-Armstrong, 1970). In mammalian skeletal muscle, triads are 
observed at the sarcomeric A-I band interface.  Thus, one SR longitudinal reticulum centers on 
the M line and the adjacent SR longitudinal reticulum centers on the Z band of a given 
sarcomere.  Helping to maintain this organization, even during lengthening and shortening of the 
fiber or sarcomere, the SR appears to attach to the M line and Z band by an intricate interaction 
between small ankyrin proteins that have an SR transmembrane domain and a protein called 
obscurin that can bind with titin (Armani et al., 2006; Bagnato et al., 2003).  Importantly, this 
structural arrangement brings the excitable membrane of the T tubule, the SR terminal cisternae, 
and the myofilaments into close proximity to each other, which, as will be discussed, is crucial 
for muscle force production. 
 The SR is adept at storing high concentrations of Ca++. Within the lumen of the SR, total 
[Ca++] is ~10 or 20 mM in slow and fast muscle fibers respectively, which is quite large 
compared to normal resting cytosolic [Ca++] (10 – 100 nM) under resting conditions (Allen et al., 
2008; Gissel, 2005; Rossi & Dirksen, 2006).  This steep concentration gradient is achieved 
because the SR is outfitted with Ca++ ATPase pumps (SERCA) and calsequestrin, a low-affinity 
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high-capacity Ca++ binding protein.  SERCA localizes to the longitudinal reticulum of the SR 
and actively pumps Ca++ from the cytosol into the SR lumen, which is the primary means by 
which resting cytosolic [Ca++] is restored following activation.  However, the effectiveness of 
SERCA to pump Ca++ into the SR lumen is greatly enhanced by Ca++ buffering by calsequestrin.  
Calsequestrin Ca++ binding effectively lowers the luminal free [Ca++] to ~0.3 – 1 mM, which 
reduces the gradient that SERCA must pump Ca++ against by ~10 – 100 fold (Allen et al., 2008; 
Rossi & Dirksen, 2006).  In tandem, these proteins allow the SR to store an extraordinary 
amount of Ca++ in a cell in which the cytosol is nearly devoid of this ion, thereby creating a large 
potential for Ca++ signaling within the cell.  
 The key proteins involved in skeletal muscle E-C coupling are the dihydropyridine 
receptor (DHPR, or Cav1) and the ryanodine receptor (RYR1).  The DHPR is an L-type voltage-
gated Ca++ channel located in the T tubule at the triad.  The DHPR has five subunits (α1, β, δ, γ, 
α2) (Dulhunty, 2006).  Of note, the α1s –subunit comprises the transmembrane ion channel and 
contains the channel’s voltage sensor (Bannister, 2007).  Electrophysiological experiments that 
have characterized DHPR function in single muscle fibers highlight that the skeletal DHPR 
charge movement is initiated at ~-60 mV, while the channel Ca++ conductance is not initiated 
until ~-20 mV (Z. M. Wang et al., 1999).  More commonly known as the SR Ca++ release 
channel, RYR1 is a homotetramer (~560 Kda per subunit) that spans the SR terminal cistern 
membrane (Hamilton, 2005).  RYR1 is noted for having a large cyoplasmic component known as 
the “foot” with a small transmembrane component forming the ion pore (Block et al., 1988; 
Franzini-Armstrong, 1970; Hamilton, 2005).  At the triad, the DHPR and RYR1 are 
stereologically associated:  Four DHPRs form a unit (i.e., tetrad) that aligns directly across from 
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a single RYR1, one DHPR per subunit of RYR.  In skeletal muscle, a quaternary unit of DHPRs 
opposes every other RYR1 (Bers & Stiffel, 1993). 
 There is evidence to suggest that the skeletal muscle DHPR and RYR1 are physically 
coupled.  Electron micrographs illustrate that the T tubule and SR membranes are only ~12 nm 
apart and the large cytoplasmic, or foot region of RYR1 spans this gap, presumably making 
physical contact with DHPR (Block et al., 1988; Franzini-Armstrong, 1970; Ikemoto et al., 1997; 
Lu et al., 1994).  Biochemical studies have indicated that there are indeed specific interactions 
between skeletal muscle DHPR subunits and RYR1 (Bannister, 2007; Dulhunty, 2006; Suda et 
al., 1997; Takekura et al., 1995; Tanabe et al., 1988). For example, the cytoplasmic loop between 
transmembrane domains II and III of the α1s of DHPR has been found to increase the open 
probability of purified RYR1 in lipid bilayers and to increase [H3] ryanodine binding in skeletal 
muscle SR microsomes (Suda et al., 1997; Takekura et al., 1995).  While the α1s subunit has 
been identified as crucial for DHPR-RYR1 physical coupling, other studies have also indicated 
that interactions amongst the multiple DHPR subunits and between these multiple DHPR 
subunits and RYR1 are likely involved in physically coupling DHPR and RYR1 in skeletal 
muscle (Bannister, 2007; Dulhunty, 2006). 
 While the DHPR and RYR1 appear to physically couple at the triad, these channels do 
not appear to be solely responsible for the development of this close spatial relationship.  Two 
similar studies were conducted in which skeletal muscle isoforms of DHPR and RYR were 
expressed in Chinese hamster ovary cells (Suda et al., 1997; Takekura et al., 1995).  The 
collective results of these studies revealed that the DHPR located to the plasmalemma and 
exhibited a normal L-Type Ca++ current and that the RYR1 located to the ER/SR membrane and 
could be activated with Ca++ or caffeine (see below).  However, when both channels were co-
  7
  
 
expressed in these cells no junctions between the channels were present.  These findings suggest 
that expression of muscle specific accessory proteins are required for physical coupling between 
DHPR and RYR1 in vivo (Suda et al., 1997; Takekura et al., 1995). 
 DHPR – RYR1 physical coupling requires the formation of triads. The number of 
identified proteins that are associated with membrane junction complexes (i.e., diads and triads) 
is growing rapidly (Weisleder et al., 2008).  Of these proteins, junctophilins (JPs) appear to be 
the primary proteins that maintain the diad and triad structures in cardiac and skeletal myocytes 
respectively (Ito et al., 2001; Komazaki et al., 2002; Takeshima et al., 2000).  Amino acid 
sequence analysis of the JPs reveal that the C-terminus contains a single-pass membrane domain 
that crosses the SR membrane and the N-terminus possesses MORN (membrane occupation and 
recognition nexus) motifs, which form non-covalent bonds with phospholipids in the 
plasmalemma or T tubule membrane (Takeshima et al., 2000).  The middle of the protein is 
thought to form an alpha helix secondary structure (Weisleder et al., 2008).  JP1 (72 kDa) and 
JP2 (90 kDa), which are different gene products, are both expressed in mature skeletal muscle, 
while only JP2 is expressed in cardiac muscle (Ito et al., 2001; Takeshima et al., 2000).  Both of 
these proteins localize to the triad structure in skeletal muscle fibers (Ito et al., 2001).  Based on 
the structure and cellular location of JP1 and JP2, it would appear that these proteins serve as a 
“molecular spring” that tethers the T tubule and terminal cistern membranes in skeletal muscle 
fibers. 
 Takeshima et al. (2000) first demonstrated the role of junctophilins in forming junctional 
complexes.  They injected plasmids with JP cDNA into amphibian embryonic cells and observed 
the formation of junctions between the plasmalemma and ER membrane.  No junctions were 
observed in cells injected with control plasmids, or in cells injected with truncated JP cDNA 
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plasmids that did not express the C terminus of JP1.  Interestingly, the gap distance between the 
ER and plasmalemma membrane in embryonic cells expressing JP was ~7 nm (Takeshima et al., 
2000).  Ryanodine receptors were not present on the ER membrane in these cells.  In dyspedic 
muscle cells (i.e., ryanodine receptors are not expressed) the gap distance between the T tubule 
and SR membrane is ~7 nm, however in muscle cells that express RYR1 the gap distance is 12 
nm (Ikemoto et al., 1997).  These findings indicate that JPs are involved in the formation of 
membrane junction complexes and suggest that JPs have an elastic property that may apply 
tension on the adjacent membranes. 
 Further evidence that JP1 and JP2 are specifically involved in triad and diad formation in 
skeletal muscle cells was provided by two studies in which JP1 gene expression was ablated in 
mice (Ito et al., 2001; Komazaki et al., 2002).  JP1 deficient mice (JP1-/-) died within one day 
after birth.  Electron micrographs of neonatal hindlimb muscles indicated that the number triads 
that formed in JP1-/- muscle was reduced by ~90% compared to WT values, in spite of the fact 
that JP2 expression and diad formation were not reduced in these JP1-/- mice (Ito et al., 2001; 
Komazaki et al., 2002).  These findings indicate that JP1 is required for triad formation, while 
JP2 mediates diad formation.  Additionally, JP1 and JP2 do not appear to be functionally 
redundant, as JP2 expression cannot mediate triad formation or sustain post-natal life. 
 Targeting of DHPRs to the T tubule in the triad and alignment of DHPRs over RYR1 
subunits is required for the direct physical coupling between DHPRs and every other RYR1 
(Anderson et al., 2006; Delbono et al., 2007).  While it is not entirely understood how these 
processes occur, junctional protein 45 (JP45; 45 kda) is thought to play a role in DHPR T tubule 
membrane targeting.  JP45 is first expressed early during development (~15 days into embryonic 
development), associates in the cell with the DHPR and calsequestrin in the SR lumen, and 
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therefore has an SR transmembrane domain (Anderson et al., 2003).  More specifically, JP45 
binds to the I-II loop and C-terminus of α1s subunit as well as the β1s subunit of DHPR 
(Anderson et al., 2006).  This association is of significance because the α1s C-terminus and β1s 
subunit have been implicated in DHPR triad targeting and membrane expression respectively 
(Chien et al., 1995; Flucher et al., 2000; Flucher et al., 2002). Both knock-down of JP45 in 
myotubes and chronic ablation of JP45 expression in JP45-/- mice has reduced DHPR protein 
expression in microsomal vesicles containing T tubule membranes, as well as DHPR peak 
molecular charge movement (- ~40%) in myotubes and mature muscle fibers (Anderson et al., 
2006; Delbono et al., 2007).  Of note, JP45 ablation is not lethal, does not appear to have an 
effect on protein expression of other key triadic proteins (e.g., RYR1, SERCA, triadin, 
calsequestrin), and does not appear to reduce SR Ca++ load in adult muscle fibers (Delbono et al., 
2007).  These results suggest that JP45 expression is involved in the proper positioning of DHPR 
in the triad, but may have some functional redundancy with another triadic protein.            
Current Theory of E-C Coupling 
 The current theory of skeletal muscle E-C coupling indicates that T tubule membrane 
depolarization induces an intermolecular charge movement in DHPR, which corresponds to a 
conformation change in the DHPR, that then physically opens RYR1 (Bannister, 2007; Chandler 
et al., 1976; Dulhunty, 2006; Z. M. Wang et al., 1999).  Although the skeletal muscle DHPR is 
an L-type Ca++ channel, skeletal muscle E-C coupling is not dependent on influx of Ca++ through 
this channel, and therefore is classified as “voltage” induced Ca++ release.  As noted above, the 
DHPR charge movement occurs at a more negative membrane potential than the L-type Ca++ 
current, indicating that the DHPR charge movement occurs before the L-type Ca++ current.  
Careful examination of the membrane potential at which voltage-induced whole cell Ca++ 
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transients (i.e., RYR1 Ca++ release) begin reveals that SR Ca++ release is initiated before the L-
type current in skeletal muscle, suggesting that RYR1 may reciprocally augment the L-type 
current (i.e., regrograde coupling) (Z. M. Wang et al., 1999).  Retrograde coupling does not 
occur in dyspedic myotubes in which the L-type Ca++ current and voltage-induced Ca++ release is 
abolished, but may be restored by expression of RYR1, but not the cardiac RYR isoform (RYR2) 
(Nakai et al., 1998).  Thus, retrograde coupling is isolated to skeletal muscle, although the 
physiological significance is not yet clear. 
 It is important to contrast the mode of E-C coupling in skeletal muscle to cardiac muscle 
to highlight the distinct characteristics of each mode. While skeletal muscle employs an 
extracelluar Ca++ independent mode of E-C coupling (i.e., votage-induced SR Ca++ release), 
cardiac muscle relies on extracellular Ca++ dependent mode of E-C coupling (i.e., Ca++ induced 
Ca++ release; CICR).  Briefly, CICR is the process wherein an action potential depolarizes the 
cardiac myocyte membrane.  The drop in membrane potential opens the cardiac DHPR allowing 
extracellular Ca++ to enter the cytosol.  The localized increase in Ca++ entry proceeds to open the 
cardiac RYR (RYR2), which results in a SR Ca++ efflux into the cytosol providing a robust 
stimulus for force production (Lamb, 2000).  There are number of contrasting characteristics of 
both skeletal and cardiac DHPRs and RYRs that support their respective mode of E-C coupling.  
For example, the cardiac DHPR exhibits a greater Ca++ current that is initiated at a more negative 
membrane potential than the skeletal muscle DHPR (Tanabe et al., 1990).  Additionally, RYR2 
has a greater sensitivity to Ca++ activation in the presence of physiological levels of Mg++ than 
RYR1 (Lamb, 2000).  However, as demonstrated above, potentially the most important 
difference between these tissue specific channel isoforms is the ability for the skeletal muscle 
DHPR and RYR1 to physically couple (Suda et al., 1997; Tanabe et al., 1988).  
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 Physical interaction between DHPR and RYR1 is crucial for the initiation of E-C 
coupling in skeletal muscle.  Based on the discussion above, it is clear that the specific skeletal 
muscle DHPR and RYR isoforms promote physical coupling.  The functional implication of this 
coupling is demonstrated by Tanabe et al. (1990) who reported that expression of the α 1s and not 
α 1c (cardiac version) subunit of DHPR in dysgenic cells was required for voltage-induced SR 
Ca++ release in the absence of extracellular Ca++, as well as Nakai et al. (1998) who reported that 
expression of RYR2 in dyspedic myotubes cannot support voltage-induced Ca++ release.   
 Equally as important, although potentially less tissue specific, is the expression of triadic 
proteins that promote the union of the key skeletal muscle E-C coupling proteins.  In the absence 
of associating triadic proteins DHPR-RYR1 junctions do not form (Suda et al., 1997; Takekura 
et al., 1995).  Importantly, in these studies the DHPR exhibited a L-Type Ca++ current and RYR1 
was capable of being activated with Ca++ or caffeine.  However, electrical stimulation only 
elicited a Ca++ -induced Ca++ release from the ER, and when electrical stimulation was 
performed with 0 mM extracellular Ca++, no ER Ca++ release was observed (Suda et al., 1997; 
Takekura et al., 1995).  Therefore, it appears that in spite of expressing skeletal muscle DHPR 
and RYR1, if skeletal muscle accessory triadic proteins are not expressed then the cell does not 
support voltage-induced Ca++ release.   
 In support of this finding, ablation of JP45, which decreased the density of DHPRs 
presumably in the triadic T tubule membrane, also significantly decreased DHPR peak charge 
movement, RYR1 peak Ca++ transient, and whole muscle twitch and tetanic force production, 
suggesting that proper localization of DHPRs in the triad is critical to voltage-induced E-C 
coupling (Delbono et al., 2007).  Additionally, JP1 and JP2 knock-down in adult muscle, which 
resulted in marked triad deformation, reduced voltage induced Ca++ release in single fibers by 
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~50% (1 Hz; 0 mM [Ca++]o) (Hirata et al., 2006). Thus, it is clear that accessory triadic proteins 
are required for in vivo skeletal muscle E-C coupling.       
RYR1 is a Molecular “Hub” 
 The ryanodine receptor appears to be a molecular “hub” in the cell that is modulated by a 
number of factors including endogenous molecules (i.e., Ca++, Mg++, & ATP), pharmaceutical 
agents (e.g., caffeine & 4-chloro-m-cresol), cytosolic and luminal proteins (e.g., FKBP12, 
calmodulin, and calsequestrin), enzymes (glyocgen phosphorylase), and cellular redox status. 
 On the cytosolic portion of RYR1, each subunit is thought to have two ATP binding sites, 
indicating that a total of 8 ATP molecules may bind with RYR1 (Dias et al., 2006).  ATP may 
activate RYR1, in the absence and presence of cytosolic Ca++ (Godt & Maughan, 1988).  
Additionally, the cytosolic portion of each RYR1 subunit bears an activation site as well as an 
inactivation site that may bind Ca++ or Mg++ (Lamb, 2000).  Ca++ binds with a greater affinity 
than Mg++ to the activation site (Laver et al., 1997).  While Mg++ binding does not open RYR1, 
Ca++ binding (1 µM Ca++) to the activation site of isolated RYR1 increases the open probability 
of the channel.  Conversely, the inactivation site binds Ca++ and Mg++ with equal affinity.  
Isolated RYR1 are inactivated by 1 mM cytosolic [Ca++] (Laver et al., 1997; Meissner, 1986, 
1994).  However, under resting conditions where cytosolic [Ca++] and [Mg++] are approximately 
50 nM and 1 mM respectively, Mg++ would predominantly bind and inactivate the channel.  
Interestingly, in the presence of Mg++, isolated RYR1 open channel probability is greatly reduced 
(Po ≈ 0.10) across a physiologically relevant range of [Ca++] (~10-7 – 10-2 M), which suggests that 
at physiological concentrations of Mg++ isolated RYR1 are “stuck” in a closed state (Lamb, 
2000).  Clearly, this is not the case in vivo, as RYR1 opens in response to the DHPR charge 
movement.  Therefore, DHPR-RYR1 coupling and potentially associative proteins (e.g., 
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FKBP12) must reduce the sensitivity of Mg++ inhibition on RYR1 (Lamb & Stephenson, 1994).  
Of course, this would allow for coupled receptors to become more responsive to cytosolic Ca++  
(for both activation and inactivation) and more importantly to enter an open state upon 
activation, but does not speak to the inhibitory effect of Mg++ on the open probability of 
uncoupled RYR1.  To date, it is unknown how uncoupled RYR1 are opened during E-C 
coupling.   
 Luminal calcium content may also regulate SR Ca++ release and force production.  
During repeated activation of a muscle fiber, not all of the released Ca++ is returned to the SR.  
Instead, other organelles (e.g., mitochondria) and Ca++ binding proteins (e.g., parvalbumin) may 
buffer some Ca++ or Ca++ may leave the cell via various ion channels or pumps, which can result 
in SR Ca++ store depletion (Gissel, 2005).  Demonstrating that reductions in SR Ca++ content 
regulates RYR1 Ca++ release, Dutka et al. (2005) reported that a ~35% reduction in SR Ca++ 
content resulted in an ~45% reduction in peak tetanic force, despite the fact that there was still 
enough Ca++ stored in the SR to elicit maximal tetanic force.   
 A portion of the luminal Ca++ regulation is mediated via interaction between RYR1 and 
calsequestrin.  At resting levels of free SR Ca++ (~1mM), RYR1, calsequestrin, junctin, and 
triadin form a quaternary complex that inhibits SR Ca++ release (Rossi & Dirksen, 2006).  Both 
junctin and triadin bind to RYR1 and therefore localize calsequestrin (and a large amount of 
Ca++) near the release channel.  Triadin and junctin binding to calsequestrin appears to be [Ca++] 
dependent, whereby higher and lower concentrations will result in the release of calsequestrin 
and thus the removal of RYR1 inhibition (Zhang et al., 1997). 
 Decrements in SR Ca++ stores are clearly not advantageous for force production.  To 
counteract the lose of Ca++ during repeated fiber activation, the SR Ca++ stores are “monitored” 
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and presumably upon store depletion a signal is sent from the SR to the T tubule membrane to 
allow the entry of extracellular Ca++ for SR store replenishment.  This process is called store 
operated Ca++ entry (SOCE). The molecular mechanism underlying this process is not entirely 
understood.  Currently, stromal interaction molecule 1 (STIM1) is thought to be the SR Ca++ 
sensor involved in SOCE (Stiber et al., 2008).  However, the T tubule membrane channel has not 
been conclusively determined.  Candidates include Orai1 and transient receptor ion channels 
(TRPCs), and it may be that complexes of both proteins comprise the SOCE channel (Liao et al., 
2008).  Malfunction of SOCE is thought to play a role in high intensity (frequency) fatigue 
(Germinario et al., 2008).  Interestingly, animal models that no longer express triadic proteins 
known to assist in the development and maintenance of triads [JP1, JP2, & mitsugumin 29 
(MG29)] exhibit reductions in SOCE and greater fatigability (Hirata et al., 2006; Nagaraj et al., 
2000).  Conversely, in one animal model in which ablation of a SR luminal protein 
(sarculumenin), whose function is unknown, resulted in an increased expression of MG29, 
SOCE was enhanced and fatigability was reduced (Zhao et al., 2005).  While purely speculative, 
these findings do suggest that high-intensity exercise may disrupt triads, hinder SOCE, and thus 
promote fatigue in active muscle fibers.         
 RYR1 channel function can be modulated by a number of pharmacological agents.  For 
example, at nanomolar concentrations, the plant alkaloid, ryanodine, activates RYR1, while at 
higher concentrations (>100 microM), ryanodine closes RYR1 (Carroll et al., 1991).  Ruthenium 
red has been used to study RYR1 function because of its ability to close RYR1 (Stoyanovsky et 
al., 1997).  Additionally, dantrolene has been found to be an effective treatment for malignant 
hyperthermic episodes because of its ability to stabilize RYR1 in a closed state (Cherednichenko 
et al., 2008). 
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 Both 4-chloro-m-cresol and caffeine have been used to study E-C coupling because each 
of these compounds directly activate RYR1 and therefore by-pass the voltage-gated DHPR 
(Balnave & Allen, 1995; Ingalls et al., 1998b).  This strategy allows for the assessment of SR 
Ca++ content, RYR1 functionality, and, under some assumptions (e.g., constant Ca++ sensitivity), 
contractile protein integrity.  Both compounds appear to increase SR Ca++ release in response to 
voltage and Ca++ activation (Corona et al., 2008a; Lamb et al., 2001), however, 4-cholor-m-cresol 
is a 10 – 25% more potent activator of RYR1 than caffeine (Fessenden & Ehleringer, 2003; 
Westerblad et al., 1998).  
 Ryanodine receptor binding by various proteins in the cytosol such as FKBP12/12.6 and 
calmodulin, and in the SR lumen, such as calseqeustrin, junctin, and triadin, appear to be crucial 
for normal channel function.  Skeletal muscle expresses a 12 and 12.6 kDa protein that binds to 
the immunosuppressant drug FK506 (FKBP12 and FKBP12.6).  Each subunit of RYR1 has an 
FKBP12/12.6 binding site, which has a greater binding affinity for FKBP12.6 than FKBP 12, 
however, because there is a higher concentration of FKBP12 than FKBP12.6, FKBP12 
predominantly binds RYR1 (Chelu et al., 2004).  FKBP12 appears to modulate isolated RYR1 
channel function by stabilizing the channel in a closed state and by coordinating the actions of 
each RYR1 subunit (Ahern et al., 1997; Brillantes et al., 1994; Gaburjakova et al., 2001).   
Additionally, FKBP12 may play a significant role in RYR1 coupled gating, or the gating of 
uncoupled RYR1s by RYR1s coupled to DHPRs (Marx et al., 1998).  Maintenance of a resting 
closed channel state via FKBP12-RYR1 binding appears to be important for E-C coupling gain, 
as myotubes and EDL muscle in which FKBP12-RYR1 interaction was eliminated show signs of 
diminished E-C coupling gain (Avila et al., 2003; Tang et al., 2004).  However, these alterations 
were not observed in the diaphragm or soleus muscles from FKBP12 knock-out mice raising the 
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possibility that FKBP12 may augment E-C coupling gain in a muscle specific manner (Tang et 
al., 2004).   
 Calmodulin is a 17 Kda protein with four Ca++ binding domains (E-F Hands) that is 
prevalent in skeletal muscle (Tang et al., 2002). Each subunit of RYR1 has a calmodulin binding 
domain on its cytoplasmic face (Wagenknecht et al., 1994).  Single channel and binding assay 
studies indicate that calmodulin activates and inhibits RYR1 at nanomolar and micromolar 
[Ca++] respectively (Buratti et al., 1995; Tripathy et al., 1995).  Additionally, calmodulin may 
also bind to the α1-subunit of the DHPR, although the functional consequence of this binding has 
not been determined (Tang et al., 2002).  Interestingly, the binding sites for calmodulin on the 
skeletal muscle DHPR and RYR1 may be in close proximity to where these channels interact, 
suggesting that the effects of calmodulin binding to either channel in vivo may be different than 
those identified in single channel studies (Tang et al., 2002).  The exact role that calmodulin 
plays in skeletal muscle E-C coupling has not been determined. 
 Muscle glycogen depletion has been associated with reduced force producing capacity 
during fatiguing exercise, however, it is not entirely understood how glycogen depletion alters 
the production of force (Allen et al., 2008).  Partially explaining the effects of the decrease in 
force, mouse flexor digitorum brevis muscle that performed repeated tetanic contractions 
exhibited a 25% decrease in glycogen content and a 30% decrease in tetanic force.  Muscle fibers 
from these mice exhibited a ~25% decrease in voltage-induced Ca++ transients, suggesting that 
glycogen content may modulate RYR1 channel activity (Chin & Allen, 1997).  Alternatively, 
reductions in glycogen associated with the SR could also result in T tubule membrane 
depolarization, since the Na+ - K+ pump is thought to require glycolysis derived ATP (Dutka & 
Lamb, 2007), which would also result in a reduction in voltage-induced SR Ca++ release.   
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 The reductive and oxidative (redox) conditions surrounding RYR1 can alter channel 
function.  Each RYR1 subunit possesses 100 cysteine residues, which have thiol groups that may 
be reactive to redox conditions (i.e., reactive thiol groups may be directly oxidized or covalently 
modified via S-glutathionylation & S-nitrosylation) (Stamler & Meissner, 2001).  Oxidation or 
reduction of these thiol groups can effectively alter RYR1 conformation promoting a greater 
probability of channel opening or closure.  Both reactive oxygen species (ROS) and nitric oxide 
(NO) are produced constitutively in skeletal muscle, with increased production of both ROS and 
NO occurring during activity (Reid, 1998, 2001; Reid & Durham, 2002; Smith & Reid, 2006; 
Stamler & Meissner, 2001).  ROS are primarily produced in the mitochondria, but may be 
produced in the cytosol as well (e.g., via sarcolemmal NADPH oxidase) (Smith & Reid, 2006).  
NO is also produced in the mitochondria and cytosol by different nitric oxide synthase (NOS) 
isoforms (endothelial and neuronal NOS respectively), in a Ca++ and calmodulin dependent 
manner (Stamler & Meissner, 2001; J. G. Tidball et al., 1998).  Studies in which RYR1 is 
oxidized in vitro via application of redox reactive agents (e.g., hydrogen peroxide) have 
indicated that RYR1 oxidation increases RYR1 open probability, sensitivity to activators (e.g., 
caffeine), and Ca ++-induced Ca++ release (CICR), while decreasing the sensitivity of the channel 
to inhibition by Mg++ (Aracena et al., 2003; Donoso et al., 2000; Favero et al., 1995; Oba et al., 
2002; Zaidi et al., 1989).  Similar studies describing the effect of NO on RYR1 function indicate 
that NO may either reduce or increase channel activity (Meszaros et al., 1996; Stoyanovsky et 
al., 1997).  The disparity of these results is likely tied to the different experimental conditions 
used in each study (Stamler & Meissner, 2001).  In the case where NO reduces RYR1 channel 
activity, this effect may be the direct result of NO modification of the channel or the result of 
antioxidant effects of NO. 
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 ROS and NO alter force production differently.  ROS appear to increase maximal and 
submaximal force production (Reid et al., 1993).  However, ROS may exert this effect at the 
level of the myofilaments as opposed to E-C coupling proteins (Andrade et al., 2001; Smith & 
Reid, 2006).  In support, Posterino et al. (2003) reported that ROS (H2O2) do not increase RYR1 
Ca++ release during voltage-induced twitch or tetanic contractions, although force production is 
increased.  Thus, it would appear that, in non-fatigued muscle under conditions in which the T 
tubule membrane is fully depolarized, ROS exert their influence on troponin C Ca++ sensitivity 
and not E-C coupling gain.  On the other hand, NO appears to depress submaximal force 
production in skeletal muscle (Kobzik et al., 1994).  NO may depress force production by 
increasing production of cyclic GMP, which reduces force production through an unknown 
mechanism, and a cyclic GMP independent mechanism, which may include reducing SR Ca++ 
release and/or opposing the effects of ROS on RYR1 and the myofilaments (Kobzik et al., 1994; 
Reid et al., 1998; Stamler & Meissner, 2001). 
 While RYR1 oxidation does not appear to influence SR Ca++ release under normal 
conditions, RYR1 Ca++ release is likely augmented by oxidizing agents when E-C coupling is 
disrupted (Posterino et al., 2003).  Posterino and colleagues (2003) reported that application of 
hydrogen peroxide to mechanically skinned muscle fibers enhanced CICR and, when E-C 
coupling was disturbed (i.e., the T system was only partially depolarized), augmented twitch 
force.  Presumably, under conditions in which voltage induced Ca++ release would be 
diminished, augmentation of twitch force by oxidizing agents is the result of a greater reliance on 
RYR1 Ca++ induced Ca++ release.     
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Muscle Actions and Force Production 
Skeletal muscle can perform isometric, shortening (concentric), or lengthening 
(eccentric) muscle actions (contractions) to produce force.  An isometric contraction has no 
length change and thus a shortening or lengthening velocity of zero.  During this type of 
contraction, muscle fiber force production is determined by muscle length, in addition to other 
factors (e.g., physiological cross-sectional area, PCSA).  The isometric muscle length-tension 
relationship indicates that tension rises, plateaus, and then descends at shorter, optimal, and 
longer muscle lengths respectively (Gordon et al., 1966; Josephson, 1999).  The force produced 
corresponds to sarcomere lengths at which actin-myosin overlap progressively increases until it 
is optimal and then decreases (Gordon et al., 1966).  During concentric contractions, the fiber 
shortens and therefore has a positive velocity.  In this case, the amount of force produced during 
a concentric contraction is not only dependent on the initial length of the muscle, but also the 
magnitude of shortening velocity.  A.V. Hill described the effects of shortening velocity on 
muscle force production in 1938.  Notably, muscle force production falls precipitously as 
shortening velocity increases (e.g., ~10% of maximal velocity shortening results in a ~35% 
decrease in force from Po), indicating from a practical perspective that an object with a relatively 
large mass must be moved at a relatively slow shortening velocity (Hill, 1938).  Because 
concentric contractions by definition must have a positive velocity, maximal peak isometric 
force (Po) is greater than concentric force, assuming that all other things are equal (i.e., muscle 
size, architecture, etc.) 
 In contrast to isometric and concentric contractions, during an eccentric contraction the 
force produced by the muscle is less in magnitude and opposite in direction than the force 
applied by an external load, which results in active lengthening of the muscle.  Eccentric 
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contractions therefore have a negative velocity.  However, interestingly maximal eccentric force 
is relatively velocity-independent and is significantly greater in magnitude (≥ 50%) than 
maximal isometric force (Po) (Corona et al., 2008a, 2008b; Friden & Lieber, 1992).   
 The greater peak force and velocity independence of force production during eccentric 
contractions may be explained by differences between contraction types at the cross-bridge level.  
The cross-bridge theory proposed by Huxley (1957) does not appear to accurately describe the 
mechanics and metabolism of eccentric contractions.  Part of the cross-bridge theory indicates 
that for myosin and actin to dissociate ATP must first bind to myosin (Huxley, 1957).  However, 
detachment of the myosin head from actin is not necessarily propagated by ATP hydrolysis 
during an eccentric contraction.  Instead actomyosin bonds may be pulled apart as the 
sarcomeres are actively lengthened (Flitney & Hirst, 1978).  It has been shown in single muscle 
fiber experiments that detachment of myosin heads from actin without ATP hydrolysis results in 
an enhanced rate of reattachment in a strong binding state (Lombardi & Piazzesi, 1990).  Thus, 
during eccentric contractions there may be more myosin heads strongly bound to actin that are 
producing force than during an isometric contraction of similar duration (Linari et al., 2000). 
 Active force production in skeletal muscle requires that myosin and actin interact.  From 
the abbreviated description above of the cross-bridge cycle, it is apparent that ATP plays a key 
role in this process.  However, it is important to remember that Ca++ must bind with troponin C, 
which removes tropomyosin from the myosin binding site on actin, for myosin and actin to 
interact.  Thus, at the most basic level, skeletal muscle active force production results from the 
repetitive interaction of a motor (myosin) with a highly organized molecular pathway (actin), 
which is dependent on energy (ATP) and an electrical signal (voltage-induced Ca++ release).  
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General Description of Contraction-Induced Muscle Injury 
Skeletal muscle injury is defined as “damage or harm to a tissue that functions to produce 
motion, and is associated with a prolonged (i.e., days to weeks) impairment of muscle function” 
(Warren et al., 1999b).  Muscle may be injured by a variety of stressors (i.e., crush injury, cryo-
injury, chemical injury); however, the most commonly observed muscle injury is induced by 
contractions.  Immediately after contraction-induced muscle injury, force-bearing proteins are 
damaged (Lieber et al., 1996), T Tubule and SR membrane cellular arrangement is disorganized 
(Takekura et al., 2001; Warren et al., 1995), and sarcolemmal integrity may be compromised 
(Armstrong et al., 1983; Warren et al., 2002a). A number of exercise-induced muscle injury 
symptoms are frequently documented in the literature to indicate the presence of muscle injury.  
For example, increased serum levels of creatine kinase and muscle soreness are commonly used 
as evidence of muscle injury in human studies (Warren et al., 1999b). However, the most 
meaningful manifestation of muscle injury is the loss of muscle force producing capacity. 
Following the performance of eccentric contractions, strength is immediately diminished and 
remains depressed for an extended amount of time (days to weeks).  In a well-documented 
mouse anterior crural muscle eccentric contraction injury protocol, the greatest deficit in peak 
isometric force is observed early (0-3 days) after the muscle is injured and does not fully recover 
until ~28 days later (Ingalls et al., 1998a; Lowe et al., 1995).  Over the course of this period of 
time, the primary cause of strength deficits changes from failure to activate myofilaments to the 
actual loss of contractile protein (Balnave & Allen, 1995; Ingalls et al., 1998a; Ingalls et al., 
1998b; Lowe et al., 1995; Warren et al., 2002b; Warren et al., 1993c).  The underlying cause of 
strength deficits through time will be discussed in greater detail below.   
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Basis of Contraction-Induced Muscle Injury:  Metabolic vs. Mechanical 
Metabolic Basis of Injury 
The exact mechanism explaining how eccentrically biased exercise injures muscle has 
not been determined.  However, Armstrong et al. (1991) has proposed that the initial stage of the 
injury mechanism is believed to be mechanical, as opposed to metabolic, in nature.  In theory, a 
metabolic initiation of muscle injury is based on a deficiency to meet the increasing energy 
demands of the exercise.  It is suggested that a growing disparity between ATP supply and ATP 
demand will result in an inability to energize various endergonic cellular mechanisms (i.e. Na+-
K+ ATPase and Ca++ ATPase) thereby jeopardizing the homeostatic integrity of the cell 
(Armstrong et al., 1991).  However, the metabolic cost to perform concentric contractions is 
greater than the cost for eccentric contractions (Constable et al., 1976; Enoka, 1996; Newham et 
al., 1983b; Ryschon et al., 1997), and yet it is the performance of eccentric contractions and not 
isometric or concentric contractions that induces muscle injury (Armstrong et al., 1983; Warren 
et al., 1993c).   
Patel and colleagues (1998) tested the hypothesis that muscle injury is metabolically 
induced in a clever study that took advantage of the metabolic plasticity of muscle.  They 
observed that type II fibers were predominantly injured during eccentric exercise, and postulated 
that this preferential injury could have been due to a lower oxidative capacity in these fibers.  To 
test this hypothesis they increased the oxidative capacity of rabbit anterior compartment muscles 
by pre-treating the muscles with low frequency (10 Hz) electric stimulation intermittently for 
four weeks. Increased oxidative capacity was indicated by significant increases in citrate 
synthase activity and capillary density.  However, Po deficits in animals with higher oxidative 
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capacity were not different than control animals following injury, indicating that an increased 
oxidative capacity does not protect fibers from injury (Patel et al., 1998). 
Some researchers have contended that the initiation of muscle injury does have a 
metabolic component, especially during prolonged endurance exercise.  Theoretically, enhanced 
free radical production, via the electron transport chain, during prolonged exercise can damage 
membrane lipids and induce a cascade of events leading to muscle injury (Close et al., 2005).  
There are reports of prolonged cycling and endurance running resulting in muscle soreness, 
increased blood levels of muscle-borne proteins (e.g., creatine kinase and lactate 
dehyodrogenase), prolonged strength deficits, and even satellite cell infiltration (Goodman et al., 
1997; Mackey et al., 2007; Mastaloudis et al., 2006; Romano-Ely et al., 2006; Saunders et al., 
2007).  However, antioxidants, which should alleviate ROS induced muscle damage, do not 
appear to reduce muscle injury after a 50 km run (Mastaloudis et al., 2006).  Additionally, we 
have observed that inhibition of nitric oxide synthase activity during and after eccentric 
contractions actually enhances EDL muscle in vitro force deficits, although this may be due to 
the attenuation of antioxidant effects of NO (unpublished findings).   
Nevertheless, it should be noted that eccentric contractions are performed during the 
stance phase of the gait cycle (Josephson, 1999) and that the number of eccentric contractions 
performed is directly related to the magnitude of muscle injury (Hesselink et al., 1996; Warren et 
al., 1993b). Therefore, during a marathon in which it is estimated that ~10,000 eccentric 
contractions are performed (Horita et al., 1999) it is likely that muscle injury is due to the 
repetitive performance of eccentric contractions and not metabolic stress.    
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Mechanical Basis of Injury 
Performance of maximal eccentric contractions places great mechanical stress and strain 
on force-bearing components in skeletal muscle, which may result in injury to these cellular 
constituents (McCully & Faulkner, 1986; Warren et al., 1993a). Mechanical strain refers to the 
“stretchiness” of the muscle tendon complex and is defined as the change in length relative to 
initial length.  Mechanical stress refers to the amount of the force generated by the muscle at a 
given muscle length and is defined as force divided by the cross-sectional area of the tissue.  A 
stress-strain curve indicates that muscles may stretch while activated and return to the initial 
length until the stress exceeds the yield strength.  However, when both strain and stress increase 
to the point where stress equals the tensile strength of the muscle, components of the active fiber 
may fail (Warren et al., 1993a). Thus, mechanically sensitive elements in muscle fibers may be 
damaged by exposure to both high stress and strain during eccentric contractions. 
There are a number of studies to date that have determined that the unique mechanical 
properties of eccentric contractions cause muscle injury (Hesselink et al., 1996; Lieber & Friden, 
1993; McCully & Faulkner, 1986; Talbot & Morgan, 1998; Warren et al., 1993a; Warren et al., 
1993b).  However, within the literature there appears to be some debate as to whether peak 
mechanical stress or peak mechanical strain during an eccentric contraction is the primary 
determinant of the magnitude of muscle injury. The argument between peak mechanical stress 
and strain is exemplified by the findings of McCully and Faulkner (1986). Using an in situ 
mouse extensor digitorum longus muscle preparation, muscles were electrically stimulated (150 
Hz) and lengthened (20% of fiber length) at varying contraction velocities and durations.  The 
magnitude of injury was assessed 3 days post-injury by measuring histological alterations and 
reductions in isometric strength.  The results indicated that the peak force generated during the 
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eccentric protocol was primarily associated with the reductions in isometric strength (r = -0.70).  
Interestingly, when the amount of force produced between eccentric, concentric, and isometric 
muscle contractions were similar (85% Po), only the eccentric contractions resulted in muscle 
injury (McCully & Faulkner, 1986).  These results were interpreted as circumstantial evidence 
that the lengthening component of an eccentric contraction and not just the peak force generated 
promotes the incidence of muscle injury. 
Suggestive that muscle strain is the predominant cause of injury, Lieber and Friden 
(Lieber & Friden, 1993) reported that the magnitude of mechanical strain was the primary 
predictor of reductions in isometric force following eccentric contractions performed by isolated 
rat tibialis anterior muscle.  In this study, muscles were allotted to a 25% or 12.5% strain group, 
with the 25% strain group being comprised of a high force (~1500 g) and moderate force (~1300 
g) sub-group and the 12.5 strain group being comprised of a moderate force (1300 g) and low 
force (1200 g) sub-group.  Because the 25% strain group exhibited greater strength deficits than 
the 12.5% strain group (~60 vs. ~40% respectively) regardless of peak force production, the data 
suggest that peak strain was the primary determinant of muscle injury (Lieber & Friden, 1993).  
However, by not controlling for force production while manipulating strain, the interpretation of 
these results may be fundamentally flawed. 
 Interestingly, the same research group reported in a subsequent study that strain 
experienced during a lengthening contraction protocol did not associate with the incidence of 
injury (Peters et al., 2003).  In this study, fibers from EDL and TA muscles were stained using 
immunochemistry to detect the absence or presence of desmin and embryonic myosin heavy 
chain respectively.  The researchers found that although the EDL muscle experienced twice the 
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amount of strain than the TA muscle, EDL muscle fibers did not show any alteration in staining 
pre- to post-injury while the TA muscle fibers showed evidence of injury (Peters et al., 2003).   
Comparatively, Talbot and Morgan (1998) investigated the effects of varying strain 
during eccentric contractions using toad sartorius muscle and found that the initial length at 
which the muscle begins an eccentric contraction mostly determines the degree of isometric 
force deficit.  Peak tension during the first stretch of the lengthening protocol was not 
significantly correlated with the magnitude of strength loss even though the correlation 
coefficient was still high (r = -0.75; p = 0.98).  However, there are methodological concerns 
when applying these findings to mammalian skeletal muscle.  First, to assess the contribution of 
initial muscle length to the magnitude of muscle injury, muscles were lengthened by as much as 
~33% of Lo before being actively stretched by 10% Lo (Talbot & Morgan, 1998).  Thus, during 
each eccentric contraction muscles were lengthened to ~140% of Lo, which is much greater than 
would likely be experienced by a mammalian muscle under a “physiological” setting.  This 
“over-stretching” of muscle could result in overestimation of the emphasis of initial muscle 
length on immediate force deficits. Second, these experiments were conducted at 20 to 22 ºC, 
which is suitable for amphibian muscle but grossly underestimates the temperatures at which 
mammalian muscle normally functions (human & mouse; ~37˚C).  Because temperature is 
directly related to peak eccentric force production and consequent isometric force deficits 
(Warren et al., 2002a), it is possible that these lower temperatures masked a significant 
relationship between peak eccentric force and isometric force deficits. 
Warren and colleagues (1993a) conducted a highly-controlled study to determine which 
mechanical factor, strain or stress, predominantly induced muscle injury.  Forty-two different 
eccentric protocols, each controlling for peak eccentric contraction force, length change, 
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lengthening velocity, and initial muscle length were employed to injure rat isolated soleus 
muscle.  The results revealed that immediate peak isometric force deficits were primarily related 
to peak forces (stress) produced during the eccentric contractions.  Importantly, these 
experiments were conducted at 37˚C and muscle lengths were kept within a physiological range.  
The results of this study indicate that 1) muscle injury is indeed mechanically induced and 2) 
peak force during eccentric contractions performed at 37˚C is the primary determinant of the 
magnitude of mammalian muscle injury when muscle length is kept within a physiological range 
(Warren et al., 1993a).  
Studies comparing level versus downhill treadmill running highlight that exercise-
induced muscle injury has a mechanical basis.  At similar running speeds, the rate of oxygen 
consumption (dotVO2) during uphill running, which has a pronounced quadriceps concentric 
contraction component, is higher than during downhill running, which has a pronounced 
quadriceps eccentric contraction component. Yet, it has been shown in humans and animals that 
downhill running often results in skeletal muscle injury (Armstrong et al., 1983; Green et al., 
2008; Minetti et al., 2002).  Based on these findings, contraction-induced muscle injury most 
likely stems from the high mechanical loads placed on muscle tissue during the performance of 
eccentric contractions.   
Experimental Factors Affecting the Magnitude of Force Deficits 
Mechanical Factors 
There are a number of experimental factors that can be manipulated in an injury protocol 
that have an impact on the magnitude of force deficits.  From the above discussion on stress and 
strain, clearly peak eccentric force, the initial muscle length, and the total change in muscle 
length can play a role in determining the severity of strength deficits (Lieber & Friden, 1993; 
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McCully & Faulkner, 1986; Talbot & Morgan, 1998; Warren et al., 1993a).  For instance, rat 
soleus muscle strength deficits were ~50% greater when initial peak eccentric force was ~150% 
versus 125% of Po during five eccentric contractions (Warren et al., 1993a).  Additionally, Talbot 
and Morgan (1998) clearly demonstrated the effect of initial muscle length on strength deficits 
(albeit at non-physiological lengths), as they reported a significant correlation between initial 
muscle length and force deficits (r = 0.960). 
Number of Eccentric Contractions 
The number of eccentric contractions performed during an injury protocol may also 
determine the magnitude of immediate force deficits (Hesselink et al., 1996; Warren et al., 
1993b).  Whereas peak eccentric force may injure muscle fibers under the “normal stress theory 
mechanism of failure”, which states that failure occurs when the tensile strength is greater than 
the yield strength of a cellular component, repetitive eccentric contractions may injure muscle 
under a “materials fatigue mechanism” (Warren et al., 1993a).  Demonstrating materials fatigue, 
rat tibialis anterior muscle exhibited an increase in the % of damaged fibers (Hematoxylin & 
Eosin staining) from 1.2 to 14.8 and 36.2% twenty-four hours after performing 60, 180, and 300 
in vivo eccentric contractions respectively (Hesselink et al., 1996).  Similarly, rat soleus muscle 
exhibited a precipitous decrease in in vitro isometric tetanic force production after the 
performance eight eccentric contractions, but not after contractions 1 through 7 (Warren et al., 
1993b).  Based on these studies, it appears that the number of eccentric contractions performed 
can partly determine the magnitude of muscle injury. 
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Repeated Eccentric Bouts  
Skeletal muscle may adapt to a single bout of eccentric contractions, whereby the muscle 
is injured significantly less following a subsequent injury bout.  The “protection” from eccentric 
contractions afforded by an initial injury bout is termed the repeated bout effect (Nosaka & 
Clarkson, 1995).  In humans, eccentric contraction-induced muscle injury is often characterized 
by increases of muscle proteins in the blood (e.g., creatine kinase), muscle stiffness, soreness, 
and strength deficits (Clarkson & Sayers, 1999; Green et al., 2008; Warren et al., 1999b).  An 
initial bout of eccentric contractions can attenuate these perturbations following a second injury 
bout (Ingalls et al., 2004b; McHugh, 2003).  For example, peak tetanic force produced by mouse 
anterior crural muscles following a single injury bout of 150 eccentric contractions is reduced by 
~50%, while force is only reduced by ~40% following an identical injury bout (Ingalls et al., 
2004b). However, some studies have reported that immediate strength deficits following 
subsequent injury bouts are not significantly reduced after an initial injury bout (Corona et al., 
2008b; Newham et al., 1987).  For example, following each of three bouts of maximal voluntary 
eccentric contractions performed by humans with their elbow flexors, immediate strength deficits 
were similar (~50%) (Newham et al., 1987).  Therefore, it appears that there is little to no change 
in immediate strength deficits and repeated injury bout (Corona et al., 2008b; Ingalls et al., 
2004b).  Nevertheless, the rate at which force is recovered after repeated bouts of eccentric 
contractions is enhanced.  For example, three days after four weekly bouts of eccentric 
contractions mouse anterior crural muscle isometric tetanic torque was only reduced by ~20% as 
opposed to ~50% following an initial injury bout (Corona et al., 2008a). 
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Muscle Temperature during Eccentric Contractions 
Experiments performed at sub-physiological temperatures (e.g., 15 – 30˚C) indicate that 
hypothermic conditions will, in general, reduce the deleterious effects of a variety of injury 
models on skeletal and cardiac muscle.  For example, there are numerous reports of hypothermic 
conditions during skeletal muscle ischemia helping to maintain sarcolemmal integrity and 
muscle function upon reperfusion at physiological temperatures (Bolognesi et al., 1996; Gurke et 
al., 2000; Wilson et al., 1997).  Similarly, maintenance of isolated cardiac muscle at 22˚C 
attenuated sarcolemmal damage in response to the removal and subsequent replenishment of 
extracellular [Ca++] from the bathing medium (i.e., subphysiological temperatures protect muscle 
from the Ca++ paradox) (Ganote & Sims, 1984). 
Warren et al. (2002a) addressed the temperature dependency of contraction-induced 
muscle injury.  In vitro studies were performed with mouse EDL muscle across a range of 
temperatures (15 – 37˚C).  EDL muscles were either injured by performing five eccentric 
contractions or used as exercised controls by performing five concentric contractions.  When 
EDL muscles were injured at 15˚C, isometric force deficits were not different from isometric 
control force values.  However, as the experimental temperature increased the force deficits 
generally increased predominantly for the injured muscle.  For instance, at 25 – 30˚C injured 
EDL muscles exhibited a ~15% decrease of Po, while controls exhibited no deficit.  At 37˚C, Po 
was reduced by ~30% for the injured muscles and ~5% for the isometric control muscles 
(Warren et al., 2002a).   
In an effort to explain the temperature sensitivity of contraction induced muscle injury, 
the authors determined that the temperature dependent force deficits were not associated with 
sarcolemmal damage, intracellular Ca++ accumulation, reductions in SR Ca++ re-uptake rates, or 
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increases in Ca++ sensitive neutral protease activity (Warren et al., 2002a).  Additionally, it does 
not appear that an enzymatic process mediated the temperature sensitive loss of force, as 
decreasing the temperature to 15˚C between eccentric contractions performed at 37˚C did not 
grossly attenuate force deficits (lowering the temperature during the rest interval should 
theoretically reduce enzyme activity). Instead, it appears that the force deficits are primarily due 
to a “failing component within the muscle whose integrity is temperature dependent” (Warren et 
al., 2002a).  The authors suggest that the T tubule membrane may undergo a phase transition at 
temperatures between 25 – 30˚C that presumably plays a role in mediating force deficits (Warren 
et al., 2002a).    
Causes of Eccentric Contraction-Induced Force Deficits 
Myofiber Damage 
Strength deficits following the performance of eccentric contractions are the most 
pronounced immediately and during the first few days after injury, but may persist for prolonged 
periods of time depending on the muscle injured, the novelty of the injury, and the severity of the 
injury protocol.  Historically, immediate force deficits associated with muscle injury were 
thought to be due solely to damage of force bearing proteins (Armstrong et al., 1991).  This 
assertion was based on the principle that muscle force production is directly related to a given 
muscle’s functional area. However, throughout the literature there appears to be dissociation 
between the degree of damage and the magnitude of early force deficits.   
There are reports of the magnitude of force deficits being greater than the presence of 
muscle damage (Hesselink et al., 1996; Lowe et al., 1995; McCully & Faulkner, 1986; Warren et 
al., 1994).  For example, following the performance of 150 eccentric contractions in vivo by 
mouse anterior crural muscles, Lowe et al. (1995) reported that force was reduced immediately 
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by ~55% while less than 1% of the muscle fibers in the TA showed signs of damage.  Similarly, 
Hesselink et al. (1996) indicated that rat anterior crural muscles (TA muscle) injured in vivo with 
60 or 120 eccentric contractions exhibited damage in < 1 to ~5% of muscle fibers 24 hours after 
injury respectively. However, isometric torque was reduced by ~35 to 45%, when correcting for 
fatigue, for each respective condition at this time (Hesselink et al., 1996).  Additionally, Warren 
et al. (1994)  also reported that EDL muscle that had performed 15 eccentric contractions in vitro 
exhibited greater specific force deficits (~60%) than could be explained by the number of fibers 
that showed signs of damage per cross section (≤ 3%) immediately after the injury. 
It is also possible to have robust muscle damage without a marked reduction in force 
production (Hortobagyi et al., 1998; Newham et al., 1983a; Newham et al., 1983b; Street & 
Ramsey, 1965).  Street and Ramsey reported in 1965 that muscle damage per se does not 
necessarily disrupt force production.  In these experiments, frog muscle fiber bundles underwent 
a unique crush-injury that resulted in the retraction of myofibrils from the point of injury, which 
left an empty tube surrounded solely by the sarcolemma.  Amazingly, the majority of the fibers 
or fiber bundles analyzed retained 70 to 80% of their force producing capacity – One fiber even 
maintained 100% of its pre-injury force.  The ability of the muscle to generate near maximal 
force despite being damaged was attributed to lateral transmission of force propagated by the 
still-intact sarcolemma (Street & Ramsey, 1965). 
The contribution that damage to force bearing structures makes to immediate force 
deficits may also be determined via a functional approach.   Application of maximally activating 
Ca++ or caffeine to skinned or intact fibers directly activates the myofilaments.  Thus, a decrease 
in peak Ca++ of caffeine induced- force indicates that force bearing proteins have either been 
damaged or lost from the cell. Warren et al. (1994) found that EDL muscle voltage-induced 
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maximal isometric force was reduced by ~70% after the muscle performed 15 eccentric 
contractions in vitro. Meanwhile, maximal Ca++ activated force produced by single fibers from 
these injured EDL muscles was only decreased by ~34% (Warren et al., 1994).  These findings 
indicate that damage to force bearing proteins may account for ~50% of the immediate force 
deficits with this injury model.  
In comparison, Balnave and Allen (1995) reported that caffeine-induced force produced 
by single mouse flexor digitorum brevis (FDB) muscle fibers was not altered after performing 10 
eccentric contractions in vitro (length change of 25% Lo), although voltage-induced peak 
isometric force (100 Hz) was reduced by ~20%.  These findings suggest that damage to force-
bearing structures did not contribute to the immediate strength deficits.  Together the studies of 
Warren et al. (1994) and Balnave & Allen (1995) indicate that 0 to 50% of immediate force 
deficits are explained by damage to force-bearing proteins. 
The interpretation of the above single fiber measurements assumes that the Ca++ 
sensitivity of the myofilaments is not altered immediately after performing eccentric 
contractions.  However, it is possible that myofilament Ca++ sensitivity could be reduced by 
elevations of factors known to decrease the sensitivity of the myofilaments, such as inorganic 
phosphate or oxidative stress, after injury (Andrade et al., 2001; Godt & Nosek, 1989; Perkins et 
al., 1997).  Importantly, Balnave and Allen (1995) reported that myofilament Ca++ sensitivity 
was not significantly reduced in single fibers following a physiological muscle injury protocol, a 
finding made by measuring intracellular Ca++ transients during a force-frequency test.  
Morgan and colleagues have proposed a theory explaining how muscle damage 
contributes to initial strength deficits (Morgan, 1990).  Based on the previous observation that 
sarcomere inhomogeneity may exist on the descending limb of the sarcomere length tension 
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relationship (Gordon et al., 1966), Morgan proposed that when muscle fibers are lengthened, 
weaker sarcomeres will lengthen more than shorter stronger serial sarcomeres (Morgan, 1990), a 
finding recently supported by Faulkner’s laboratory (Panchangam et al., 2008).  According to 
Morgan, weak sarcomeres will become even weaker as they move further down the descending 
limb of length tension curve, eventually reaching a point where thick and thin filaments do not 
overlap.  Beyond this point, the passive structures of the lengthened sarcomere bear the stress 
and strain of adjacent myofibrils and serial sarcomeres respectively.  As a result, the lengthened 
sarcomere may fail (Morgan & Allen, 1999; Proske & Morgan, 2001).   
Morgan and colleagues postulate that 1) weak sarcomeres are located randomly 
throughout a muscle fiber, 2) that sarcomeres will become disrupted progressively based on 
initial vulnerability, 3) and that the sarcomere damage will eventually spread adjacently, 
damaging parallel myofibrils, the sarcolemma, and structures involved in the E-C coupling 
process (Morgan & Allen, 1999; Proske & Morgan, 2001).  This group of researchers contend 
that sarcomeric damage may be the initial event in contraction-induced muscle injury. 
It is possible that force production by the myofibrils is not diminished following muscle 
injury, but the transmission of force from the myofibrils ultimately to the muscle tendon is 
impeded (Gao et al., 2008).  Desmin is an integral part of the cyoskeleton that connects adjacent 
Z disks together and connects the Z disks to the sarcolemma forming a structure called a 
costamere and is involved in lateral transmission of force (K. Wang & Ramirez-Mitchell, 1983).  
Lieber et al. (1994) indicated that eccentric contractions reduced desmin protein content 
(Western blot) by 23 and 35% at 1 and 3 days after injury induction and that the reduction in 
desmin content was highly correlated with force deficits.  These findings indicate that eccentric 
contractions may indeed damage desmin, which may result in force deficits and lends support to 
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the radial propagation of damage from “popped” sarcomeres (Morgan & Allen, 1999; Proske & 
Morgan, 2001).   
However, in a subsequent study conducted by Lieber’s research group, it was reported 
that only ~250 of ~15,000 fibers in rat TA muscle demonstrated abnormal immunohistochemical 
staining for desmin 12 hours after eccentric contraction injury induction (Peters et al., 2003).  It 
was concluded by the authors that desmin could not possibly explain the ~45% isometric 
strength deficit observed immediately after the injury protocol, as complete functional failure of 
the desmin negative fibers would only explain a 2% force deficit (Peters et al., 2003).     
Loss of Contractile Protein 
In response to the physical damage to force-bearing proteins and potentially the 
sarcolemma, skeletal muscle exhibits a degenerative and regenerative process that initially 
removes proteins within and surrounding focal sites of injury and then eventually rebuilds the 
degraded areas (Ingalls et al., 1998a; Lowe et al., 1995; Newham et al., 1983a; J.G. Tidball, 
2005).  To partially explain the degeneration of muscle proteins following injury, it has been 
thought that contraction-induced sarcolemmal damage may allow extracellular Ca++ to 
accumulate within injured muscle fibers (Armstrong et al., 1991). In support, the performance of 
eccentric contractions has been shown to increase intracellular [Ca++] (Balnave & Allen, 1995; 
Ingalls et al., 1998b; Lynch et al., 1997), total muscle [Ca++] (Lowe et al., 1994), and 
mitochondrial [Ca++] (Duan et al., 1990) immediately and for 2 – 3 days after injury. Increases in 
intracellular [Ca++] may activate Ca++ - sensitive degradative pathways (e.g. calpain, 
phospholipase A2, ROS production, proteasome), which may further damage force-bearing 
proteins and the sarcolemma (Armstrong et al., 1991; Clarkson & Sayers, 1999; Costelli et al., 
2005; K. J. Davies, 2001).   
  36
  
 
Because elevated intracellular [Ca++] is observed immediately after injury, it has been 
suggested that myofiber Ca++ accumulation is driving initial functional deficits (Armstrong et al., 
1991). However, it does not appear that a rise in intracellular [Ca++], at least when the source of 
Ca++ is extracellular, plays a role in immediate strength deficits.  Lowe et al. (1994) reported that 
increasing extracellular [Ca++] to 5.0 mM from 1.25 mM following the performance of eccentric 
contractions did not promote greater strength deficits.   Moreover, Ca++ activated neutral 
proteases (i.e., Calpain) do not appear to play a role in immediate strength deficits as incubation 
of EDL muscle with calpain inhibitors (e.g., luepeptin, calpeptin) before and during the 
performance of 5 eccentric contractions in vitro at 37˚C did not attenuate immediate force 
deficits (~ -30% Po) (Warren et al., 2002a).  Nevertheless, while eccentric contraction induced 
intracellular [Ca++] elevations may not be involved in initial force deficits, the activation of Ca++ 
sensitive degradative pathways may contribute to prolonged force deficits.  
Additionally, in response to physical damage to force bearing proteins an immune 
response is activated that also results in further degeneration of proteins in the injured muscle 
fiber (Lowe et al., 1995; J.G. Tidball, 2005).  The time-course of the immune response is typified 
by macrophages invading injured skeletal muscle fibers within 24 hours after injury, with the 
presence of these phagocytic cells peaking between 2 to 3 days after injury induction (Armstrong 
et al., 1983; Lowe et al., 1995; McCully & Faulkner, 1985).  Endogenous proteases and 
enhanced phagocytic activity in injured muscle fibers results in a marked increase of the rate of 
protein degradation by 2 to 3 days after injury induction (Ingalls et al., 1998a; Lowe et al., 1995).  
Consequently, contractile protein content begins to decrease in injured muscle around this time 
(~3 – 5 days), and remains depressed over the next two weeks (Ingalls et al., 1998a).  Because 
contractile protein content is not significantly reduced until ~5 days after injury induction, 
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degeneration of force-bearing proteins does not likely play a significant role in early (0 – 3 days) 
strength deficits, but is the predominant cause of prolonged strength deficits (Ingalls et al., 
1998a; Warren et al., 2002b). 
While the immune response plays a large role in mediating the degeneration of injured 
muscle, it also appears to play a role in tissue regeneration as well (Summan et al., 2006; J.G. 
Tidball, 2005; Warren et al., 2005; Warren et al., 2004a).  For example, selective depletion of 
peripheral monocytes with systemic injections of liposomal clodronate resulted in a prolonged 
clearance of necrotic muscle fibers during the weeks after freeze-injury (Summan et al., 2006).  
This finding is possibly reflective of a depressed immune response-mediated satellite cell 
activation, which is required for muscle regeneration after freeze- and contraction-induced 
muscle injury (Rathbone et al., 2003). 
Excitation-Contraction Coupling Failure 
Human studies in which low-frequency force was decreased by a greater extent than 
high-frequency force following eccentric contractions initially suggested that E-C coupling was 
disrupted in injured muscle(C. T. Davies & White, 1981; Newham et al., 1983b).  For example, 
Newham et al. (1983b) reported that the twitch (10 Hz) to tetanic (50 Hz) force ratio was 
depressed ~20% more in an eccentrically than concentrically exercised leg.  In order to assert 
that greater force deficits at low- than high-frequencies are indicative of E-C coupling, 1) the 
high frequency force must be located on the plateau region of the force-frequency relationship, 
2) the low-frequency force must be located on the steep slope of this relationship, and 3) there 
must be a uniform decrease in the SR Ca++ transient at all stimulation frequencies (e.g., the Ca++ 
transient is reduced by 10% at all frequencies).  Under these conditions, a similar reduction in SR 
Ca++ transient will reduce force production at lower frequencies to a greater extent than at 
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maximal frequencies.  It should be noted, however, that this interpretation has been challenged as 
the greater deficits at lower frequencies could also be due to an increased compliance of muscle 
fibers after injury (Morgan & Allen, 1999; Proske & Morgan, 2001). 
Warren et al. (1993c) were the first to provide evidence of E-C coupling failure 
immediately after the performance of eccentric contractions.  In this study, voltage-induced 
tetanic (150 Hz) and caffeine-induced (50 mM) contracture force produced by mouse soleus 
muscle was assessed after the performance of 20 eccentric contractions or 20 isometric 
contractions in vitro (37˚C).  Peak isometric force was reduced by ~43% immediately after 
performing 20 eccentric contractions, while there was no significant decrease in Po after 20 
isometric contractions (~ -4%).  Caffeine-elicited force, which was ~65% of Po, was not reduced 
after the performance of either eccentric or concentric contractions (Warren et al., 1993c).  
Because caffeine-induced force bypasses upstream components of E-C coupling by directly 
inducing SR Ca++ release, these results suggest the immediate deficits in voltage-induced 
strength was due to E-C coupling failure.  
Substantiating that E-C uncoupling plays a predominant role in immediate force deficits 
induced by eccentric contractions Balnave et al. (1995) reported that voltage-induced peak SR 
Ca++ transients are reduced in injured muscle fibers.  For example, intracellular [Ca++] measured 
during tetanic isometric contractions in isolated mouse FDB muscle fibers was reduced across a 
range of stimulation frequencies (30 – 100 Hz) after performing 10 eccentric contractions (22˚C; 
stretch of 25% Lo) (Balnave & Allen, 1995).  Applying 10 mM caffeine during the 100 Hz 
stimulation restored the magnitude of the intracellular Ca++ transient back to pre-injury values.  
In the same fibers, it was also shown that peak isometric force (100 Hz) was reduced by ~20%, 
which could be restored back to pre-injury values by the addition of caffeine during 100 Hz 
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stimulation.  Ca++ sensitivity of the contractile apparatus was not disturbed after injury (Balnave 
& Allen, 1995).  Therefore, these findings indicate that immediate force deficits of injured fibers 
are solely due to a reduced voltage-induced SR Ca++ release, under these experimental 
conditions.  
While in vitro experiments are useful because experimental conditions may be precisely 
manipulated and controlled, the conditions in which isolated muscles are injured may not be 
physiological (i.e., low temperature or too great of a length change).  In an effort to injure muscle 
under a more physiological setting (at least in regards to temperature and length changes), Ingalls 
et al. (Ingalls et al., 1998b) investigated the effects of 150 eccentric contractions performed in 
vivo by mouse anterior crural muscles (TA and EDL muscles) on voltage induced or caffeine (or 
4-chloro-m-cresol) elicited force and EDL SR Ca++ transients.  Immediately after injury, in vivo 
anterior crural muscle torque was reduced by ~50%.  Immediately and three days after injury, 
isolated EDL muscle peak isometric force was reduced by ~50%, while caffeine-induced force 
was reduced by ~15%.  The authors therefore asserted that E-C coupling disruption accounted 
for ~75% of the strength deficits at this time (Ingalls et al., 1998b).  In support, peak tetanic (100 
Hz) Ca++ transients, measured in superficial fibers from the EDL muscle simultaneously, were 
reduced similarly in all fibers immediately (~25%) and three days after injury (~50%).  Ca++ 
transients were restored to uninjured values during caffeine-like compound contractures 
immediately after injury, although three days after injury SR Ca++ release was not fully restored 
upon chemical exposure (Ingalls et al., 1998b).  These findings indicate that an in vivo injury 
model results in force deficits that are primarily explained by disruption of E-C coupling and that 
this disruption persists for days after injury induction.  Also, these findings and others (Balnave 
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& Allen, 1995) suggest that E-C coupling failure is experienced by all actively injured muscle 
fibers, and is therefore not focal in nature. 
E-C coupling failure does not appear to significantly adapt to repeated bouts of injurious 
exercise.  For example, following a single injury bout (150 maximal eccentric contractions in 
vivo), mouse EDL muscle specific tetanic force and caffeine contracture force may be reduced 
by ~50 and ~15% respectively, through the first five days after injury induction (Ingalls et al., 
1998b; Ingalls et al., 2004b).  Thus, ~75% of force deficits observed during the first five days of 
injury are explained by E-C coupling failure.  However, following five repeated bouts of the 
same injury protocol, EDL muscle specific tetanic force was reduced by 33% immediately after 
five injury bouts and recovered rapidly over the next five days, although there was still 
significant force deficits three (17%) and five (7%) days post-injury.  Meanwhile, caffeine-
induced (50 mM) force was reduced by ~5%, at most, at these times after the fifth injury bout 
(Ingalls et al., 2004b).   Therefore, E-C coupling failure explains ≥85% of strength deficits after 
the fifth injury bout, but appears to recover at an enhanced rate.   
Additionally, E-C coupling failure induced by eccentric contractions appears to be 
temperature sensitive.  In a study in which EDL muscles were injured by performing eccentric 
contractions in vitro at either 15 or 37˚C, voltage-induced isometric tetanic force deficits were 
only induced at 37˚C (Warren et al., 2002a).  However, caffeine contracture force (50 mM at 
37˚C) was similar between muscle injury temperature groups and was not different from an 
isometric control group (Warren et al., 2002a).  Therefore, it appears that E-C uncoupling 
involves failure of a temperature sensitive component. 
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Sites of Excitation-Contraction Coupling Failure After Eccentric Contractions 
It is clear that SR Ca++ transients are diminished in injured muscle during the first three 
days after injury and that the reduction in SR Ca++ release most likely contributes to early force 
deficits (Balnave & Allen, 1995; Ingalls et al., 1998b).  However, the above experiments do not 
indicate where the breakdown in the E-C coupling process occurs.  Potential sites of E-C 
coupling failure include disruption of the plasmalemma or T tubule network, a loss or reduced 
function of DHPRs or RYR1s, or disruption to the communication between DHPR and RYR1.   
Plasmalemma and T Tubule 
E-C coupling could fail because of a reduced ability of the plasmalemma to depolarize or 
propagate an action potential.  Supporting this possibility, McBride et al. (2000) reported that rat 
tibialis anterior muscle membranes remained partially depolarized for up to 24 hours after 
perfoming eccentric contractions.  In contrast, Warren et al. (1993c) reported that the resting 
membrane potential of injured soleus muscle was not different than the resting membrane 
potential of control muscle (~74 mV).  These conflicting results may stem from the differences 
in the contractile protocols employed by each study [e.g., 100 Hz, 2.5 s train vs. 300 Hz, 120 ms 
train; (McBride et al., 2000; Warren et al., 1993c), respectively]. 
To further assess the excitability of skeletal muscle after eccentric contractions, mouse 
tibialis anterior muscle electrical activity (EMG) was measured during electrically stimulated 
isometric contractions before, immediately after, and during the days after performing eccentric 
contractions in vivo (Warren et al., 1999a).  Peak isometric torque was reduced by ~50%, while 
the root mean square of the electromyographic signal (EMG RMS), which is indicative of the 
amplitude of the muscle action potential, was reduced by ~20% immediately after eccentric 
contractions.  However, EMG RMS was reduced to a similar degree immediately after the 
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performance of concentric contractions that did not induce muscle injury. One and three days 
after the eccentric contractions, EMG RMS was not different from pre-injury values, while 
anterior crural muscle torque remained reduced, indicating that muscle action potential 
generation and plasmalemma propagation were not affected by muscle injury per se (Warren et 
al., 1999a). 
Similarly, the propagation of action potentials by and the structural integrity of the T 
tubule system do not appear to be adversely affected immediately after muscle injury.  Evidence 
for this is provided by in vitro experiments in which EDL muscle K+ contractures were 
performed immediately after eccentric contractions were performed (Ingalls et al., 1998b).  
Compared to contralateral control force values, peak isometric force produced by the EDL 
muscle was reduced by ~50% and K+ contracture force was reduced to a similar magnitude. 
Because K+ -induced force directly stimulates the T tubules to depolarize, a similar decrease in 
voltage-induced and K+ induced force immediately after injury likely indicates that the site of 
failure is located at or below the DHPR (Ingalls et al., 1998b).  However, it should be noted that 
K+ -induced contracture could simply “skip-over” a non-excitable component of the T tubule 
membrane by diffusing past this disrupted component. Under this circumstance, only voltage-
induced force production would be impeded.  
A decreased K+ contracture force (Ingalls et al., 1998b) accompanied with an unaltered 
EMG RMS and membrane potential (Warren et al., 2000; Warren et al., 1993c) suggests that 
action potentials may be delivered throughout the fiber and that E-C uncoupling is due to a 
disturbance at the site of the voltage sensor or below.  However, it is also possible that the T 
tubule membrane may be damaged or may become sheered-off between myofibrils during 
eccentric contractions resulting in failure to deliver the action potential to a portion of the fiber 
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(Proske & Morgan, 2001).  To address this possibility, lipophilic fluorescent markers were used 
to observe the structural integrity of the plasmalemma and T tubule network in soleus muscle 
following the performance of 20 eccentric or 20 isometric contractions in vitro (Warren et al., 
1995).  In unexercised muscle, the staining pattern was reflective of T tubules crossing 
transversely across the muscle fiber at regular intervals, which corresponded with the presumed 
distance between each A-I band interface of serial sarcomeres.  However, immediately after 
performing either eccentric or isometric contractions, there does appear to be a loss of membrane 
integrity, as the staining pattern became longitudinally oriented in 20 – 80% of the fibers 
observed in each muscle, suggesting that the fluorescent label that was confined to the T tubule 
is now binding to SR membrane (Warren et al., 1995).  Therefore, it does appear that T tubule 
disruption results from contractile activity, although this disruption may be transient and not 
specific to eccentric contractions.  
Specific to performing eccentric contractions, the same study reported regions of fibers 
(10 – 20% of fibers in the muscle) that appeared swollen with an isolated increased intracellular 
[Ca++] (Warren et al., 1995).  Interestingly, there was an absence of fluorescent membrane 
markers next to the swollen regions of the fiber, indicating that the T tubule membrane system 
had circumvented the damaged area of the fiber (Warren et al., 1995).  These findings are 
fascinating because they suggest that the membrane network may become re-organized to isolate 
the damaged area of a fiber.   
A separate study has also documented distinct disruptions of the T tubules following the 
performance of eccentric contractions (Yeung et al., 2002).  In this study, the T tubular system in 
single muscle fibers was visualized following the performance of eccentric contractions with a 
length change of either a 40% or 25% of Lo.  The most prominent physical change following the 
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40% Lo eccentric contractions was the appearance of vacuoles associated with the T tubule 
membrane.  However, these vacuoles were not present following eccentric contractions with only 
a 25% change in Lo, even though peak tetanic isometric force was reduced by 65% (Yeung et al., 
2002).  Thus, it does not appear the vacuolization of T tubules per se is instigating force deficits.  
Additionally, experiments were performed with the dye already loaded in the T tubules of the 
fiber prior to performing eccentric contraction. If the dye remained in the fibers then this would 
provide evidence for a “sealing” off of T tubules following the performance of eccentric 
contractions.  The results, however, indicated that all of the dye eventually diffused out of the 
visualized portion of the T tubule system (Yeung et al., 2002).  Therefore it does not appear that 
the T tubules become “sealed off” after eccentric contractions (Warren et al., 1999a; Warren et 
al., 1995; Yeung et al., 2002).  
DHPR and RYR1 Content and Function 
E-C coupling failure could result from a reduced function or reduced presence of DHPRs 
or RYR1s following injury.  Measurement of SR Ca++ release and re-uptake rates with a Ca++ 
sensitive minielectrode indicated that release (6%) and re-uptake (12%) are reduced immediately 
after injury induction (Ingalls et al., 1998b).  Three days after injury induction the reductions in 
SR Ca++ release (20%) and re-uptake (17%) rates worsen.  While the reduced rate of SR Ca++ 
release could contribute to immediate force deficits, the small reduction observed immediately 
after injury (at most 6%) cannot account for the ~50% reduction in peak isometric force 
observed in this study (Ingalls et al., 1998b).  Additionally, a separate study indicated that the 
binding sensitivity and amount of DHPR and RYR1 immediately after injury induction does not 
appear to be adversely affected (Ingalls et al., 2004a).  At this time, RYR1 content is not altered 
while DHPR content actually increases 20%.  Three days after injury induction, RYR1 content 
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does decrease (16%) and DHPR content remains increased by 20% (Ingalls et al., 2004a).  
Therefore, it does not appear that a loss of DHPR or RYR1 or a reduced functional capacity of 
RYR1 leads to eccentric-contraction induced E-C coupling failure immediately after injury, but 
does not rule out a reduced functional expression of DHPRs, as the location of DHPRs in the 
muscle was not determined.   
DHPR and RYR1 Communication 
Physical coupling between DHPR and RYR1 is paramount for skeletal muscle E-C 
coupling (see the beginning of this review).  However, the reductions in voltage-gated SR Ca++ 
transients accompanied by relatively un-changed caffeine-induced Ca++ transients observed in 
injured muscle suggests that DHPR-RYR1 coupling has failed (Balnave & Allen, 1995; Ingalls 
et al., 1998b).  Following the performance of eccentric contraction-biased exercise, Takekura et 
al. (2001) reported that the organization of the T tubule membrane system was structurally 
disrupted in rat forelimb triceps brachii muscle. Electron micrographs of the injured tissue 
demonstrated the appearance of longitudinal T tubular segments unaccompanied by SR terminal 
cisternae, disoriented tetrad structure (i.e., T tubule no longer perpendicular to sarcomere at A-I 
band), and irregular pentad and heptad structures.  These robust perturbations were observed 
throughout the injured muscle (i.e., the disruptions were not focal), but were not observed in 
muscle from mice that only performed level treadmill running (Takekura et al., 2001). These 
findings indicate that the high mechanical stress and strain placed on muscle fibers during 
eccentric contractions can alter the architecture of E-C coupling membranes and thus the spatial 
arrangement between DHPR and RYR1.  Additionally, dissociation of T tubule and SR 
membranes suggests that eccentric contractions directly damage the proteins that maintain the 
triad structure.   
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Junctophilins Involvement in Force Production and E-C Coupling 
 Strength deficits due to E-C coupling failure are potentially the functional effect of 
damage to triadic proteins that appear to span the gap between the T tubule and SR membranes.  
As mentioned previously, JP1 and JP2 are involved in the development and maintenance of 
triads and diads respectively in skeletal muscle (Hirata et al., 2006; Ito et al., 2001; Komazaki et 
al., 2002).  The lack of triad formation in JP1 deficient mice profoundly affected hind-limb 
neonatal skeletal muscle function and Ca++ homeostasis (Ito et al., 2001).  Neonate vastus 
medialis muscle bundles from JP1 deficient mice were weaker at low frequency stimulation 
compared to muscle from WT mice (i.e., twitch force was reduced by 50% for JP1-/- muscle), 
although maximum force was not different between groups.  JP1 deficient neonatal muscle was 
also more sensitive to extracellular [Ca++] than WT muscle.  For example, when [Ca]o was 
increased from 2.5 to 5.0 mM twitch tension increased to a greater extent (~30%) over the 
following 30 minutes for JP1 deficient muscle than WT muscle.  Conversely, when extracellular 
Ca++ is removed, twitch tension measured over the following 20 minutes decreased at a faster 
rate and to a greater extent for JP1 deficient muscle than WT muscle (Ito et al., 2001).  
Collectively, these findings suggest that JP1 deficient muscle has a reduced E-C coupling 
efficiency, an increased dependence on Ca++ induced Ca++ release, and a reduced capacity to 
restore SR Ca++ content. 
Evidence that junctophilins are involved in maintaining normal E-C coupling in adult 
muscle fibers was demonstrated in a study conducted by Hirata and colleagues (2006). Mature 
flexor digitorum brevis (FDB) and extensor digitorum longus (EDL) mouse skeletal muscles (5 -
7 weeks old) were injected with adenovirus containing shRNAs targeted at JP1 and JP2 mRNA.  
Three to five days after injection, JP1 and JP2 protein content was reduced by ~50 and ~60%, 
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respectively.  As a result of this diminished expression of JP1 and JP2, a two-fold increase in 
triad deformation was observed, which was accompanied by an elevated resting cytoplasmic 
[Ca++] and a ~50% reduction in voltage-induced Ca++ release (1 Hz; 0 mM [Ca++]o) in single 
fibers from these muscles.  Additionally, store operated Ca++ entry was depressed in JP1 and JP2 
knock-down muscles (Hirata et al., 2006).  These findings indicate that knock-down of JP1 and 
JP2 expression disrupts triad structure (i.e., DHPR-RYR1 arrangement), cellular Ca++ regulation, 
and E-C coupling in adult skeletal muscle fibers.  
The relationship between junctophilin expression and E-C coupling efficiency has also 
been demonstrated in a cardiac pressure overload-induced hypertrophy model (Xu et al., 2007).  
This model is characterized by a progressive degeneration from compensated (CHT) to 
decompensated hypertrophy (DHT) states, in which left ventricular hypertrophy is accompanied 
by normal or depressed contractile indices, respectively.  Using whole-cell patch clamping 
techniques, Xu et al. (2007) indicate that CHT E-C coupling gain is not altered while DHT e-c 
coupling gain is reduced by ~50%.  However, by employing loose-patch clamp techniques with 
confocal imaging, which allows for the simultaneous measurement of L-type Ca++ channel 
transients (LCC) (sparklet) and subsequent whole-cell [Ca++] changes via RYR2 Ca++ release 
(sparks) (i.e., Ca++ induced Ca++ release; CICR), it was found that the probability of LCC 
sparklets inducing an SR spark progressively decreased from ~67 % in control fibers to ~46% 
and ~36% in CHT and DHT fibers, respectively (Xu et al., 2007). These findings indicate that 
CICR is disrupted in both hypertrophy conditions.   
In an effort to determine the underlying mechanism resulting in decreased CICR 
efficiency in the CHT condition, SR Ca++ content, T tubule structure, and JP2 expression were 
analyzed (Xu et al., 2007).  SR Ca++ content, as determined by caffeine induced calcium release 
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was not different between control, CHT, and DHT groups.  T tubule structure was not degraded 
in this early stage of cardiac hypertrophy, as has been observed in later stages of heart failure.  
However, JP2 expression normalized to GAPDH was decreased in CHT fibers by ~50% 
compared to control fibers.  Based on these findings, the authors suggest that reduced JP2 
expression prompts a subtle physical alteration of the E-C coupling membranes that reduces 
CICR efficiency (Xu et al., 2007).     
JP1 may also augment RYR1 Ca++ release via redox sensitive association with RYR1 
(Phimister et al., 2007).  RYR1 has numerous reactive cysteine residues that render the channel 
sensitive to cellular redox regulation.  Phimister et al. (2007) indicated that thiol sensitivity was 
reduced when junctional SR complexes were incubated in a solution promoting an RYR1 open 
state (100 µM Ca++, 10mM caffeine, and 5mM ATP) compared to a solution promoting a closed 
state (10 mM Mg++).  However, when oxidants (e.g., nitric oxide & hydrogen peroxide) were 
added to the closed state incubation medium thiol reactivity was reduced, like when the open 
state medium was applied.  JP1 was identified as one of the proteins with reactive thiols in the 
junctional SR complex along with RYR1.  It was determined using SDS-PAGE, in-gel tryptic 
digestion, high pressure liquid chromatography, and peptide sequencing using mass spectrometry 
that JP1 possesses three highly reactive cysteine residues (101, 402, 627) and a CXXC motif, 
which are known to form inter- and intra-molecular disulfide bonds with other reactive cysteine 
residues (Phimister et al., 2007).  RYR1 has five CXXC motifs suggesting that JP1 and RYR1 
may bind to one another under oxidizing cellular conditions.  To determine if RYR1 and JP1 are 
physically associated, RYR1 was immunoprecipitated in junctional SR complexes under open 
state, closed state, and oxidized conditions.  Immunoblots revealed that JP1, but not JP2, co-
precipitated with RYR1 under all conditions.  However, more JP1 was bound to the same 
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amount of RYR1 under open-state and/or oxidized conditions, as opposed to closed state 
conditions (Phimister et al., 2007).  These findings suggest, but do not conclusively indicate, that 
cellular redox conditions coordinate physical binding of JP1 to RYR1 and that this association 
augments RYR1 function. 
Junctophilin binding to the plasmalemma may be sensitive to mechanical or chemical 
stress.  JP1 and JP2 contain eight MORN motifs, each comprised of 14 amino acids, near the N-
terminus of the protein.  MORN motifs have been recognized in only a few proteins that are 
expressed across a broad range of organisms (Im et al., 2007; Takeshima et al., 2000).  For 
example, the plant Arabidopsis expresses phosphatidylinositol-4-phosphate (PIP) 5-kinase, 
which possesses seven MORN motifs, each comprised of 24 amino acids (Im et al., 2007).  In 
both JP and PIP 5-kinase, MORN motifs result in binding of the protein to the plasmalemma (Im 
et al., 2007; Takeshima et al., 2000).  Interestingly, when plant cells experience hyperosmotic 
stress, PIP 5-kinase exhibits a ~30% reduction in plasmalemmal binding and a similar increase in 
endomembrane binding (e.g., endoplasmic retiuculum) (Im et al., 2007).  Although speculative, 
these findings suggest that JP binding to the plasmalemma is designed to be plastic, in which the 
stress-sensitive MORN motifs shift from binding the plasmallema to the SR when the cell 
membrane is stressed.    
Working Hypothesis of E-C Coupling Failure After Eccentric Contractions 
 Eccentric contractions result in immediate force deficits that are predominantly due to E-
C uncoupling.  E-C uncoupling appears to be due to a disturbance of the communication between 
DHPR and RYR1.  A direct physical coupling between the DHPR and RYR1 is required for 
voltage-induced Ca++ release, raising the possibility that E-C uncoupling is simply due to a loss 
of the physical contact between these channels.  JP1 and JP2 play a role in maintaining voltage-
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induced SR Ca++ release in skeletal muscle.  The existing literature suggest a plausible 
explanation of early strength deficits after the performance of eccentric contractions is that 
eccentric contractions damage triadic proteins that are associated with both the T tubule and SR 
membranes.  Damage to these proteins would presumably result in T tubule and SR membrane 
dissociation, disruption of DHPR-RYR1 communication, and thus, E-C coupling failure and 
strength deficits. 
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CHAPTER 2 
JUNCTOPHILIN DAMAGE CONTRIBUTES TO EARLY STRENGTH DEFICITS AND EC 
COUPLING FAILURE AFTER ECCENTRIC CONTRACTIONS 
 
Abstract 
 Junctophilins (JP1 & JP2) are expressed in skeletal muscle and are the primary proteins 
involved in transverse (T)-tubule and sarcoplasmic reticulum (SR) membrane apposition.  
During the performance of eccentric contractions, the apposition of T-tubule and SR membranes 
may be disrupted, resulting in excitation-contraction (EC) coupling failure and thus reduced 
force-producing capacity.  In this study, we made three primary observations: 1) Through the 
first three days after the performance of 50 eccentric contractions in vivo by the left hindlimb 
anterior crural muscles of female mice, both JP1 and JP2 were significantly reduced by ~50 and 
35%, respectively, while no reductions were observed after the performance of non-fatiguing 
concentric contractions; 2) following the performance of a repeated bout 50 eccentric 
contractions in vivo, only JP1 was immediately reduced (~30%) but recovered by 3d post-injury 
in tandem with the recovery of strength and EC coupling; and 3) following the performance of 
10 eccentric contractions at either 15 or 35˚C by isolated mouse EDL muscle,  isometric force, 
EC coupling, and JP1 and JP2 were only reduced after the 35˚C eccentric contractions.  
Regression analysis of JP1 and JP2 content in TA and EDL muscles from each set of 
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experiments indicated that JP damage is significantly associated with early (0 – 3d) strength 
deficits after performing eccentric contractions (R = 0.49; P < 0.001).  As a whole, the results of 
this study indicate that JP damage plays in role in early force deficits due to EC coupling failure 
following the performance of eccentric contractions.       
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Introduction  
Force producing capacity of skeletal muscle is reduced both immediately and for a 
prolonged period of time after performing lengthening or eccentric contractions (9, 15, 25, 29). It 
is generally accepted that prolonged force deficits (5 days to 4 weeks) are primarily due to a loss 
of force-generating and force-transmitting proteins mediated by a well-characterized 
inflammatory response (15, 26, 32, 42). On the other hand, early force deficits (0 to 5 days) 
induced by a mouse anterior crural muscle in vivo injury model are primarily due to an inability 
to electrically stimulate sarcoplasmic reticulum (SR) Ca2+ release (i.e., excitation-contraction 
coupling failure), although damage to force-generating or force-transmitting proteins can also 
play a role in these early strength deficits (16, 25). To date, it is not completely understood how 
excitation-contraction (EC) coupling is impeded in injured skeletal muscle.   
  In skeletal muscle, excitation-contraction coupling involves the propagation of a muscle 
action potential along the plasmalemma and transverse (T)-tubule membranes to sites, called 
triads, where the T-tubule is met on each side by the terminal cisternae of two adjacent SR.  At 
the triad, L-type Ca2+ channels (dihydropyridine receptors or Cav1.1) located in the T-tubule 
membrane physically couple with approximately every other SR Ca2+ release channel (ryanodine 
receptor, RyR1)(4, 6, 11). T-tubule membrane potential depolarization results in a 
conformational change in Cav1.1 that physically opens RyR1 and promotes release of Ca2+ from 
the SR (4, 11), which then incites force production. 
Immediately after the performance of eccentric contractions, the primary components of 
the EC coupling process are still present and appear functional when tested in isolation. 
Specifically, immediately after performing short-duration (i.e., ≤ 200 ms) eccentric contractions 
the ability of the T-tubule to propagate an action potential does not appear to be impeded (16, 43, 
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44), Cav1.1 and RyR1 protein content are not diminished (17), and SR Ca2+ release and re-
uptake rates are at most only modestly reduced (16).  However, it does appear that the cellular 
organization of the T-tubule network is disrupted after the performance of eccentric contractions 
(35, 43).  Thus, the EC coupling failure observed after eccentric contractions may result from a 
disruption in the communication between Cav1.1 and RyR1. 
Although the physical coupling of Cav1.1 and RyR1 is essential for voltage-induced Ca2+ 
release (VICR), the expression of these ion channels in cell culture is not sufficient for channel 
co-localization or VICR, despite both channels exhibiting signs of independent functionality 
(e.g., Ca2+ induced Ca2+ release was observed) (34, 36).  Therefore, expression of accessory 
triadic proteins in skeletal muscle is crucial for VICR.  There are a number of triadic proteins 
that have been identified (45), however, in skeletal muscle two junctophilin isoforms, JP1 and 
JP2, are thought to be the primary proteins involved in embryonic development and post-natal 
apposition of T-tubule – SR membranes (19, 21, 37).  Junctophilins possess a SR transmembrane 
domain at the C-terminus and a membrane occupation and recognition nexus (MORN) motif at 
the N-terminus that binds to the plasmalemma or T-tubule membrane (37).  These characteristics 
allow JP1 and JP2 to tether the T-tubule membrane to the SR membrane, allowing direct 
interaction between Cav1.1 and RyR1. 
  Previous studies have indicated that reductions in junctophilin protein expression carry 
structural and functional consequences. For example, reduced expression of JP1 and JP2 in adult 
skeletal muscle results in loss of triad formation, reduced VICR, and diminished store-operated 
Ca2+ entry (13).  Moreover, ablation of JP1, which is lethal, impedes SR – T-tubule membrane 
junction development and reduces force-producing capacity of neonatal skeletal muscle (19, 21). 
Similarly, in cardiomyocytes, reductions in junctophilin protein expression have been associated 
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with a failure to release Ca2+ from the SR in response to external stimuli and, therefore, to play a 
role in hypertrophic cardiomyopathy (28, 30, 46).  
Based on the cellular location of junctophilins in skeletal muscle and the functional 
implications of junctophilin loss, we hypothesized that eccentric contractions would damage 
junctophilins, and that damage of junctophilins contributes to EC coupling failure and early 
strength deficits after injury.  Therefore, our first objective was to characterize JP1 and JP2 
content in mouse anterior crural muscles after the performance of a single bout of either 
eccentric or concentric contractions in vivo. Upon finding immediate reductions in JP1 and JP2 
with only eccentric contractions, our next objective was to determine the content of JP1 and JP2 
in mouse anterior crural muscle under conditions known to alter the magnitude and/or timing of 
E-C uncoupling and strength deficits.  
Methods 
Animals  
Female CD1 mice 2 to 5 months old were used in this study.  The mice were housed in 
groups of 10 animals per cage, supplied with food and water ad libitum, and maintained in a 
room at 20-22°C with a 12-h photoperiod.  Mice were euthanized with an overdose of sodium 
pentobarbital (200 mg⋅kg-1) followed by cervical dislocation.  All animal care and use procedures 
were approved by the institutional animal care and use committee and met the guidelines set by 
the American Physiological Society. 
Experimental Design 
Three studies were conducted to determine if junctophilins are damaged by eccentric 
exercise and to determine if junctophilin damage is associated with early strength deficits and EC 
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coupling failure.  In study one, mice performed a single bout of 50 concentric or eccentric 
contractions with the left anterior crural muscles (TA & EDL muscles).  Isometric torque 
produced by this muscle group as a function of stimulation frequency (20-400 Hz) was measured 
in anesthetized mice before and immediately after the concentric or eccentric contraction bout. 
The recovery of anterior crural muscle strength was also evaluated in vivo by measuring 
isometric torque as a function of stimulation frequency (20-400 Hz) in different groups of mice 1 
day after the concentric contractions and 1 and 3 days after performing eccentric contractions.  
For each respective group of mice, junctophilin protein content was assessed via Western 
blot and the extent of myocellular damage was assessed in uninjured and injured anterior crural 
muscles at 0, 1, and 3 days post injury. Additionally, isometric force production of isolated 
extensor digitorum longus (EDL) muscle as a function of stimulation frequency (10-300 Hz) and 
caffeine contracture force was assessed in vitro for uninjured muscles and muscles that had 
previously performed concentric (0 or 1d post) or eccentric (0, 1, or 3d post) exercise.  Because 
caffeine elicits SR Ca2+ release by acting directly on RyR1 and therefore by-passes the upstream 
components of EC coupling (22), relative reductions in caffeine induced and electrically 
stimulated force were compared to evaluate EC coupling failure. 
Upon finding that JP1 and JP2 exhibited reductions in protein expression during the first 
three days after eccentric exercise, we sought to perform experiments that would manipulate the 
magnitude and time-course of eccentric contraction-induced strength deficits and EC coupling 
failure.  In study two, mice performed two bouts of 50 eccentric contractions in vivo separated by 
two weeks.  It has been shown previously that the performance of repeated bouts of eccentric 
contractions results in at most a small attenuation in immediate force deficits but a robust 
enhancement in the rate of recovery of early force deficits (8, 9, 18).  Therefore, in this study we 
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hypothesized that JP1 and JP2 protein content would be reduced immediately after performing a 
second bout of eccentric contractions, but would recover at a faster rate in conjunction with 
recovery of force and EC coupling.  In this study, there were three groups of mice that performed 
a single bout of 50 eccentric contractions, with isometric torque-frequency testing occurring 
immediately before and after the contraction bout.  Then, one group of mice performed an 
isometric torque-frequency test 14 days later, while the other two groups performed a second 
bout of 50 eccentric contractions with immediate pre- and post-injury isometric torque frequency 
testing.  At this point, one of the repeated eccentric contraction groups ceased testing (i.e., 0d 
post eccentric bout 2) and the other group performed a follow-up isometric torque frequency test 
three days later.  As in study one, on the final day of testing EDL muscles were isolated and 
underwent an isometric force-frequency and caffeine contracture test. JP1 and JP2 protein in the 
TA muscle was determined by Western blot. 
In study three, the temperature that EDL muscles were injured in vitro was manipulated, 
as it has been shown previously that force deficits and EC coupling failure after performing 
eccentric contractions in vitro are temperature dependent (41).  Specifically, force deficits and 
EC coupling have been observed when eccentric contractions are performed at ~35˚C, while 
significant force deficits and EC coupling failure is not observed when the same intensity 
eccentric contractions were performed at ~15˚C. Thus, we hypothesized that JP1 and JP2 protein 
content would only be reduced after the performance of eccentric contractions at 35˚C, further 
supporting that the loss of junctophilins after performing eccentric contractions is contributing to 
immediate force deficits and EC coupling failure.  In this study, isolated EDL muscles performed 
10 eccentric contractions at either 15 or 35˚C, or 10 isometric contractions at 35˚C.  JP1 and JP2 
protein content was then determined via Western blot. 
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Experimental Methodology 
In vivo muscle strength analysis and injury induction 
Contractile function (i.e., torque-frequency relationship) of the left anterior crural 
muscles was measured in vivo as previously described (8, 16). After mice were anesthetized (0.3 
mg kg-1 fentanyl citrate, 16.7 mg kg-1 droperidol, 5.0 mg kg-1 diazepam), the left hindlimb was 
aseptically prepared. The mouse was then placed on a heated platform and halogen lamps were 
directed at the torso of the mouse in order to maintain core body temperature between 35 to 
37˚C.  The left knee was clamped and the left foot was secured to an aluminum “shoe” that is 
attached to the shaft of an Aurora Scientific 300B servomotor.  Sterilized needles were inserted 
through the skin for stimulation of the left common peroneal nerve. Stimulation voltage and 
needle electrode placement were optimized with 5 to 15 isometric contractions (200 ms train of 
0.1 ms pulses at 300 Hz).  Contractile function of the anterior crural muscles was assessed by 
measuring peak isometric torque as a function of stimulation frequency (20-400 Hz).  The 
anterior crural muscles performed either 50 concentric or eccentric contractions (38° angular 
movement at 2,000° s-1 starting from a 19° plantarflexed or dorsiflexed position, respectively).  
Core body temperature was monitored continuously during all functional testing with a mouse 
rectal thermocouple.  
In vitro analysis of EDL muscle 
EDL muscles were dissected free and studied using an in vitro preparation as previously 
described (8, 16).  EDL muscles were mounted in a chamber containing a Krebs-Ringer 
bicarbonate buffer (pH 7.4) with (in mM) 144 Na+, 126.5 Cl-, 6 K+, 1 Mg2+, 1 SO42-, 1 PO43-, 25 
HCO3-, 1.25 Ca2+, 0.17 leucine, 0.10 isoleucine, 0.20 valine, 10 glucose, and 10 µg ml-1 
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gentamicin sulphate and 0.10 U ml-1 insulin (the buffer was equilibrated with 95% O2-5% CO2 
gas).  The distal tendon was attached by silk suture and cyanoacrylate adhesive to a fixed 
support, and the proximal tendon was attached to the lever arm of a servomotor system (Aurora 
Scientific 300B).  Optimal physiological muscle length (Lo) in the chamber was set with a series 
of twitch contractions (0.2 ms pulse at 150 V).  
In studies one and two, peak isometric force as a function of stimulation frequency (10-
300 Hz) was measured at 37˚C during isometric contractions (200 ms trains of 0.2 ms pulses), 
with 3 min between contractions. Caffeine sensitivity was assessed by measuring changes in 
baseline force during exposure to caffeine (50 mM) and twitch contractions at a rate of 0.2 Hz.  
Force (N) produced by the EDL muscle was normalized to physiological cross-sectional area 
(PCSA) as described previously (27).  
In study three, once Lo had been set to peak twitch force, EDL muscles performed a 
twitch contraction followed 30 seconds later by a second twitch contraction, and then 30 seconds 
later by a tetanic contraction (300 Hz), all at 35˚C.  Three minutes later a second tetanic 
contraction was performed.  The muscle then remained at rest for 5 minutes while the organ bath 
chamber temperature was either changed to 15˚C or maintained at 35˚C.  The muscles then 
performed either 10 isometric or 10 eccentric contractions.  During the eccentric contractions, 
the muscle was shortened to 87.5% and then lengthened to 112.5% of Lo over 133 ms at 1.9 
muscle lengths per second.  Because peak mechanical stress during eccentric contractions has 
been shown to be a primary determinant of loss of force producing capacity (40), the stimulation 
frequency during the 35˚C eccentric contractions was reduced to 160 Hz in order to match peak 
eccentric force at 15˚C (62 Hz).  The isometric control group performed 10 submaximal tetanic 
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contractions at 160 Hz at 35˚C. Caffeine contracture force was assessed for all treatment groups 
as described above for studies one and two.     
Histology 
Muscles intended for histological analysis were embedded in a cryomold with O.C.T. 
compound, frozen in liquid nitrogen chilled by 2-methylbutane, and stored at -80˚C until further 
use.  Cryosections (10 µm) were obtained from the middle of the TA muscle and stained with 
hematoxylin and eosin (H&E) to estimate the extent of muscle damage caused by exercise.  
Myofibers were counted in the muscle cross-sections using BioQuant Nova Prime (V6.90.10) 
software.  Discolored myofibers containing ≥ 3 internal nuclei were classified as active 
degenerating, or injured myofibers. 
 Western Blotting 
Following dissection, muscles intended for Western blot analysis were weighed, frozen in 
liquid nitrogen, and stored at -80˚C until further use.  Muscles were homogenized in a buffer of 
the following constituents (in mM): 0.1 sucrose, 46 KCl, 10 NaEDTA, 10 TrisCl (pH 7.4). Total 
protein content was determined spectrophotometrically using the Bradford assay.  A portion of 
the whole muscle homogenate was diluted in SDS reducing buffer.  25 µg of protein from the 
whole muscle homogenate was loaded into a 7% polyacrylamide gel (Acrylamide to Bis-; 
37.5:1) and separated according to molecular weight (100 V for 30 min; 150 V for 45 min).  The 
protein was then transferred to a nitrocellulose membrane (100 V for 60 min).  Following 
transfer, the membrane was blocked overnight at ~4˚C in 5% non-fat dried milk (w/v) in tris-
buffered saline with 0.1% Tween-20 (TBS-T).  The following morning, the membranes were 
then probed with rabbit anti-mouse primary antibodies for 2 hours at room temperature on an 
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orbital shaker.  Junctophilin 1 and 2 (Invitrogen, Catalog #s 40-5100 & 40-5300, respectively) 
primary antibodies were diluted to 1:20,000, while tubulin antibody (Sigma, T 3526) was diluted 
1:2,500 in TBS-T.  Following incubation in primary antibody, membranes were washed with 
TBS-T (3 x 15 minutes) and then probed with horseradish peroxidase conjugated goat anti-rabbit 
IgG secondary antibody (Invitrogen, G21234) diluted in TBS-T (1:25,000) for 1 hour at room 
temperature with shaking.  The membranes were then washed as described above and treated 
with enhanced chemilumescent solution (Thermo Scientific) prior to detection with 
autoradiograpy film.  Optical density of the blot was determined using SigmaGel (Jandel 
Scientific).  JP1 and JP2 optical density was normalized to the tubulin content of each muscle. 
Data Modeling and Statistics 
Torque- and force-frequency relationships were modeled with the following equation: 
  f(x) = min + (max – min) / [1 + (x / EC50)n].  Eqn. 1 
Where x is the stimulation frequency, min and max are the smallest (i.e., twitch) and largest (i.e., 
peak tetanic) respective forces estimated.  EC50 is the stimulation frequency at which half the 
amplitude of force (max – min) is reached and n is the coefficient describing the slope of the 
steep portion of the curve. 
Torque- and force-frequency parameters, anthropometric measurements, histological 
degeneration, and protein content values were analyzed separately using a one-way ANOVA.  
Eccentric and concentric contractions during each type of exercise bout in all three studies, as 
well as pre- and post-exercise protocol force values in study three were analyzed using a group 
by contraction or time split-plot ANOVA.  Post-hoc means comparisons testing was performed 
when a significant ANOVA was observed.  Statistical significance was achieved with p < 0.05.  
All statistical testing was performed with SPSS 12.0.    
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Results 
Study One:  A Single Bout of Concentric or Eccentric Contractions 
In vivo Torque and Injury Induction 
There were no significant differences in pre-exercise anterior crural muscle isometric 
torque values between concentric and eccentric groups (Figure 1 & Table 1).  Peak eccentric 
torque was significantly greater than peak concentric torque and, over the 50 contractions, 
exhibited a significant decline (~40%), while concentric torque was not significantly reduced 
(Figure 2).  Following the performance of concentric contractions, there were no significant 
alterations in isometric torque-frequency parameters compared to pre-exercise values (Figure 1 
& Table 1).  In contrast, throughout the three days following the performance of eccentric 
contractions both peak twitch and tetanic isometric torque values were significantly reduced and 
the stimulation frequency required to elicit half maximal force (EC50) was shifted to higher 
frequencies, compared to pre-injury values (Figure 1 & Table 1).  By three days after eccentric 
exercise all altered isometric torque parameters exhibited a significant but incomplete recovery. 
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Figure 1.  In vivo isometric torque as a function of stimulation frequency.  Measurements were 
made before (Pre), immediately (0d), and one day (1d) after a single bout of concentric (a) or 
eccentric contractions (b), as well as three days (3d) after a single eccentric bout.  Each data set 
was modeled with Equation 1 listed in the methods.  Values are listed as means ± SE. 
 
 
Table 1.  Study one in vivo torque-frequency parameters
Pre 0d 1d Pre 0d 1d 3d
Sample size n = 10 10 4 28 28 9 10
Body Weight (g) 30.8 ± 1.6 - 30.5 ± 0.9 28.6 ± 0.9 - 27.0 ± 1.5 29.3 ± 1.4
Min measured  (N·mm·kg
-1) 21.8 ± 1.0 19.4 ± 0.9 25.5 ± 1.5 22.1 ± 0.7 5.1 ± 0.2* 6.1 ± 0.5* 11.8 ± 1.2*,†,§
Max measured  (N·mm·kg
-1) 111.2 ± 3.1 107.7 ± 2.6 111.5 ± 4.8 111.9 ± 2.5 70.7 ± 1.6* 77.4 ± 3.1*,† 89.2 ± 3.9*,†
Min estimated  (N·mm·kg
-1) 20.9 ± 1.1 19.3 ± 0.9 24.6 ± 1.6 21.2 ± 0.7 5.8 ± 0.2* 5.9 ± 0.6* 11.8 ± 1.2*,†,§
Max estimated  (N·mm·kg
-1) 109.8 ± 3.0 106.0 ± 2.7 110.3 ± 5.0 110.2 ± 2.5 70.8 ± 1.6* 77.0 ± 3.2* 88.2 ± 3.9*,†
EC50 (Hz) 91.2 ± 1.9 97.9 ± 2.3 84.2 ± 3.4 91.0 ± 1.2 130.1 ± 1.4* 116.0 ± 3.0*,† 100.7 ± 3.3*,†,§
n coefficient -4.8 ± 0.2 -5.1 ± 0.2 -4.5 ± 0.2 -4.9 ± 0.2 -5.2 ± 0.1 -4.6 ± 0.2 -5.1 ± 0.1
Concentric Eccentric
Values are listed as mean ± SE.  The minimum (Min) and maximum (Max) torques measured and estimated represent twitch 
and peak tetanic torques, respectively.  EC50 is the stimulation frequency at which half of the rise in amplitude of torque 
occurred.  The Hill coefficient describes the slope of the steep portion of the torque-frequency curves depicted in Figure 1. * 
different than Pre Ecc; † different than Ecc 0d; and § different than Ecc 1d (p < 0.05).
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Figure 2. Peak torque produced during either 50 concentric or eccentric contractions performed 
in vivo.  Values are listed as means ± SE. 
 
In vitro EDL muscle force 
EDL muscle isometric specific force was measured as a function of stimulation frequency 
for mice that had either previously performed in vivo concentric or eccentric exercise or had 
performed no prior exercise (control).  Compared to control values the prior performance of 
concentric exercise did not significantly alter isometric specific force parameters (Figure 3; 
Table 2).  However, within an hour after performing eccentric exercise peak twitch and tetanic 
isometric forces were significantly reduced and EC50 was significantly greater compared to 
control values.  By three days after performing eccentric exercise, isometric peak twitch and 
tetanic specific force exhibited a significant but incomplete recovery, while EDL muscle EC50 
recovered to control values one day after performing eccentric contractions (Figure 3; Table 2). 
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Figure 3. In vitro EDL muscle isometric force as a function of stimulation frequency. Muscles 
were dissected and tested immediately (0d), and one day (1d) after a single bout of concentric 
(a) or eccentric contractions (b), as well as three days (3d) after a single eccentric bout. 
Additionally, measurements were made with EDL muscles that had performed no prior exercise 
(Control).  Each data set was modeled with Equation 1 listed in the methods.  Values are listed 
as means ± SE. 
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EDL muscle caffeine (50mM) contracture force was measured after the force-frequency 
test (Table 2).  Compared to control values, there were no significant reductions of caffeine-
contracture force ~1 to 24 hours after performing concentric contractions.  In contrast, ~1 to 24 
hours after performing eccentric contractions caffeine contracture force was significantly 
reduced but was not statistically different from control values three days after performing 
eccentric contractions.  When comparing the caffeine contracture and peak tetanic force deficits 
to estimate EC coupling failure, ~40, 58, and 45% of the force deficit observed 0, 1, and 3 days 
after the injury bout is explained by EC coupling.  
Histological Indications of TA muscle degeneration 
Despite the reduction in caffeine contracture force immediately and one day after the 
performance of 50 eccentric contractions, the degree of muscle degeneration assessed via H & E 
Table 2.  TA and EDL muscle characteristics and in vitro EDL muscle force parameters
Control
0d 1d 0d 1d 3d 14d 0d 3d
Sample size n = 4 4 4 4 4 4 5 5 5
TA muscle wt (mg) 55.0 ± 1.7 52.8 ± 3.3 59.0 ± 2.6 49.1 ± 3.0 58.2 ± 3.0 57.3 ± 2.7 60.4 ± 3.4 66.1 ± 3.5 65.4 ± 1.9
TA muscle protein (mg) 24.1 ± 1.3 21.0 ± 1.3 21.2 ± 0.7 23.0 ± 1.7 22.8 ± 1.2 21.8 ± 0.6 22.2 ± 1.5 21.4 ± 2.4 22.8 ± 3.8
EDL muscle wt (mg) 9.0 ± 0.6 10.9 ± 0.6 11.4 ± 0.5 11.8 ± 1.6 10.9 ± 1.1 12.3 ± 0.2 10.3 ± 0.2 11.2 ± 0.4 11.2 ± 0.2
Lo (cm) 1.47 ± 0.02 1.52 ± 0.04 1.56 ± 0.02 1.47 ± 0.07 1.44 ± 0.07 1.56 ± 0.01 1.55 ± 0.34 1.55 ± 0.34 1.58 ± 0.02
Minmeas.  (N·cm
-2) 2.8 ± 0.2 2.9 ± 0.1 3.1 ± 0.2 1.2 ± 0.2* 1.3 ± 0.1* 2.0 ± 0.1*,†,§ 2.4 ± 0.1 1.7 ± 0.1*,†,‡ 3.1 ± 0.4!,‡,"
Maxmeas. (N·cm
-2) 22.2 ± 0.5 20.7 ± 0.4 20.8 ± 0.7 12.2 ± 1.5* 11.0 ± 1.3* 15.8 ± 1.0*,† 20.5 ± 0.6 14.0 ± 0.6*,‡ 22.1 ± 0.9!,"
Minestim.  (N·cm
-2) 2.8 ± 0.2 3.0 ± 0.2 3.2 ± 0.2 1.2 ± 0.2* 1.3 ± 0.1* 2.2 ± 0.1†,§ 2.6 ± 0.1 2.0 ± 0.1*,†,‡ 3.3 ± 0.4!,‡,"
Maxestim.  (N·cm
-2) 22.8 ± 0.3 21.3 ± 0.5 21.2 ± 0.6 13.6 ± 1.6* 11.7 ± 1.4* 16.3 ± 1.1* 20.8 ± 0.7 14.9 ± 0.7*,‡ 22.2 ± 0.8!,"
EC50 (Hz) 116.5 ± 5.5 108.8 ± 5.1 109.9 ± 4.1 160.2 ± 6.0* 135.4 ± 5.1† 120.9 ± 5.3† 116.3 ± 2.7 140.1 ± 6.3*,‡ 120.0 ± 5.5"
n coefficient -3.4 ± 0.2 -3.8 ± 0.2 -4.0 ± 0.2 -3.3 ± 0.1 -3.4 ± 0.2 -4.0 ± 0.2* -4.3 ± 0.2* -4.3 ± 0.1*,† -4.5 ± 0.4*
Caffeine (N·cm-2) 7.7 ± 0.1 7.1 ± 0.4 7.5 ± 0.2 5.6 ± 0.2* 6.1 ± 0.3* 6.5 ± 0.3 7.3 ± 0.2 6.5 ± 0.2*,†,‡ 7.9 ± 0.4!,"
Concentric Eccentric Bout 2Eccentric Bout 1
Values are listed as mean ± SE.  TA muscle protein content was determined in whole muscle homogenate. Lo is the muscle length that coincided with peak 
twitch force.  The minimum (Min) and maximum (Max) forces measured and estimated represent twitch and peak tetanic forces, respectively.  EC50 is the 
stimulation frequency at which half of the rise in amplitude of force occurred.  The n  coefficient describes the slope of the steep portion of the force-
frequency curves depicted in Figures 3 & 8.  * different than Control; † different than Bout 1 Ecc 0d; § different than Bout 1 Ecc 1d; ! different than Bout 1 
Ecc 3d; ‚‡ different than Bout 1 Ecc 14d; and " different than Bout 2 Ecc 0d (p < 0.05).
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staining through the first three days after injury induction was not significantly different among 
groups.  The percentage of total fibers counted exhibiting signs of degeneration for unexercised 
control, and 0d, 1d, and 3d post-eccentric groups was 0.2 ± 0.1, 0.5 ± 0.1, 1.0 ± 0.4, and 1.3 ± 
0.3%, respectively.  Approximately 2000 fibers were counted in each TA muscle cross-section.  
The relatively small amount of muscle fiber degeneration observed at three days after performing 
50 eccentric contractions is in contrast to the degree of degeneration (~10% degenerating fibers) 
we have observed previously in wild type TA muscle three days after the performance of 150 
eccentric contractions in vivo (8).  
 
 
Figure 4.  Histological signs of muscle degeneration in TA muscle that had performed no 
exercise (A) or had previously performed 50 eccentric contractions in vivo three days before 
collection (B).   
 
  79
  
 
Junctophilin Protein Content Alterations Following Exercise 
Junctophilin 1 and 2 protein content normalized to tubulin content was not different from 
unexercised control values immediately or one day after performing 50 concentric contractions 
in vivo (Figure 5).  In contrast, immediately, one day, and three days after performing 50 
eccentric contractions JP1 and JP2 protein content was reduced by ~50 and 35% respectively.  
There were no significant differences among groups for tubulin protein content (ANOVA p = 
0.833).  
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Figure 5.  Junctophilin protein content in TA muscle following in vivo concentric and eccentric 
exercise.  Normalized JP1 (b) and JP2 (c) content, and tubulin (d) content were determined via 
Western blot (a) in unexercised muscle (control), in muscles collected immediately and one day 
after the performance of concentric contractions (C-0d & C-1d), in muscles collected 
immediately, one day, three days, and fourteen days after performing a single bout of eccentric 
contractions (E-0d, E-1d, E-3d, & E-14d), and immediately and three days (E2-0d & E2-3d) 
after performing a repeated bout of eccentric contractions. * Values are significantly different 
from control values (p < 0.05).  Values are listed as mean ± SE. 
 
Study Two:  Repeated Bouts of Eccentric Contractions 
In vivo adaptation of force deficits 
In this study, mice performed two bouts of 50 eccentric contractions in vivo separated by 
14 days (Figure 6).  Peak torque during the first eccentric contraction of both bouts were similar, 
although through the course of the 50 eccentric contractions eccentric torque was reduced to a 
greater extent during the first than the second eccentric bout (~ -36 vs. -25%). 
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Figure 6.  In vivo eccentric torque produced during two bouts of eccentric contractions 
separated by 14 days.  * Significantly different between bouts (p < 0.05).  Values are listed as 
means ± SE. 
 
Isometric torque was measured as a function of stimulation frequency immediately before 
and after each eccentric bout, as well as three days after the second eccentric bout (Figure 7; 
Table 3).  In response to the first eccentric bout, isometric torque parameters were immediately 
altered in a similar fashion as reported above for study one (Table 3).  Fourteen days after the 
initial eccentric bout, peak tetanic torque was still reduced by ~10%, while twitch torque and all 
other isometric torque parameters had returned to pre-injury levels.   In comparison to these 
fourteen-day post-injury values, immediately after the second eccentric injury bout all isometric 
torque parameters were altered similarly to that observed after the initial eccentric contraction 
bout (Table 3).  Twitch and peak tetanic isometric torque values measured immediately after the 
first and second eccentric contraction bouts were similar, indicating that immediate strength 
deficits exhibited little adaptation.  Three days after the second injury bout, twitch and peak 
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tetanic isometric torque was recovered to values observed before the initial eccentric contraction 
bout.  This is in stark contrast to twitch and peak tetanic isomeric torque values that were still 
reduced by ~47 and 20%, respectively, three days after a single eccentric contraction bout in 
study one.  
 
Figure 7. In vivo isometric torque, as a function of stimulation frequency, produced before and 
after the performance of two eccentric contraction injury bouts separated by 14 days.  
Measurements were made before (Pre) and immediately (0d) after an initial and a repeated in 
vivo eccentric contraction bout, as well as three days (3d) after the repeated eccentric bout.  
Each data set was modeled with Equation 1 listed in the methods.  Values are listed as means ± 
SE. 
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In vitro force 
Fourteen days after the initial eccentric contraction bout, EDL muscle twitch and peak 
tetanic isometric force and caffeine contracture force was similar to unexercised control values 
(Figure 8; Table 2).  Immediately after the second eccentric contraction bout, twitch and peak 
tetanic isometric force and caffeine contracture force was reduced in comparison to control and 
14 day post-injury values.  The immediate reductions in peak tetanic isometric force was similar 
after the initial and second bout of eccentric contractions (Bout 1 vs. 2; ~ -45 vs. -37%), although 
there was less of a reduction in twitch (Bout 1 vs. 2; ~ -60 vs. -40%) and caffeine contracture 
force after the second than the initial eccentric bout (Table 2).  Approximately 56% of the 
strength deficit is explained by EC uncoupling, as estimated by the comparison of caffeine 
contracture and peak tetanic force deificits.  Three days after the second eccentric contraction 
bout peak twitch and tetanic isometric forces and caffeine contracture force was recovered to 
unexercised control values. 
Table 3.  Study two in vivo torque-frequency parameters
Pre 0d Pre/14d 0d 3d
Sample size n = 15 15 15 10 4
Body Weight (g) 32.0 ± 0.5 - 32.8 ± 0.6 - 31.5 ± 1.2
Min measured  (N·mm·kg
-1) 22.1 ± 1.1 5.5 ± 0.3* 20.6 ± 0.9 6.7 ± 0.6§ 23.4 ± 1.7!
Max measured  (N·mm·kg
-1) 114.4 ± 2.5 74.0 ± 2.1* 103.3 ± 3.2* 81.4 ± 3.1§ 105.7 ± 3.5!
Min estimated  (N·mm·kg
-1) 21.5 ± 1.0 5.9 ± 0.3* 20.0 ± 0.9 7.0 ± 0.5§ 22.9 ± 1.8!
Max estimated  (N·mm·kg
-1) 112.6 ± 2.5 74.1 ± 2.1* 101.6 ± 3.2* 81.1 ± 3.1§ 104.6 ± 3.5!
EC50 (Hz) 91.7 ± 1.8 132.2 ± 1.6* 88.7 ± 1.4 123.8 ± 1.6†,§ 81.7 ± 3.5*,!
n coefficient -5.3 ± 0.2 -5.4 ± 0.1 -5.1 ± 0.2 -5.4 ± 0.1 -4.4 ± 0.1†,!
Eccentric Bout 1 Eccentric Bout 2
Values are listed as mean ± SE.  The minimum (Min) and maximum (Max) torques measured and 
estimated represent twitch and peak tetanic torques, respectively.  EC50 is the stimulation 
frequency at which half of the rise in amplitude of torque occurred.  The n coefficient describes 
the slope of the steep portion of the torque-frequency curves depicted in Figure 7. * different than 
Eccentric Bout 1 Pre; † different than Eccentric Bout 1 0d; § different than Eccentric Bout 2 
Pre/14d; and ! different than Eccentric Bout 2 0d (p < 0.05).
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Figure 8. In vitro EDL muscle isometric force as a function of stimulation frequency in response 
to a repeated bout of eccentric contractions performed in vivo. Muscles were dissected and 
tested 14 days (14d) after the initial injury bout and immediately (0d), and one day (3d) after the 
repeated bout of in vivo eccentric contractions. Additionally, measurements were made with 
EDL muscles that had performed no prior exercise (Control).  Each data set was modeled with 
Equation 1 listed in the methods.  Modeled curves for data immediately (0d) and three days (3d) 
after a single eccentric bout are illustrated for reference. Values are listed as means ± SE. 
 
 
Western blots 
Fourteen days after the initial injury bout, JP1 and JP2 protein contents were recovered to 
control levels (Figure 5).  Immediately after the second bout of 50 eccentric contractions, JP1, 
but not JP2, protein content was reduced compared to control values.  Three days after the 
second injury bout, JP1 protein content was recovered to control levels. 
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Study Three:  Temperature Dependence of Muscle Injury 
In vitro Force 
There were no significant differences among isometric or eccentric (15˚C and 35˚C) 
groups for average EDL muscle wet weight (10.6 ± 0.2, 10.5 ± 0.2, & 11.1 ± 0.3 mg, 
respectively), EDL muscle protein content (3.6 ± 0.2, 3.6 ± 0.1, & 3.6 ± 0.1 mg, respectively)  
and Lo (1.53 ± 0.02, 1.52 ± 0.01, & 1.55 ± 0.02 cm, respectively).  As such, initial twitch and 
peak tetanic specific forces were similar among groups (Figure 9).  Peak eccentric force 
produced during the 1st eccentric contraction was similar between 15 and 35˚C groups (Figure 
10).  From the 1st to 10th eccentric contraction there was a similar significant decrease in 
eccentric force at 15 and 35˚C.  In contrast, submaximal isometric force was not significantly 
reduced from the beginning to the end of the isometric contraction protocol (Figure 10).  
Following the 10 isometric or eccentric contractions, twitch and peak tetanic forces produced at 
35˚C were similar between the 35˚C isometric and 15˚C eccentric group and, in comparison, 
were significantly reduced for the 35˚C eccentric group (Figure 9).  Despite the 35˚C eccentric 
contraction group exhibiting significant reductions in electrically stimulated force values, 
caffeine contracture force was similar among 35˚C isometric, 15˚C eccentric, and 35˚C eccentric 
groups (6.3 ± 0.1, 6.1 ± 0.1, and 6.1 ± 0.1 N·cm-2, respectively).  
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Figure 9.  In vitro isometric specific twitch and maximal tetanic force before and after 10 
isometric or eccentric contractions performed at 35 or 15˚C.  Values (mean ± SE) with different 
letters are significantly different (p < 0.05).   
 
 
 
Figure 10.  In vitro specific isometric or eccentric force produced during a 10-contraction injury 
(eccentric; Ecc) or control (isometric; Iso) protocol at 35 or 15˚C.  Values are listed as mean ± 
SE. 
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Junctophilin Protein Content 
The performance of 10 isometric contractions at 35˚C or eccentric contractions at 15˚C 
did not result in a significant reduction in JP1 and JP2 protein content in comparison to 
unexercised control values (Figure 11).  However, within 15 minutes after performing eccentric 
contractions at 35˚C, both JP1 and JP2 protein content was reduced by ~25% in comparison to 
unexercised control, 35˚C isometric, and 15˚C eccentric group values.  
 
Figure 11.  Temperature dependence of EDL muscle JP1 and JP2 protein loss after performing 
eccentric contractions in vitro.  Normalized JP1 (b) and JP2 (c) content, and tubulin (d) content 
were determined via Western blot (a) in unexercised EDL muscle (C or control), in muscles that 
performed 10 isometric contractions at 35˚C (I-35) or 10 eccentric contractions at 15 or 35˚C 
(E-15 or E-35, respectively).  * Values (mean ± SE) are significantly different from control 
values (p < 0.05). 
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Regression Analysis of JP Content and Force Deficits 
JP content of all TA muscles from studies one and two and EDL muscles from study 
three that had a corresponding pre- and post-exercise functional measurement were included in a 
single regression analysis (Figure 12). Based on this analysis JP damage and force-producing 
capacity are significantly associated (Figure 12).   
 
Figure 12.  Regression analysis of skeletal muscle JP1 and JP2 protein content to force 
producing capacity.  All muscles in study one, two, and three that performed pre- and post-
treatment force measurements were included in this analysis (f(x) = 0.11x + 0.66; R = 0.486; 
SEE = 0.11; p < 0.001). 
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Discussion 
Skeletal muscle can be injured when the contractile stress and/or strain exceeds what the 
muscle normally accommodates.  As seen in this study and numerous others, the functional 
consequence of this injury is immediate and prolonged impairment in force producing capacity 
(Figs. 1-3). Force producing and transmitting structures are known to fail with eccentric 
contractions and certainly contribute to the strength deficits (5, 24, 48).  However, with our 
mouse injury model, we have documented that the majority of strength deficits stem from failure 
with EC coupling, specifically with the interaction between Cav1.1 and RyR1 (16).  The primary 
findings of this study are that JP1 and JP2, proteins thought to localize triadic membranes, are 
damaged after a small number of eccentric contractions, and that the loss of JP1 and JP2 is 
associated with EC uncoupling and strength deficits.   
The magnitude and time course of JP1 and JP2 damage following injury were 
comparable with force deficits and EC coupling failure. In this study, through the first three days 
after a single bout of eccentric contractions, peak tetanic force was reduced by ~30 to 45% and 
JP1 and JP2 content was reduced by a similar 33 to 55%.  Additionally, in two separate studies 
that also observed an ~45% isometric tetanic force loss after eccentric contractions, electrically 
stimulated SR Ca2+ release was shown to be reduced by 25 to 40% immediately and 3 days after 
the injury (3, 16).  Thus, during the first three days after injury induction, a 40 to 50% loss of JPs 
appears to result in a slightly lower relative disruption to EC coupling, which is in agreement 
with the ~50% reduction in electrically stimulated Ca2+ release reported after JP1 and JP2 have 
been knocked-down via shRNA in adult skeletal muscle to ~60% of control values (13).   
Furthermore JP1 and JP2 damage during the in vitro injury protocol used in this study induced a 
much smaller force deficit than observed after in vivo injury (i.e., only a ~15% force deficit), but 
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in concert with this smaller deficit only ~25% of JP1 and JP2 were damaged.  Although, JPs 
exhibit a close circumstantial association with eccentric contraction-induced force deficits and 
EC coupling failure, regression analysis of JP content and force producing capacity indicated a 
significant but modest relationship (Figure 12).  
The obvious means by which JP1 and JP2 damage can reduce EC coupling is through 
dissociation of Cav1.1 and RyR1.  However, JP1 and JP2 damage after eccentric contractions 
may contribute to disruptions in electrically stimulated Ca2+ release and force deficits by 
disrupting store-operated Ca2+ entry (SOCE).  It has been shown previously that knockdown of 
JP1 and JP2 to 60% of control values disrupts SOCE and therefore drastically reduced caffeine-
induced Ca2+release by ~60% (13).  Comparably, caffeine-induced Ca2+ release is reduced 
immediately after injury in single muscle fibers by ~50%, which manifested a ~40% decrease in 
caffeine contracture force (3). In the current study, at nearly all time points that JPs were 
damaged following in vivo injury there was a concomitant reduction in caffeine contracture 
force.  Because there were no significant signs of muscle degeneration after in vivo injury 
induction (Figure 4), caffeine contracture force deficits may result primarily from reductions in 
SR Ca2+ stores, which may have been due to disturbances in SOCE with JP damage.  
It is remarkable that JP1 does not exhibit protection from damage immediately after a 
repeated bout of eccentric contractions, while JP2 appears to be fully protected from damage 
after a second bout of eccentric contractions.  We are not aware of another protein that has been 
implicated in contributing to early force deficits that does not exhibit significant protection from 
damage immediately after repeated bouts of eccentric contractions.  For example, it is has been 
shown that the cytoskeletal and structural proteins desmin, dystrophin, and titin all exhibit an 
immediate protective repeated bout effect (24).  Immediate force deficits can be only minimally 
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attenuated following repeated bouts of eccentric contractions in humans (7, 31) and in animals 
(8, 9, 18) because EC coupling failure, in line with serving as a protective mechanism, is not 
significantly attenuated after injury (18).  That JP1 content is reduced after a second injury bout, 
but then recovers at an enhanced rate, is telling in its role in EC coupling failure and strength 
deficits after injury. 
 Although we did not investigate potential causes of the loss of JP1 and JP2 in the current 
study, it is reasonable to assume that the proteins are either enzymatically cleaved or that 
chemical bonds that normally anchor JPs to the T-tubule are mechanically disrupted.  Following 
both in vivo and in vitro eccentric contraction-induced muscle injury, intracellular Ca2+ 
concentration increases (3, 16, 27, 33, 41, 47), presumably as a result of activation of stretch-
activated channels (33, 47). It has been demonstrated in mechanically skinned and in intact 
muscle fibers, that elevated intracellular Ca2+ can disrupt depolarization-induced Ca2+ release 
and may result in triad deformation (23, 47).  Recently, pharmacological calpain inhibition has 
been shown to attenuate EC coupling failure in mechanically skinned muscle fibers with elevated 
cytosolic [Ca2+] (38, 39) and to attenuate force deficits after injury in isolated EDL muscle (48).  
Given these results, it is possible that JP1 and/or JP2 are cleaved by calpains during the injury 
response. 
Triad deformation has also been observed following the performance of eccentric 
contractions, raising the possibility that JP damage is a mechanically induced event (35).  JPs 
possess MORN motifs on their N-terminus that non-covalently bind to the T-tubule membrane 
(12), and it has been shown in plant cells that MORN motif binding to the plasmalemma is 
disturbed by hyperosmotic stress (14).  In the current study, JP1 and JP2 were damaged only 
when eccentric contractions were performed at physiological temperatures.  We have shown that 
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the temperature dependency of force loss is not entirely explained by enzymatic processes, but 
may be related to a more readily compromised plasmalemma during eccentric contractions at 
physiological temperatures (41). Based on these observations, and because membranes are 
known to undergo a phase transition as temperature increases from 20 to 40˚C (20), it is 
interesting to speculate that the binding of the MORN motif to the plasmalemma is mechanically 
disrupted during eccentric contractions. 
Given the complexity of Ca2+ handling in skeletal muscle fibers, it is likely that other 
triadic proteins may also be damaged during eccentric contractions and may therefore contribute 
to EC coupling failure and strength deficits in injured muscle (45).  For example, JP-45 locates to 
the triad, binds to Cav1.1 in the T-tubule membrane and calsequestrin in the SR, appears to play 
a role in targeting Cav1.1 to the triad, and is required for normal EC coupling  (1, 2, 10).  
Interestingly, Cav1.1 muscle content is increased by ~20% immediately after injury (17), which 
may be in response to improper cellular location due to JP-45 damage.  Future study should be 
directed at assessing the contribution of other triadic proteins, especially those that cross the T-
tubule membrane gap like JP-45, to EC coupling failure in injured skeletal muscle.  
In the current series of studies, we have demonstrated that junctophilins are damaged by 
the performance of maximal and submaximal eccentric contractions, but not non-fatiguing 
concentric or isometric contractions, at physiological temperatures.  Additionally, we have 
provided circumstantial evidence indicating that JP1 and potentially JP2 damage is involved in 
early strength deficits and EC coupling failure.  This was shown by first demonstrating that JP1 
is damaged to a similar degree following an initial and repeated bout of eccentric contractions, 
and then by demonstrating that JP damage, force reductions, and EC coupling failure are 
similarly temperature dependent.  Lastly, a combined regression analysis for all three studies of 
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JP1 and JP2 content to muscle force producing capacity indicated that reductions in force 
producing capacity after injury are significantly associated with JP content (Figure 12).  While 
we have not determined the role of other triadic proteins such as JP-45 (10, 45), the results of the 
current study indicate that JP damage plays a role in early force deficits due to EC coupling 
failure following the performance of eccentric contractions.   
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ANIMAL USE PROTOCOL  
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Institutional Animal Care and Use Committee 
Georgia State University 
 
RESEARCH PROTOCOL FOR ANIMAL CARE AND USE 
    
For Office Use Only 
Date Received:   
Biosafety Approval Needed:   Yes    No  Approval Date___________ Approval Number________ 
Radiation Safety Approval Needed:   Yes    No  Approval Date___________ Approval Number________ 
 
 
 
DATE: 12-22-2008 
PRINICPAL INVESTIGATOR: Christopher P. Ingalls, PhD      
DEPARTMENT:  Kinesiology and Health         
E-MAIL: cingalls@gsu.edu 
PROTOCOL TITLE: The role of triadic proteins in strength deficits in injured skeletal muscle 
 
Over a period of three (3) years I would like to use a total of   354  (number) animals. 
common name  Mouse     
scientific name  Mus Musculus  
 
All mice used under this protocol will be:  Female outbred CD1 (CF1, Swiss Webster Mice, CFW) 
mice aged two to six months or ~20 to 35 g body weight. 
       
*(PLEASE COMPLETE A SEPARATE PROTOCOL FOR EACH DIFFERENT TYPE OF ANIMAL.)* 
I would like to begin using these animals on   February 1, 2009 (date). 
I will obtain animals from Charles River (name of supplier).   
I will breed these animals:  yes X  no. (If yes, justify in question 7 below). If yes, from where 
will breeding stock be obtained        (name of supplier). 
List grants, if any, under which the procedures listed in this protocol will be used. 
 
-- 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
Protocol 
Number: 
 
 
Approval Date ______________________________ 
 
 
Signature of Attending Veterinarian _____________________ 
 
 
Signature of IACUC Chair _____________________ 
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Veterinary Care and Consultation: Principal Investigators must obtain consultation from the Attending 
Veterinarian before submission of the application to the IACUC.   
 
X   I consulted with the Attending Veterinarian about this protocol.   
Highest Pain Category within this protocol:  D   
Date of consultation:  1-2-2009 
 
 
Certification of Compliance:  I will comply with the procedures described in the NIH Guide for the 
Care and Use of Laboratory Animals, with PHS policy, the Animal Welfare Act, and applicable GSU 
IACUC policies. I acknowledge responsibility for the procedures described with and assure that 
the faculty, staff and students who perform these procedures are qualified (or will be adequately 
trained) to conduct them in a humane manner.  Failure to comply may result in sanctions by the 
IACUC including, but not limited to suspension of research activities. 
 
Signature of the Principal Investigator ______________________    Date 1-7-2009 
 
1. Briefly state the objective and rationale for each of your major projects (e.g. grants) in lay language 
(i.e., minimal scientific terms, define all acronyms) 
 
Begin with a broad statement concerning the overall problem (e.g., “Pancreatic cancer kills 
~50,000 Americans each year. We are addressing this problem by ….”). Include a statement 
about the long term benefit(s) of this research.  
  
Disruptions in the process that lead to calcium release inside skeletal muscle cells are 
known to be associated with human disease (e.g., malignant hyperthermia, central core disease), 
fatigue, and injury. Normally, force production in skeletal muscle is initiated when electrical 
signals from the nervous system are delivered to muscle cells.  This electrical signal is then 
conducted into the interior of the muscle cell by a specialized membrane system called the 
transverse-tubular (T-tubule) system. The excitation signal from the T-tubule is then transferred 
to nearby structures that store calcium inside the muscle cell called the sarcoplasmic reticulum 
(SR). In skeletal muscle cells, two SR oppose the T-tubule creating an anatomical structure called 
the triad. The release of this stored calcium inside the muscle cell will then trigger certain 
proteins to interact resulting in force generation.  In general, the amount of force produced by 
skeletal muscle cells depends on the amount of calcium released by the SR.   
Skeletal muscle injury is a common occurrence when an individual performs exercise 
that is unaccustomed in intensity and/or duration.  Injury to skeletal muscle during 
unaccustomed exercise (i.e., exercise-induced muscle injury) is known to stem from muscle 
“contractions” that are used to slow the body’s limbs (called an eccentric contraction).  We 
have documented that the majority of strength loss early (i.e., 0-5 days) after exercise-induced 
injury of skeletal muscles stems from a failure in the signal from the T-tubule to the SR (i.e., 
excitation-contraction coupling failure).  However, the exact cause of the communication 
failure between the T-tubule and SR is unknown.  A number of recently identified triadic 
proteins (e.g., JP1, JP2, SRP-27, MG29, JP45) are thought to help maintain the normal close 
association of the T-tubule and sarcoplasmic reticulum membranes in muscle cells.  Of these 
proteins, junctophilin 1 and 2 (JP1 and JP2) appear to be crucial for normal triad development 
and maintenance.  The goal of this research project is to determine if JP1 and JP2 are damaged or 
altered during the course of performing eccentric contractions in a manner that corresponds to 
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excitation-contraction coupling failure and strength loss.  To achieve this goal, three studies will 
be conducted. Study 1 will characterize the general alterations to JP1 and JP2 that occur during 
the days after a single injury bout, while studies 2 and 3 will assess the relationships amongst JP 
alterations, functional deficits, and excitation-contraction coupling failure by injuring muscles 
under conditions known to manipulate the degree of functional deficits and excitation-contraction 
coupling (i.e., repeated injury bouts or temperature). 
Justify the use of animals in these studies in general. 
  
The investigator is unaware of any alternative to the animal model proposed for this specific 
research question. Studying the effects of eccentric contractions on triadic protein functional 
expression should be examined in vivo in adult tissue, as injury recovery is a multi-system 
process and triad structure may not be fully developed in cell culture. 
 
 
Justify the use of the proposed species in these studies.   
   
There are many reasons that make the mouse an appropriate model for the proposed study. First, 
the mouse model that will be used in this research is an accepted preparation for the study of 
skeletal muscle physiology. Second, the investigator has previously established the exercise 
model in the mouse (J. Appl.Physiol. 79:1260, 1995; J. Appl. Physiol. 80: 332, 1996; J. Appl. 
Physiol.80:1660, 1996; J. Mus. Res. Cell Motil. 19:215, 1998; J. Appl. Physiol.85:58, 1998; J. 
Physiol.515:609, 1999; J. Appl. Physiol.87:189, 1999; J. Appl. Physiol. 96: 1619-1625, 2004; 
FASEB J. 18:1597-9, 2004; J. Appl. Physiol.. 98: 1674-1681, 2005). Third, the functional 
response of mouse skeletal muscle to exercise-induced injury closely simulates the response of 
human limb muscle to the same injury stimulus. 
 
 
 
 I certify that the information provided herein is consistent with the information provided 
on the corresponding grant for sponsored research. 
     
     
     
 
OR 
 
X  This protocol application is not associated with sponsored research. 
 
Signature of the Principal Investigator _________________    Date       
  
 
 
2.  JUSTIFICATION FOR THE USE OF ANIMALS: 
Explain what alternatives exist in place of using animals. 
 The investigator is unaware of any viable alternative to the animal model proposed for this specific 
research question. Studying the effects of eccentric contractions on triadic protein functional expression 
should be examined in vivo in adult tissue, as injury recovery is a multi-system process and triad structure 
may not be fully developed in cell culture (i.e., myotubes vs. myofibers). 
 
 
Do any of the procedures cause more than momentary pain or distress?  Please describe them. 
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 The exercise protocols themselves should not be associated with pain as the mice will be under 
fentanyl, 
droperidol, and diazepam anesthesia. In humans, mild-to-moderate muscle soreness has been reported 1- 
3 days after novel eccentrically biased exercise. Muscle soreness is known to be absent or greatly 
attenuated in subsequent eccentrically biased exercise bouts. 
 
 
 
Please provide a brief summary of the results of a recent database searches that you have used to verify 
the investigation of alternatives to painful or distressful procedures?  (Alternatives incorporate some 
aspect of replacement, reduction or refinement of animal use in pursuit of the minimization of animal pain 
and distress.  Alternatives or alternative methods include use of non-animal systems, less sentient animal 
species or techniques that lessen or eliminate pain or distress such as chemical instead of physical 
castration or reducing the size of implants and incisions).  
 
Names of two databases used PubMed and NLM Gateway 
(Use PubMed plus one of the following: PsyInfo, AltWeb, NLM Gateway, AVAR, Galileo, AGRICOLA or 
AWIC).  Date(s) of searches   12-10-2008 
 
Search keyword(s): include hits for combinations of terms in this listing. You must use ‘alternative’ and 
‘animal welfare’ (i.e., Alternative AND Obesity; Alternative OR Animal Welfare AND Obesity etc.) 
 
Summarize the hits below.  (Note:  this is a general summary, you do not need to go into the details of 
each hit but rather summarize meaning of hits by relevant groups) 
 Keywords: (Alternative OR "Animal Welfare") AND (skeletal muscle) AND (injury OR 
damage) AND (eccentric OR lengthening) 
PubMed:  2 hits 
NLM Gateway:  14 hits 
 
The hits from these searches describe findings relating to the topic of muscle injury (i.e., the 
inflammatory process) and do not provide alternatives for replacement, reduction, or refinement. 
 
 
3. Please provide a brief summary of the results of recent searches of two databases that verify the 
proposed studies do not unnecessarily duplicate previous work.   
Name of  the database(s)  PubMed and NLM Gateway  
Date(s) of search  12/10/2008 
 
Search keyword(s): include hits for combinations of terms in this listing (i.e., Hamster AND 
Obesity; Hamsters AND Obesity AND Insulin) 
 Keywords: (skeletal muscle) AND (injury OR damage) AND junctophilins 
PubMed: 0 hits 
NLM gateway: 1 hits 
 
Keywords: Muscle AND junctophilin 
PubMed: 15 
NLM gateway: 19 hits 
 
 
Summarize the hits below.  (Note:  this is a general summary, you do not need to go into the 
details of each hit but rather summarize hits by relevant groups) 
 The published research studies on junctophilins in skeletal muscle have identified the protein 
as being crucial for triad formation during development and triad maintenance in adult muscle.  
Additionally, studies have illustrated that junctophilin 1 and 2 ablation during development is lethal 
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and reducing juntophilin 1 and 2 in adult muscle alters intracellular calcium homeostasis.  No 
study has addressed the role of junctophilns in functional deficits of injured skeletal muscle. 
 
Does the proposed work duplicate any previous work?  
     Yes (please justify below) 
   X   No 
 
 
 
 
 
4. Please describe in detail all of the work or procedures you will be doing with animals.  Include for 
each procedure: 
Procedure name:  In vivo anterior crural muscle strength measurement 
Infectious?   yes  X no  (If yes, also see Question 6) 
Radioactive?  yes X no  (If yes, also see Question 6) 
Antibody production?   yes X no      
(If you are using intradermal or multiple injections of complete Freund’s adjuvant (CFA), 
please state and justify) 
 
Detailed description of EACH PROCEDURE including: 
Will these animals be restrained during this procedure for any reason? 
 X Yes  (If yes, explain below*)  
  No  
 Please see description of protocol below 
 
Will animals be subjected to multiple survival surgeries (i.e. more than one penetration of a body 
cavity including the brain, or more than one procedure that impairs physical or physiologic 
function at different times) 
  Yes  (If yes, scientifically justify below*)  
 X No  
      
 
 
The maximum number of times the treatment/procedure will be done to any animal is:  
Mice will be anesthetized a maximum of 3 times for this procedure.  However, the maximum 
number of times that strength will be measured is 5 (twice during the first anesthetic induction for 
the first exercise  bout, twice during the second anesthetic induction for the second exercise bout 
(2 weeks after first exercise bout), and one time point (either 3, 6, 24, OR 72 h) following the 
second exercise bout (Study 2).  
 
If anesthesia is used, please describe: 
 Anesthesia: Mice will be anesthetized with fentanyl (0.3 mg/kg ip), droperidol (16.7 mg/kg 
ip), and diazepam (5 mg/kg ip).  Supplemental doses of fentanyl-droperidol cocktail will be 
administered to maintain the proper level of anesthesia (i.e., absence of pedal reflexes from each 
limb).  We have found that this anesthetic regimen is superior to others (methoxyflurane, 
ketamine-xylazine, pentobarbital) in measuring peak muscle force in anesthetized mice (J. 
Appl.Physiol. 80:332-340, 1996).  In addition, multiple anesthetic inductions are well tolerated by 
the mice, with mice showing no significant adverse health effects (e.g., no loss in body weight, 
decrease in grooming habits, or in muscle functional capacity of control mice) (J. Physiol. 515: 
609, 1999; J. Appl. Physiol. 97: 1067-1076, 2004; J. Appl. Physiol. 98: 1674-1681, 2005; J. Appl. 
Physiol. 105:1542-1553, 2008; J. Appl. Physiol. 105: 527-537, 2008). 
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General description of procedure 
 Experimental design: Two of the three studies proposed in this protocol will employ in vivo 
muscle testing. The first study (N=198) will characterize the effect of performing eccentrically or 
concentrically biased exercise in vivo on JP1 and JP2 protein content and cellular location in the 
anterior crural muscles [i.e., Tibialis anterior (TA) and Extensor digitorum longus (EDL) 
muscles] during the first 3 days after exercise.  The second study (N=83) will characterize the 
effect of performing two bouts of eccentrically or concentrically biased exercise in vivo on JP1 
and JP2 protein content and cellular location in the anterior crural muscles during the first 3 days 
after the second injury bout.  (The third study (N=73) is described in the “In vitro muscle testing” 
procedure section).  In all studies, the alterations to JP1 and JP2 will be compared to muscle 
function and excitation-contraction coupling failure. 
 
Animal transport: On the day of the experiment, one cage of mice (n=1-4) will be transported to 
the Muscle Biology Laboratory (Room G19) in the Sports Arena building. The cage will be 
placed in a ventilated box and walked from the housing facility to the Muscle Biology 
Laboratory. It takes less than 5 minutes to reach the Sports Arena building from the animal 
housing facility. If the mice are not euthanized after the experiment, animals will be returned to 
the animal housing facility at the end of the same day of testing following recovery from 
anesthesia. The transport box will be decontaminated immediately prior to placing the mouse 
cage inside it by spraying the inside and outside surfaces with Clidox-S (diluted 1:18:1 and 
provided by DAR). The outside of the transport box will also be sprayed with Clidox-S 
immediately upon re-entry into the animal facility upon returning the animals. 
 
In vivo muscle strength testing: In study 1, contractile function (i.e., torque-stimulation 
frequency relationship) of the left anterior crural muscles will be measured in vivo immediately 
before and 0, 3, 6, 24, and 72 hrs after a single bout of eccentrically biased exercise, and before 
and 0 and 24 hours after a single bout of concentrically biased exercise (Table 1). In study 2, 
contractile function of the left anterior crural muscles will be measured in vivo immediately 
before and after two bouts of eccentrically biased exercise that are separated by two weeks. 
Contractile function of the left anterior crural muscles will also be examined at 3 or 6, 24 and 72 
hours after the second injury bout.  Additionally, in study 2, one group of mice will only perform 
in vivo strength testing immediately before, immediately after, and 14 days after the first injury, 
but will not perform the second injury bout or any further in vivo testing thereafter (Table 2). 
Therefore, in study 1, anterior crural muscle strength will be measured on either 1 or 2 different 
days.  In study 2, anterior crural muscle strength will be measured on either 2 or 3 different days.  
On non-terminal experimental days, mice will be allowed to recover under a heat lamp before 
being transported back to the animal housing facility.  
 
In study 1, 30 animals at both 3 and 6 hours after injury are required to investigate the 
ubiquination of JP1 and JP2 in injured and uninjured TA muscle.  At these early time 
points after injury, Western blotting for JP1 and JP2 may not be sensitive enough to detect 
damage to these proteins.  Proteins that have been damaged are tagged with ubiquitin for 
subsequent removal by proteasomes.  Therefore, in addition to assessing muscle damage 
with Western blotting of JP1 and JP2, we will also assess the ubiquination of these specific 
proteins at 3 and 6 hours after injury induction.  Because of technical limitations, 5 TA 
muscles will be pooled to form one sample, allowing 6 samples per time point.  For this 
analysis, the left, injured TA muscles will be compared to the right, uninjured TA muscles.      
 
The strength-testing regimen is well tolerated by the mice. Using a multiple use experimental 
protocol (i.e., J. Physiol. 515: 609, 1999; J. Appl. Physiol. 97: 1067-1076, 2004; J. Appl. Physiol. 
98: 1674-1681, 2005; J. Appl. Physiol. 105:1542-1553, 2008; J. Appl. Physiol. 105: 527-537, 
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2008), we have observed no adverse effect on the health of the mouse (i.e., no loss in body 
weight, decrease in grooming habits, or in muscle functional capacity of control mice). 
Immediately before muscle strength testing, mice will be anesthetized, and then placed on a 
heating pad to maintain body temperature. The hair on the left hindlimb will be removed using 
clippers and a depilatory, and then the skin covering the left biceps femoris and lateral 
gastrocnemius muscles will then be aseptically prepared. After aseptic preparation of the left leg, 
the mouse is transferred to a temperature-controlled platform. The tail, forelimbs, and right leg 
will be secured to the platform a mouse rectal thermometer will be inserted 2-3 mm beyond the 
anus. (At the conclusion of the experiment, the mouse rectal probe will be removed and cleaned 
with alcohol).  The ankle and knee will be held in place using a clamp device described in J. 
Appl. Physiol. 72:1205, 1992 and used previously by the investigator (i.e., J. Appl. Physiol. 
79:1260, 1995; J. Appl. Physiol. 80:332, 1996; J. Mus. Res. Cell Motil. 19:215, 1998; J. 
Appl.Physiol. 84:2171, 1998; J. Appl. Physiol. 85:58, 1998; J. Physiol. 515:609, 1999; Med. Sci. 
Sport Exerc.,32: 820, 2000; J. Appl. Physiol. 97: 1067-1076, 2004; J. Appl. Physiol. 97: 1619-
1625, 2004; J. Appl. Physiol. 98: 1674-1681, 2005). Two sterilized platinum subdermal needle 
electrodes will be inserted into the aseptically prepared skin proximal to the common peroneal 
nerve on the left hindlimb. Anterior crural muscle strength will be measured by stimulating the 
left common peroneal nerve via percutaneous needle electrodes. Anterior crural muscle torque 
will then be measured at the following stimulation frequencies: 20, 40, 60, 80, 100, 125, 150, 200, 
250, 300, 350, and 400 Hz.  For mice that will undergo in vivo strength tests on more than one 
day, on the initial day of testing, while the mouse is still anesthetized following that day’s final in 
vivo strength test, the animal’s ear/s will be systematically marked (holes and notches) for mouse 
identification.  
 
In the tables that follow, the PI outlines the design of study one and two in this proposal. These 
tables identify the various experimental groups plus the measurements that are made on the mice 
in those groups. The number of mice needed for each group is also indicated; these numbers do 
not account for experimental failures. 
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0 3 6 24 72
Unexercised 
Control 
(n=15)
In vitro 
strength; 
protein 
analyses      
(n =15)
Concentric  
(n=30)
in vivo 
strength;      
in vitro 
strength; 
protein 
analyses      
(n =15)
in vivo 
strength;      
in vitro 
strength; 
protein 
analyses      
(n =15)
Eccentric    
(n=135)
in vivo 
strength;      
in vitro 
strength; 
protein 
analyses      
(n =15)
in vivo 
strength;      
in vitro 
strength; 
protein 
analyses      
(n =45)
in vivo 
strength;      
in vitro 
strength; 
protein 
analyses      
(n =45)
in vivo 
strength;      
in vitro 
strength; 
protein 
analyses      
(n =15)
in vivo 
strength;      
in vitro 
strength; 
protein 
analyses      
(n =15)
For all cells:  5 EDL muscles will not perform in vitro caffeine contracture testing and 
will be used for immunohistochemistry instead.  Additinonally, 10 TA muscles in every 
cell will used for both JP1 and JP2 immunohistochemistry and Western blotting.                                                                                    
For Eccentric 3 and 6 hours:  30 mice from each cell will be used to study JP1 and 
JP2 ubiquination.  The right, uninjured TA muscle will be used as a control for the left, 
injured TA muscle.
Table 1. Study 1: Effects of a single injury bout on JP1 and JP2 protein expression and 
cellular location (N=180)
Treatment 
Group
Time after exercise protocol (hours)
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This following Table is in reference to the number of animals per cell listed 
in Tables 1 and 2a.   
 
15 mice 45 mice
TA-WB & IHC  L. EDL - In vitro 10 10
L. EDL - IHC 5 5
TA- Ubiquination 30
Total 15 45
For cells with:
Table 2b.  Breakdown of the analysis that each muscle will be used for in 
Studies 1 and 2 (Table 1 and Table 2a) 
Muscle and Analysis
Note:  Reference of cells is to Table 1 and Table 2a.  Western blotting 
(WB); Immunohistochemistry (IHC); Left EDL (L. EDL).  L. EDL muscles 
that undergo in vitro caffeine experiments cannot be used for 
immunohistochemistry.
0 3 or 6 24 72
Eccentric 
(n=75)
in vivo 
strength;      
in vitro 
strength; 
protein 
analyses      
(n =15)
in vivo 
strength;      
in vitro 
strength; 
protein 
analyses      
(n =15)
in vivo 
strength;      
in vitro 
strength; 
protein 
analyses      
(n =15)
in vivo 
strength;      
in vitro 
strength; 
protein 
analyses      
(n =15)
in vivo 
strength;      
in vitro 
strength; 
protein 
analyses      
(n =15)
For all cells:  5 EDL muscles will not perform in vitro caffeine contracture testing and 
will be used for immunohistochemistry.  Additionally, 10 TA muscles will be used for 
both JP1 and JP2 immunohistochemistry and Western blotting.
Table 2a. Study 2: Repeated bout effect on JP1 and JP2 protein expression and cellular 
location (N=75)
Treatment 
Group
Time after second injury bout (hours)
Immediately 
before
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Describe in detail the pre- and/or post-procedural care including drugs 
  
      
 
Justification of the number of animals required for this procedure using power analysis if possible 
(for help with power analysis see http://calculators.stat.ucla.edu/powercalc/ 
 Justification for the number of animals in study 1, 2, and 3 is based on preliminary reports 
from colleagues at Baylor College of Medicine.  From these data, the investigator predicts a 
statistical power of 0.70 in the detection of 30% differences among groups (i.e., cell size of 10 
mice) in TA or EDL muscle JP1 and JP2 protein content.  Additionally, it is estimated that 5 
muscles per cell are required in studies 1 and 2 to establish altered cellular location in 
longitudinal EDL muscle cryosections determined with immunohistology (Note:  EDL muscles 
that perform the caffeine contracture test cannot be used for protein analyses).  Moreover, in 
study 1 it is estimated that a total of 30 mice per time point (3 and 6 hr) will be required to assess 
ubiquination of JP1 and JP2 in injured and contralateral TA muscles.  For technical reasons, in 
this analysis (i.e., SR isolation) 5 TA muscles will be pooled to form 1 sample.  A power of 78.9 
was calculated with a cell size of 6 and an effect size and coefficient of variation of 20% for this 
analysis.  In study three, the number of animals required to perform the in vitro caffeine 
contracture test was based on previous research we have conducted (i.e., J. Appl. Physiol. 105:5, 
2008).  Based on these data, 4 mice per cell will achieve a power > 0.80 in detecting a 10% 
difference among groups. 
 
In the past, we have experienced failure rates of approximately 10 and 30% for in vivo and in 
vitro experiments, respectively. To account for the experimental failure, the total number of 
animals needed for study 1 is increased from 180 to 198. The total number of animals needed for 
study #2 is increased from 75 to 83. The total number of animals needed for study 3 is increased 
from 56 to 73. 
 
 
Possible/known side effects of the procedure:  
 Muscle strength testing should not result in muscle injury.  However, on rare occasions 
(approximately 1 out of 200 experiments), the common peroneal nerve is damaged by the 
placement of the sub-dermal stimulating electrodes.  If the nerve is damaged, foot-drop is 
observed and the animal will be euthanized. 
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Procedure name: In vivo exercise protocol – Single exercise bout 
Infectious?   yes  X no  (If yes, also see Question 6) 
Radioactive?  yes X no  (If yes, also see Question 6) 
Antibody production?   yes X no  
(If you are using intradermal or multiple injections of complete Freund’s adjuvant (CFA), 
please state and justify) 
 
Detailed description of THIS PROCEDURE including: 
Will these animals be restrained during this procedure for any reason? 
 X Yes  (If yes, explain below*)  
  No  
 
Please see description of “In vivo anterior crural muscle strength measurement” protocol above  
 
Will animals be subjected to multiple survival surgeries (i.e. more than one penetration of a body 
cavity including the brain, or more than one procedure that impairs physical or physiologic 
function at different times) 
  Yes  (If yes, scientifically justify below*)  
 X  No  
 
The maximum number of times the treatment/procedure will be done to any animal is:  
 
1 
 
If anesthesia is used, please describe: 
 
Anesthesia: Mice will be anesthetized as described above for “In vivo anterior crural muscle 
strength measurement”.  Please note that the exercise protocol is done immediately after strength 
testing, so the induction of anesthesia will NOT be performed.  However, anesthetic supplements 
may be given as described in “In vivo anterior crural muscle strength measurement”. 
 
General description of procedure 
 
In vivo eccentrically and concentrically biased exercise: Induction of anesthesia, the 
preparation of the left hindlimb, and animal placement and restraint for in vivo testing is the same 
as described for the “In vivo anterior crural muscle strength measurement” protocol.  All mice in 
study 1 and one group of mice in study 2 will perform a single injurious bout of exercise that 
consists of 150 eccentric contractions. In this contraction protocol, the left anterior crural muscles 
will be stimulated to contract (for 120 ms) while the foot is plantarflexed (i.e., eccentric 
contraction) over 40˚ at 2000˚/s; it takes 28 min to do the 150 contractions.  The strength losses 
that result from the eccentric contraction-induced injury protocols are approximately 50% for 
tetanic contractions. This percent loss is typical of the functional loss a human experiences 
following exercise-induced muscle injury (Med. Sci Sports Exerc. 24: 512, 1992). The loss of 
strength has no observable effect on the ability of the mouse to ambulate, as the anterior crural 
muscles are not recruited heavily except at high running speeds.  
 
In study 1, concentrically biased exercise will be accomplished by the performance of 150 
concentric contractions. In this contraction protocol, the left anterior crural muscles will be 
stimulated to contract (for 120 ms) while the foot is dorsiflexed (i.e., concentric contraction) over 
40˚ at 2000˚/s; it takes 28 min to do the 150 contractions. We have shown that maximum anterior 
muscle strength is unaffected after this concentric contraction protocol (150 concentric 
contractions at 2000o/s) (i.e., J. Physiol. 515: 609, 1999). 
111 
 
 
Describe in detail the pre- and/or post-procedural care including drugs 
 
Please see description of “In vivo anterior crural muscle strength measurement” protocol above.  
 
Justification of the number of animals required for this procedure using power analysis if possible 
 
Please see description of “In vivo anterior crural muscle strength measurement” protocol above.  
 
Possible/known side effects of the procedure:  
 
 Known side effects of the eccentric and concentric exercise are temporary skeletal muscle 
damage, weakness and/or pain. In humans, mild-to-moderate muscle soreness has been reported 
1-3 days after novel eccentrically biased exercise. Muscle soreness is known to be absent or 
greatly attenuated in subsequent eccentrically biased exercise bouts. Possible side effects of the 
eccentric and concentric exercise in certain genotypes are rhabdomyolysis, renal failure, and 
death. On rare occasions (approximately 1 out of 200 experiments), the common peroneal nerve 
is damaged by the placement of the sub-dermal stimulating electrodes.  If the nerve is damaged, 
foot-drop is observed and the animal will be euthanized. 
 
 
 
 
 
 
Procedure name: In vivo exercise protocol – Two injury bouts 
Infectious?   yes  X no  (If yes, also see Question 6) 
Radioactive?  yes X no  (If yes, also see Question 6) 
Antibody production?   yes X no  
(If you are using intradermal or multiple injections of complete Freund’s adjuvant (CFA), 
please state and justify) 
 
Detailed description of THIS PROCEDURE including: 
Will these animals be restrained during this procedure for any reason? 
 X Yes  (If yes, explain below*)  
  No  
 
Please see description of “In vivo anterior crural muscle strength measurement” protocol above  
 
Will animals be subjected to multiple survival surgeries (i.e. more than one penetration of a body 
cavity including the brain, or more than one procedure that impairs physical or physiologic 
function at different times) 
  Yes  (If yes, scientifically justify below*)  
 X  No  
 
The maximum number of times the treatment/procedure will be done to any animal is:  
 
2 
 
If anesthesia is used, please describe: 
 
Anesthesia: Mice will be anesthetized as described above for “In vivo anterior crural muscle 
strength measurement”. Please note that the exercise protocol is done immediately after strength 
testing, so the induction of anesthesia will NOT be performed.  However, anesthetic supplements 
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may be given as described in “In vivo anterior crural muscle strength measurement”. 
 
 
 
 
 
General description of procedure 
 
Induction of anesthesia, the preparation of the left hindlimb, and animal placement and restraint 
for in vivo testing is the same as described for the “In vivo anterior crural muscle strength 
measurement” protocol.  In study 2, all but one group of mice will perform two bouts of injurious 
exercise identical to that described above for a single bout of eccentric contractions (Table 2). 
Mice will perform two bouts of 150 eccentric contractions with the left anterior crural muscles, 
which will be stimulated to contract (for 120 ms) while the foot is plantarflexed (i.e., eccentric 
contraction) over 40˚ at 2000˚/s. The two injury bouts will be separated by 14 days.  In general, 
the strength loss observed immediately after a second injury bout is either similar to or lesser than 
strength loss after a single injury bout, while strength deficits 1-5 days after the second injury 
bout are significantly less than after a single injury bout.  Therefore, the second injury bout has 
lesser adverse effects on ambulation and animal well-being than a single injury bout. 
 
 
Describe in detail the pre- and/or post-procedural care including drugs 
 
Please see description of “In vivo anterior crural muscle strength measurement” protocol above  
 
Justification of the number of animals required for this procedure using power analysis if possible 
 
Please see description of “In vivo anterior crural muscle strength measurement” protocol above  
 
Possible/known side effects of the procedure:  
 
Known side effects of the eccentric and concentric exercise are temporary skeletal muscle 
damage, weakness and/or pain. In humans, mild-to-moderate muscle soreness has been reported 
1-3 days after novel eccentrically biased exercise. Muscle soreness is known to be absent or 
greatly attenuated in subsequent eccentrically biased exercise bouts. Possible side effects of the 
eccentric and concentric exercise in certain genotypes are rhabdomyolysis, renal failure, and 
death.  On rare occasions (approximately 1 out of 200 experiments), the common peroneal nerve 
is damaged by the placement of the sub-dermal stimulating electrodes.  If the nerve is damaged, 
foot-drop is observed and the animal will be euthanized. 
 
 
 
 
Procedure name: In vitro muscle testing 
Infectious?   yes  X no  (If yes, also see Question 6) 
Radioactive?  yes X no  (If yes, also see Question 6) 
Antibody production?   yes X no  
(If you are using intradermal or multiple injections of complete Freund’s adjuvant (CFA), 
please state and justify) 
 
Detailed description of THIS PROCEDURE including: 
Will these animals be restrained during this procedure for any reason? 
 X Yes  (If yes, explain below*)  
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  No  
 
Please see description of protocol below 
 
Will animals be subjected to multiple survival surgeries (i.e. more than one penetration of a body 
cavity including the brain, or more than one procedure that impairs physical or physiologic 
function at different times) 
  Yes  (If yes, scientifically justify below*)  
 X  No  
 
The maximum number of times the treatment/procedure will be done to any animal is:  
 
1  
 
If anesthesia is used, please describe: 
 
Mice will be anesthetized with sodium pentobarbital (100 mg/kg ip).  This dosage, which we 
have used for the last 14 years, is required to achieve the necessary plane of anesthesia needed for 
muscle dissection in mice.  Multiple toe pinches will be used to ensure proper plane of 
anesthesia prior to dissection.  If necessary, mice will be given supplemental doses of sodium 
pentobarbital to ensure that this plane of anesthesia (i.e., absence of leg withdrawal from toe 
pinch and reduction in ventilation rate) is maintained throughout the procedure (usually 45 
minutes).   
 
General description of procedure 
 
Study 3 experimental design:  We have previously reported that the magnitude of strength 
deficits and excitation-contraction coupling failure immediately after performing eccentric 
contractions in vitro is temperature dependent (Warren et al., Am J Physiol Regul Integr 
Comp Physiol, 282(4), R1122-1132, 2002), whereby the magnitude of excitation-contraction 
coupling failure and strength deficits increase from non-physiological (15˚C) to 
physiological temperatures (37˚C). 
 
Study 3 (N=73) will characterize the effect of experimental temperature (i.e., 15, 25, 37˚C) during 
the performance of eccentric or isometric contractions in vitro on JP1 and JP2 protein content.  
As such, in study 3 dissected EDL muscles will undergo an in vitro “exercise” protocol in which 
the muscles will perform either 5 eccentric or 5 isometric contractions at one of these 
temperatures.  (See table 3; This table identifies the various experimental groups in study 3 plus 
the measurements that are made on the mice in those groups. The number of mice needed for 
each group is also indicated; these numbers do not account for experimental failures). 
 
On the final day of in vivo testing in studies 1 and 2 and in one of group of non-exercised (in 
vivo) mice in study 1, the left EDL muscle will be isolated and tested in vitro at 37˚C only.  
For all muscles of any study undergoing in vitro testing, the muscle will at least be subjected 
to a force-frequency and caffeine contracture test.  Because caffeine directly stimulates the 
SR to release calcium and therefore by-passes upstream components of the excitation-
contraction coupling process, the ratio of caffeine contracture force to maximal voltage-
induced force may be compared between injured and uninjured muscle to assess the degree 
of excitation-contraction coupling failure in injured skeletal muscle.  
 
In vitro contractile function measurement: On the final day of in vivo testing in studies 1 and 2, 
in one group of non-exercised (in vivo) mice in study 1, and in all experiments in study 3, the left 
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EDL muscle will be dissected from anesthetized mice (sodium pentobarbital) and mounted in an 
organ bath for determination of contractile characteristics (e.g., force-frequency relationship and 
caffeine contracture test). Immediately after muscle dissection, a bandage is taped over the left 
hindlimb.  Further muscle dissection and tissue collection is described below.  Once the tissue 
necessary to perform this study has been collected, euthanasia will be achieved via sodium 
pentobarbital (200 mg/kg IP). 
 
 
 
 
Describe in detail the pre- and/or post-procedural care including drugs 
 
Mice will be checked for skeletal abnormalities, by visually examining the animal’s hindlimb 
morphology and gait, and adequate body weight prior to the experiment. 
 
Justification of the number of animals required for this procedure using power analysis if possible 
 
Please see description of “In vivo anterior crural muscle strength measurement” protocol above 
 
Possible/known side effects of the procedure:  
 
This is a terminal procedure and thus presents no side effects 
 
 
 
 
Procedure name: Tissue harvest 
37 25 15
Isometric 
(n=14)
In vitro 
strength; 
protein 
analyses      
(n =14)
Eccentric  
(n=42)
In vitro 
strength; 
protein 
analyses      
(n =14)
In vitro 
strength; 
protein 
analyses      
(n =14)
In vitro 
strength; 
protein 
analyses      
(n =14)
Treatment 
Group
Experimental Temperature (˚C)
For all cells:  Only 4 EDL muscles will perform caffeine 
contracture testing, while the remaining 10 muscles will 
be used for JP1 & JP2 Western blotting.
Table 3. Study 3: Temperature dependency of in vitro 
eccentric-contraction induced force deficits, E-C coupling, 
and junctophilin disruption (N=56)
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Infectious?   yes  X no  (If yes, also see Question 6) 
Radioactive?  yes X no  (If yes, also see Question 6) 
Antibody production?   yes X no  
(If you are using intradermal or multiple injections of complete Freund’s adjuvant (CFA), 
please state and justify) 
 
Detailed description of THIS PROCEDURE including: 
Will these animals be restrained during this procedure for any reason? 
 X Yes  (If yes, explain below*)  
  No  
 
Please see description of the “In vitro muscle testing” protocol above 
 
Will animals be subjected to multiple survival surgeries (i.e. more than one penetration of a body 
cavity including the brain, or more than one procedure that impairs physical or physiologic 
function at different times) 
  Yes  (If yes, scientifically justify below*)  
 X  No  
 
The maximum number of times the treatment/procedure will be done to any animal is:  
1 
 
If anesthesia is used, please describe: 
 
Please see description of the “In vitro muscle testing” protocol above 
 
General description of procedure 
 
Tissue dissection and animal euthanasia: Once the mouse is under a surgical plane of 
anesthesia  (sodium pentobarbital, 100mg/kg ip), which will be ensured with multiple toe 
pinches, the left hindlimb TA muscle will be dissected and frozen.  Then the left hindlimb EDL 
muscle will be dissected, functionally tested in vitro, and frozen.  During the automated 
measurement of the left EDL muscle in vitro testing, the right hindlimb TA and EDL muscles 
will be dissected and frozen.  Frozen muscle samples will be analyzed later via Western blotting 
and immunohistochemistry for JP1 and JP2 alterations.   
 
Describe in detail the pre- and/or post-procedural care including drugs 
 
Mice will be checked for skeletal abnormalities, by visually examining the animal’s hindlimb 
morphology and gait, and adequate body weight prior to the experiment. 
 
Justification of the number of animals required for this procedure using power analysis if possible 
 
Please see description of “In vivo anterior crural muscle strength measurement” protocol above 
 
Possible/known side effects of the procedure:  
 
This is a terminal procedure and thus presents no side effects 
 
 
*** COPY AND PASTE THE ABOVE HEADINGS FOR ADDITIONAL PROCEDURES IF NEEDED *** 
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USDA Classifications and Examples of Pain Categories: 
Classification B: Animals being bred, conditioned, or held for use in teaching, testing, experiments, 
research, or surgery, but not yet used for such purposes. 
Examples: 
• Breeding colonies - Includes parents and offspring.  
• Animals held under proper captive conditions or wild animals that are being observed.  
 
Classification C: Animals upon which teaching, research, experiments, or tests will be conducted 
involving no pain, distress, or use of pain-relieving drugs. 
Examples: 
• Procedures performed correctly by trained personnel such as the administration of electrolytes/fluids, 
administration of oral medication, blood collection from a common peripheral vein per standard veterinary 
practice or catheterization of same, standard radiography, parenteral injections of non-irritating substances.  
• Euthanasia performed in accordance with the recommendations of the most recent AVMA Panel on Euthanasia, 
utilizing procedures that produce rapid unconsciousness and subsequent humane death.  
• Manual restraint that is no longer than would be required for a simple exam; short period of chair restraint for an 
adapted nonhuman primate.  
 
Classification D: Animals upon which experiments, teaching, research, surgery, or tests will be 
conducted involving accompanying pain or distress to the animals and for which appropriate anesthetic, 
analgesic, or tranquilizing drugs will be used. 
Examples: 
• Surgical procedures conducted by trained personnel in accordance with standard veterinary practice such as 
biopsies, gonadectomy, exposure of blood vessels, chronic catheter implantation, laparotomy or laparoscopy.  
• Blood collection by more invasive routes such as intracardiac or periorbital collection from species without a 
true orbital sinus such as rats and guinea pigs.  
• Administration of drugs, chemicals, toxins, or organisms that would be expected to produce pain or distress but 
which will be alleviated by analgesics.  
 
Classification E: Animals upon which teaching, experiments, research, surgery, or tests will be 
conducted involving accompanying pain or distress to the animals and for which the use of appropriate 
anesthetic, analgesic, or tranquilizing drugs will adversely affect the procedures, results, or interpretation 
of the teaching, research, experiments, surgery, or tests. 
Examples: 
• Procedures producing pain or distress unrelieved by analgesics such as toxicity studies, microbial virulence 
testing, radiation sickness, and research on stress, shock, or pain.  
• Surgical and postsurgical sequela from invasion of body cavities, orthopedic procedures, dentistry or other hard 
or soft tissue damage that produces unrelieved pain or distress.  
• Negative conditioning via electric shocks that would cause pain in humans.  
• Chairing of nonhuman primates not conditioned to the procedure for the time period used.  
    
Across all of the above, describe all painful and/or distressful procedures you plan to use 
during this protocol.  If category E were selected above, please provide references 
indicating that both of the two major classes of pain-relieving medication (i.e. opiates and 
non-steroidal anti-inflammatory drugs) will interfere with your goals. 
D 
 
In vivo anterior crural muscle strength (described above) 
In vivo exercise protocol – Single exercise bout (described above) 
In vivo exercise protocol – Two injury bouts (described above) 
In vitro muscle testing (described above) 
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Tissue harvest (described above) 
 
If painful procedures must be performed, appropriate sedatives, analgesics or anesthetics must 
be used (unless withholding of these was justified above).  List the drugs you will use to prevent 
pain or distress. 
 
  Name of Drug:    fentanyl (F), droperidol (D), diazepam (DZ) 
Dose:  F: 0.3 mg/kg D: 16.7 mg/kg DZ: 5 mg/kg 
  Route of Administration: ip 
 
Name of Drug:   Sodium pentobarbital 
Dose: 100 mg/kg 
  Route of Administration: ip 
 
Name of Drug:    Buprenorphine 
Dose: 0.05 mg/kg 
 Route of Administration:  ip 
 
 
Who will be responsible for monitoring the animals for pain and/or distress during the 
experimental procedure(s)? 
 The PI and/or GRAs will monitor the level of anesthesia in the animals. 
 
How will the comfort level of the animals be determined? 
 Mice will be checked by the PI and/or his GRAs daily after the exercise procedure.  If a mouse 
is lethargic or limping on the first or second mornings after the in vivo exercise protocol, then 
0.05 mg.kg bupreorphine will be administered ip twice.  If pain and/or disability are not resolved 
by the third day and the mouse has lost more than 20% of its body weight, then 0.05 mg/kg 
buprenorphine will be re-administered twice.  If pain and/or disability are not resolved by the fifth 
day and the mouse has lost more than 20% of its body weight, then the mouse will be euthanized 
after consultation with the university veterinarian. 
 
In the event that an animal needs to be euthanized or removed from the experiment, please list 
the criteria for the decision: 
 If an animal becomes ill (as evident by a loss of 20% of body weight and lack of grooming), 
then 
it will be euthanized. 
 
Who will determine this action? 
 The PI in conjunction with the university veterinarian 
 
 
At the termination of the experiment, describe in detail the method of euthanasia (if any) you will use?  
How will remains be disposed?  Methods of euthanasia must be in accordance with the most current 
American Veterinary Medical Association Panel on Euthanasia 
http://www.avma.org/resources/euthanasia.pdf.  References must be cited to justify deviations from this 
document, or to justify use of cervical dislocation or decapitation without anesthesia.   
 Animals will be euthanized via an anesthetic overdose of either CO2 or 200 mg/kg ip of 
sodium pentobarbital. These methods are approved for mice by the AVMA Panel on Euthanasia, 
2000. After the animal ceases respiration, cervical dislocation will be performed to ensure death 
before placing the carcass in the freezer. Animal carcasses will be stored in the Muscle Biology 
Laboratory freezer until the time they are transferred to the animal care facility freezer. 
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5. EXPERIENCE AND TRAINING OF PERSONNEL 
List the experience and/or training of the personnel that will conduct each Procedure.   
 
If training has not been completed, visit http://www.gsu.edu/reseearch/iacuc.html and click 
on “How to Enroll in and Use the AALAS Learning Library”.  Complete the Required 
Education  prior to submitting this protocol application.  
 
All employees of Georgia State University who work with vertebrate animals must enroll in 
the Medical Monitoring Program for Vertebrate Animal Exposure, found at  
http://www.gsu.edu/images/vp_research/GSU_MMPVAE_Form_May06.doc 
 
 
 Principal Investigator: 
Name: Christopher P. Ingalls, PhD                                    
Procedure: All 
Experience: The PI is a physiologist with 5 years of postdoctoral experience and 14 years 
experience in rodent handling, surgery, and exercise protocols. The PI has formal training in 
animal care techniques, having completed three Texas A&M University Lab Animal Research 
and Resource courses (i.e., Mice: Basic Handling and Techniques; Asepsis and Aseptic 
Techniques; Rat: Basic Handling and Techniques), as well one workshop on Mouse Handling 
Workshop at GSU, and has completed online training courses. 
Has required training been completed? Xyes   no   If “no”, see above 
Is this person enrolled in the MMPVAE? X yes   no   If “no”, see above 
 
Note: You can copy and paste the sections below as needed to list additional personnel.   
 
 Postdoctoral personnel: 
Name:  
Procedure:  
Experience:  
Has required training been completed?  yes   no   If “no”, see above 
Is this person enrolled in the MMPVAE?  yes   no   If “no”, see above 
 
Name:  
Procedure:  
 
Experience:  
Has required training been completed?  yes   no   If “no”, see above 
Is this person enrolled in the MMPVAE?  yes   no   If “no”, see above 
 
Graduate Students: 
Name: Benjamin Corona                                                                       
Procedure: All 
Experience: 4 years experience with rodent handling and exercise protocols 
Has required training been completed? X yes   no   If “no”, see above 
Is this person enrolled in the MMPVAE? X yes   no   If “no”, see above 
 
Name:                                          
Procedure:       
Experience:       
Has required training been completed?  yes   no   If “no”, see above 
Is this person enrolled in the MMPVAE?  yes   no   If “no”, see above 
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 Technicians: 
Name:                                          
Procedure:       
Experience:        
Has required training been completed?  yes   no   If “no”, see above 
Is this person enrolled in the MMPVAE?  yes   no   If “no”, see above 
 
Name:                                          
Procedure:       
Experience:       
Has required training been completed?  yes   no   If “no”, see above 
Is this person enrolled in the MMPVAE?  yes   no   If “no”, see above 
 
Undergraduates: 
Name: Jared Wagman                                                                       
Procedure: In vivo anterior crural muscle strength; In vivo exercise protocol – Single exercise 
bout;  
In vivo exercise protocol – Two injury bouts 
Experience: Mr Wagman has no formal experience working with laboratory animals.  He will be 
trained by the PI and/or Mr. Corona.  
Has required training been completed? X yes   no   If “no”, see above 
Is this person enrolled in the MMPVAE? X yes   no   If “no”, see above 
 
Name:                                          
Procedure:       
Experience:       
Has required training been completed?  yes   no   If “no”, see above 
Is this person enrolled in the MMPVAE?  yes   no   If “no”, see above 
 
 
 
6. Biosafety and Radiation Safety Summary: 
a) Are you working with infectious agents and/or biologically-derived toxins? 
  X  No 
   Yes   I have approval from the Biosafety Committee 
  Date           Approval #          
 
List and explain the precautions that will be taken to ensure the safety of the working environment 
for personnel).  What special precautions are recommended for personnel who handle animals or 
do housekeeping?  Should cage materials or animals from these experiments be autoclaved or 
decontaminated? 
NA 
 
b) Does the project use any recombinant DNA (i.e. cloning/expression systems, viral vectors, 
etc.) material in animals? 
  X No 
   Yes   I have approval from the Biosafety Committee 
  Date           Approval #          
 
List and explain the precautions that will be taken to ensure the safety of the working environment 
for personnel).  What special precautions are recommended for personnel who handle animals or 
do housekeeping?  Should cage materials or animals from these experiments be autoclaved or 
decontaminated? 
NA 
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c)  Are any carcinogenic compounds to be used in animals? 
X   No 
   Yes   I have approval from the Biosafety Committee 
  Date           Approval #          
 
List and explain the precautions that will be taken to ensure the safety of the working environment 
for personnel).  What special precautions are recommended for personnel who handle animals or 
do housekeeping?  Should cage materials or animals from these experiments be autoclaved or 
decontaminated? 
NA 
 
  
d) Will any radioactive compounds be administered to the animals?   
X  No 
   Yes   I have approval from the Radiation Safety Committee 
  Date           Approval #          
 
List and explain the precautions that will be taken to ensure the safety of the working environment 
for personnel).  What special precautions are recommended for personnel who handle animals or 
do housekeeping?  Should cage materials or animals from these experiments be autoclaved or 
decontaminated? 
NA 
 
 
7. Animal Housing and Husbandry: 
a) Will you breed these animals? 
X   No 
  Yes  (Explain and justify below) 
      
 
b) Do the animals require housing other than standard caging/bedding? 
  No 
X   Yes  (List housing required and explain below) 
 Due to minor allergies by the PI, the PI requests that hypoallergenic bedding (i.e., alpha 
dry) be used in the cages for animal housing. 
 
 
c) Do the animals require special care? 
X   No 
   Yes  (List special care and explain below) 
      
 
 
d) Do the animals require diet other than the standard diet for this species used at GSU? 
X  No 
  Yes  (List diet and explain below) 
      
 
 
e) Will animals remain outside the Department of Animal Resources facility for more than 12 
hours? 
X   No 
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  Yes  (List where and explain below) 
      
 
 
f) Will animals undergo experimental manipulations outside the Department of Animal Resources 
facilities? 
   No 
X  Yes  (List where and explain below) 
 Animas will be transported in cages placed in a ventilated carrier to the Muscle Biology 
Laboratory in the Sports Arena room G19 where all experiments will be performed.   
 
 
 
g) Can your animals be provided environmental enrichment? 
   No (Explain below) 
X  Yes (List enrichment requested below)  
 Plastic domes 
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Study One:  Isometric Torque-Frequency (Nmm·kg-1)  – Pre Injury
Pre-Exercise Isom
etric Torque-Frequency
Condition
Nam
e
W
eight 1 (g)
W
t 2 (g)
W
eight 1 (g)
W
t 2 (g)
20
40
60
80
100
125
150
200
250
300
350
400
C
oncentric-Im
m
D
1001
23.3
23.3
20.86
24.64
41.70
67.91
83.76
94.49
100.66
106.61
108.96
110.50
111.06
111.30
D
1002
23.2
23.2
17.94
17.41
23.34
39.28
61.38
78.31
83.81
88.91
91.68
93.44
93.87
93.49
D
1019
33.2
33.2
19.90
19.86
24.94
44.08
72.60
88.18
95.44
102.26
105.53
107.48
108.30
109.20
D
1020
31.6
31.6
23.88
21.80
25.15
38.37
68.09
89.72
97.41
104.74
108.31
110.00
110.61
110.97
D
1025
37.5
37.5
25.36
29.76
39.45
59.00
82.57
96.16
102.73
106.21
109.92
110.90
111.24
112.62
D
1032
34.9
34.9
18.40
19.99
24.46
45.96
70.69
85.20
90.63
96.07
99.44
99.69
99.54
99.87
C
oncentric-1d
D
1016
30
29.1
30
29.1
23.66
21.83
26.54
43.01
69.46
90.51
97.35
103.89
105.74
105.89
106.68
106.66
D
1021
33.5
31.1
33.5
31.1
21.75
22.36
30.81
60.79
91.50
107.42
114.29
120.81
123.35
124.99
125.46
125.36
D
1023
34.3
32.6
34.3
32.6
28.31
29.73
39.10
63.60
87.46
100.63
106.52
112.71
115.90
117.71
118.44
118.70
D
1026
26.3
29
26.3
29
22.65
22.29
28.86
52.72
80.17
99.90
109.61
116.08
119.63
121.61
123.27
123.32
Eccentric-Im
m
D
1000
22.8
22.8
12.35
12.09
16.92
31.90
53.68
73.04
80.14
87.19
90.93
93.04
94.28
95.67
D
1004
22.8
22.8
18.81
19.80
27.51
45.91
69.86
87.74
93.75
99.56
102.64
104.34
105.66
106.21
D
1007
24.7
24.7
23.19
24.38
36.71
56.88
74.16
84.24
89.05
93.70
95.71
96.47
97.39
97.96
D
1022
36.4
36.4
21.23
19.39
22.83
35.57
65.28
84.87
91.54
96.97
98.93
100.73
101.12
100.38
D
1028
31.7
31.7
21.03
22.80
31.58
54.69
78.87
92.36
97.70
103.22
105.62
106.50
107.39
108.05
D
1029
31.2
31.2
26.34
29.39
38.39
64.57
87.90
101.12
106.41
111.69
113.82
113.42
111.86
111.74
D
1033
32.4
32.4
24.45
24.68
30.27
49.32
76.36
100.40
108.49
115.88
119.41
121.41
121.92
122.94
D
1047
23.7
23.7
20.65
21.27
28.47
50.41
77.64
96.36
104.11
110.90
113.70
115.22
115.11
115.56
D
1051
26.9
26.9
22.73
20.53
22.82
35.97
66.27
81.55
86.84
91.43
93.01
94.16
95.12
94.31
0
Eccentric-1d
D
1006
22.8
23.6
22.8
23.6
24.79
30.80
54.37
79.04
100.73
114.61
121.19
127.83
130.74
131.97
131.89
131.55
D
1008
22
22
22
22
26.75
27.29
36.53
56.92
80.45
96.85
103.53
109.13
112.71
114.38
115.85
116.73
D
1015
26.7
27.1
26.7
27.1
25.14
28.00
40.54
63.37
85.06
100.62
108.16
115.33
118.69
120.46
121.25
122.31
D
1027
34.7
34.7
34.7
34.7
24.78
25.03
31.28
46.60
71.71
87.44
93.55
99.76
102.78
104.44
105.17
105.73
D
1030
34.7
34.4
34.7
34.4
20.94
20.99
27.40
46.01
82.66
97.36
103.32
108.80
111.28
111.23
112.37
111.97
D
1040
27.4
25.4
27.4
25.4
23.75
22.58
28.41
44.54
77.80
96.27
102.72
110.18
112.43
112.82
115.22
115.06
D
1045
26
26.2
26
26.2
19.62
20.42
29.36
51.70
76.72
94.99
101.65
107.99
112.42
115.97
115.26
116.02
D
1046
26
25.3
26
25.3
19.12
19.51
25.27
44.00
69.27
85.56
91.12
97.22
100.19
102.28
103.68
104.40
D
1049
25.4
24.2
25.4
24.2
27.40
30.88
48.83
79.65
104.82
120.35
126.67
134.70
137.95
139.81
140.35
141.19
0
Eccentric-3d
D
1005
24.7
20.7
24.7
20.7
22.49
25.54
40.47
69.17
90.37
104.18
109.51
115.49
118.74
120.26
121.40
121.87
D
1012
31.6
32.1
31.6
32.1
26.57
24.36
30.20
46.62
70.09
85.84
91.97
97.24
99.95
101.22
101.80
102.33
D
1013
29
29.4
29
29.4
26.98
27.84
33.28
59.05
90.36
114.11
122.29
130.34
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Study One:  Concentric or Eccentric Torque (Nmm·kg-1) 
 
 
Contraction #
Condition Name Weight 1 (g) Weight (kg) 1 10 20 30 40 50
Concentric-Imm D1001 23.3 0.0233 113.652361 108.11588 112.424893 110.88412 109.961373 109.652361
D1002 23.2 0.0232 93.4396552 91.2758621 91.2758621 90.9698276 91.5862069 91.2758621
D1019 33.2 0.0332 103.51506 100.493976 100.060241 99.1987952 98.9819277 98.9819277
D1020 31.6 0.0316 104.901899 98.7753165 97.8670886 96.7341772 96.278481 94.2373418
D1025 37.5 0.0375 101.778667 97 97.1893333 96.616 96.0426667 95.6613333
D1032 34.9 0.0349 103.813754 104.020057 104.226361 104.842407 104.636103 104.842407
Concentric-1d D1016 30 0.03 101.176667 99.7433333 102.61 102.61 102.85 102.61
D1021 33.5 0.0335 117.78209 111.576119 110.722388 110.292537 109.223881 108.152239
D1023 34.3 0.0343 113.991254 109.183673 108.346939 107.093294 107.303207 106.676385
D1026 26.3 0.0263 121.680608 119.771863 119.771863 119.224335 118.680608 118.680608
Eccentric-Imm D1000 22.8 0.0228 185.635965 170.54386 140.986842 118.662281 112.372807 114.574561
D1004 22.8 0.0228 196.95614 178.403509 149.162281 133.754386 129.350877 128.407895
D1007 24.7 0.0247 195.736842 179.773279 153.651822 137.688259 131.303644 128.109312
D1022 36.4 0.0364 200.571429 175.755495 148.774725 128.489011 121.005495 114.700549
D1028 31.7 0.0317 210.634069 189.829653 159.977918 139.170347 129.44795 123.791798
D1029 31.2 0.0312 226.647436 208.035256 182.532051 161.163462 151.282051 144.391026
D1033 32.4 0.0324 235.734568 214.712963 176.657407 154.08642 147.228395 141.694444
D1047 23.7 0.0237 248.763713 221.540084 193.105485 166.185654 153.489451 149.244726
D1051 26.9 0.0269 188.256506 175.464684 153.877323 133.356877 122.431227 116.565056
Eccentric-1d D1006 22.8 0.0228 242.548246 205.758772 161.109649 140.04386 133.754386 129.666667
D1008 22 0.022 223.340909 199.881818 177.072727 163.386364 154.259091 149.368182
D1015 26.7 0.0267 232.625468 213.831461 175.973783 154.494382 145.363296 141.067416
D1027 34.7 0.0347 204.40634 186.227666 154.204611 133.956772 120.319885 113.089337
D1030 34.7 0.0347 233.123919 210.605187 186.432277 163.086455 150.48415 146.559078
D1040 27.4 0.0274 196.857664 184.29927 163.105839 144.788321 133.277372 125.689781
D1045 26 0.026 244.957692 217.657692 194.223077 174.646154 163.915385 158.1
D1046 26 0.026 198.634615 182.642308 165.546154 149.276923 141.834615 134.111538
D1049 25.4 0.0254 282.637795 244.251969 218.003937 199.094488 188.366142 180.744094
Eccentric-3d D1005 24.7 0.0247 241.88664 214.311741 183.255061 167.004049 159.45749 154.522267
D1012 31.6 0.0316 199.958861 180.218354 150.727848 132.123418 123.278481 119.873418
D1013 29 0.029 263.372414 235.931034 196.37931 168.444828 155.096552 148.668966
D1014 30 0.03 225.676667 209.903333 186.486667 163.066667 150.88 142.756667
D1017 26.4 0.0264 167.109848 152.44697 139.685606 127.734848 127.462121 123.390152
D1024 35.9 0.0359 188.587744 171.615599 146.651811 130.67688 122.490251 116.899721
D1031 39 0.039 213.671795 186.097436 158.707692 144.371795 135.364103 131.135897
D1042 24.9 0.0249 256.927711 229.289157 202.514056 182.361446 171.995984 164.799197
D1048 30.6 0.0306 240.464052 210.006536 181.660131 163.620915 153.545752 82.7973856
D1050 31.3 0.0313 223.86262 192.942492 158.357827 136.597444 125.146965 120.335463
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Study One:  Isometric Torque-Frequency (Nmm·kg-1) Estimated Parameters
Pre-Injury
Im
m
ediate
X-day
Condition
m
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am
plitude
m
ax
EC50
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ill
m
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am
plitude
m
ax
EC50
H
ill
m
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plitude
m
ax
EC50
H
ill
C
oncentric-Im
m
D
1001
18.8186077
91.7532255
110.571833
79.1976641
-3.62594575
18.8581941
89.6910196
108.549214
81.9231149
-4.01597873
D
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75.8887801
92.6876112
94.4041622
-4.96452773
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-4.33808995
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25.8344184
85.1301407
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-4.34208009
23.5357313
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D
1032
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98.9621811
90.458499
-5.107409
18.6876968
85.0681674
103.755864
100.867074
-5.42383017
C
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D
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83.8510996
105.885423
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-5.66479293
19.0965021
89.5809268
108.677429
96.4319097
-5.30777792
24.13158
85.2412288
109.372809
82.0468051
-4.91092407
D
1021
20.2039509
103.728057
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87.6231421
-5.04288296
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90.8594141
107.802556
101.046846
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-4.1947368
D
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26.8904669
90.2817016
117.172169
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-5.37716757
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74.9904384
96.7597982
83.0317254
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-6.13307033
D
1033
23.4108733
97.6275551
121.038428
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75.4174811
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-5.74805026
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19.6074199
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114.570851
92.6715801
-4.84628188
5.48079288
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77.0622217
139.839166
-5.02711027
D
1051
20.7320071
72.3513548
93.083362
94.9654678
-6.77414599
5.89867312
57.84232
63.7409931
136.076875
-5.28498225
Eccentric-1d
D
1006
23.0829555
109.056544
132.1395
78.3631249
-3.55131185
6.06521896
60.7357237
66.8009426
124.010483
-4.16088657
4.49789214
56.0791103
60.5770025
103.229055
-4.73065743
D
1008
25.3724983
89.288777
114.661275
91.4339992
-4.34310543
5.4567577
68.5800465
74.0368042
129.299357
-4.8916987
9.83428613
81.3866737
91.2209598
118.233485
-3.88267566
D
1015
23.9012679
97.1698862
121.071154
88.5604226
-3.81808694
4.91162974
69.0796039
73.9912336
141.822359
-4.8161793
5.83478341
78.1662422
84.0010256
124.120433
-4.115401
D
1027
23.8173631
80.2635338
104.080897
94.8764458
-4.78344442
5.52104025
59.7159288
65.236969
124.381942
-5.54993911
6.60456632
78.3780709
84.9826373
110.615172
-4.64711658
D
1030
20.482424
90.1519396
110.634364
90.8426584
-6.1774458
5.48222691
64.2030335
69.6852604
124.916419
-5.62153735
4.68804052
71.9168485
76.604889
126.697246
-4.97786635
D
1040
22.2891346
90.7524929
113.041628
95.0981025
-5.59184053
6.56129874
62.7503525
69.3116512
127.006692
-5.25911102
5.82973366
73.3880205
79.2177542
111.918205
-4.7794552
D
1045
18.1168988
96.4217975
114.538696
92.17425
-4.32095161
3.47138442
66.6782263
70.1496107
129.520915
-6.00141232
5.69794338
72.737412
78.4353554
117.371164
-4.91353396
D
1046
17.866652
84.1514527
102.018105
93.4679811
-4.75927591
4.485674
72.7382663
77.2239403
129.799371
-5.70400169
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66.6969025
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104.515479
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D
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114.140003
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Eccentric-3d
D
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99.3340819
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-5.25234762
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-5.64942039
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55.4771404
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D
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D
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-6.07828684
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63.5202241
69.6991056
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84.4231638
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D
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-4.12881581
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88.7128039
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80.4487885
-4.81141226
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  Study One: Isometric Specific Force at 37˚C
Muscle Weight (mg)
Muscle Length
FL
Wet Wt.
Active Specific Force (N·cm
-2)
Condition
Animal
L-TA
L-EDL
R-TA
R-EDL
inches
cm
cm
Grams
10 Hz
20 Hz
40 Hz
60 Hz
80 Hz
100 Hz
125 Hz
150 Hz
200 Hz
250 Hz
300 Hz
Caffeine 50mM
Concentric-Im
m
D1001
42.59
9.2
49.54
8.77
0.55
1.41
0.62
0.01
3.26
3.49
4.17
5.62
9.05
12.72
16.02
18.31
21.03
21.03
21.03
D1019
54.99
11.3
58.72
11.47
0.59
1.50
0.66
0.01
2.70
2.83
3.25
4.28
6.63
10.41
14.00
16.63
20.14
21.28
21.61
6.21
D1020
55.15
10.87
54.56
8.63
0.62
1.58
0.70
0.01
2.73
2.65
3.29
4.20
5.97
9.34
12.91
15.58
19.18
20.53
20.76
7.61
D1032
63.85
12.11
64.46
10.95
0.63
1.59
0.70
0.01
3.00
3.17
3.15
5.03
7.76
11.24
15.02
16.39
19.03
19.56
19.32
7.49
Concentric-1d
D1016
52.16
10.33
51.7
9.31
0.60
1.53
0.67
0.01
3.46
3.63
4.17
5.31
8.94
11.53
15.06
18.69
21.64
22.69
21.34
7.41
D1021
61.5
12.23
61.6
11.21
0.62
1.58
0.69
0.01
2.83
2.99
3.42
4.33
6.72
10.45
14.04
16.01
19.18
20.48
20.92
7.75
D1023
64.02
12.18
60.13
11.83
0.64
1.63
0.72
0.01
2.58
2.72
3.06
3.78
5.27
8.60
12.74
15.37
18.74
19.66
20.05
7.23
D1026
58.28
10.96
56.18
10.16
0.59
1.51
0.66
0.01
3.32
3.47
4.00
5.17
7.95
12.11
15.50
17.67
19.73
19.73
19.73
Eccentric-Im
m
D1000
44.7
10.02
7.47
0.52
1.31
0.58
0.01
1.12
1.17
1.31
1.59
2.33
3.53
5.25
6.70
9.55
11.42
12.38
5.25
D1007
46.04
9.25
43.91
9.56
0.55
1.41
0.62
0.01
1.78
1.83
2.08
2.61
3.64
5.61
8.19
10.08
13.91
15.69
16.44
6.23
D1022
60.07
16.34
58.05
14.34
0.64
1.63
0.72
0.02
1.09
1.13
1.21
1.46
2.01
2.91
3.94
5.12
7.59
9.37
9.94
5.63
D1028
60.17
11.43
54.15
9.47
0.60
1.53
0.67
0.01
0.85
0.86
1.06
1.13
1.60
2.39
3.76
5.17
7.76
9.03
9.96
5.45
Eccentric-1d
D1006
52.56
9.17
45.24
7.06
0.54
1.37
0.60
0.01
1.23
1.35
1.67
2.04
3.39
5.50
7.94
9.64
11.81
12.67
13.26
6.77
D1008
48.13
8.89
42.18
7.12
0.52
1.32
0.58
0.01
1.20
1.42
1.71
2.24
3.24
4.98
6.79
8.44
10.98
12.63
13.13
6.46
D1015
66.11
12.18
56.95
9.58
0.57
1.45
0.64
0.01
1.11
1.16
1.27
1.57
2.20
3.07
4.22
5.18
7.45
8.10
8.41
5.54
D1027
63
13.22
59.33
11.14
0.64
1.63
0.72
0.01
1.48
1.54
1.66
1.94
2.53
3.44
5.21
6.10
7.68
8.95
9.01
5.49
Eccentric-3d
D1012
57.01
12.98
46.52
9.82
0.61
1.55
0.68
0.01
1.99
2.02
2.38
2.91
4.00
6.08
8.77
11.15
14.46
16.15
16.61
6.35
D1013
59.54
12.28
57.05
10.26
0.63
1.60
0.70
0.01
2.37
2.50
2.85
3.38
5.18
8.24
11.20
14.01
16.93
17.74
18.20
7.02
D1014
66.73
11.87
60.5
9.74
0.61
1.55
0.68
0.01
1.70
1.82
2.00
2.60
3.84
5.80
8.37
10.78
13.01
13.73
13.83
5.70
D1024
61.7
12.17
60.34
10.86
0.61
1.55
0.68
0.01
2.10
2.25
2.64
3.27
4.80
7.30
10.18
12.32
14.27
14.58
14.30
6.87
Control
D1003-L
48.32
7.63
51.42
8.24
0.56
1.43
0.63
0.01
2.66
2.76
3.00
3.57
5.72
8.80
12.49
14.13
17.61
19.39
21.56
7.62
D1003-R
8.24
0.56
1.43
0.63
0.01
3.08
3.25
3.90
5.41
8.68
12.03
15.25
17.54
20.45
21.63
21.82
7.68
D1009
50.59
9.96
48.91
8.93
0.58
1.48
0.65
0.01
3.11
3.31
3.70
4.68
7.46
12.05
16.31
18.95
21.82
22.87
23.68
7.68
D1010
54.82
10.22
50.66
9
0.60
1.52
0.67
0.01
2.47
2.54
2.97
3.96
6.55
10.05
13.19
16.00
19.29
21.22
21.52
7.62
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 Study One: Isometric Specific Force Predicted Parameters 
 
 
Condition Animal min amplitude max EC50 Hill
Concentric-Imm D1001 3.41 18.21 21.62 99.44 -3.79
D1019 2.74 19.52 22.27 114.92 -3.66
D1020 2.76 18.80 21.56 120.05 -3.66
D1032 2.98 16.83 19.81 100.87 -3.93
Concentric-1d D1016 3.62 19.20 22.81 108.43 -3.74
D1021 2.85 18.55 21.39 113.16 -3.59
D1023 2.72 17.67 20.39 118.54 -4.23
D1026 3.49 16.57 20.06 99.26 -4.40
Eccentric-Imm D1000 1.11 13.00 14.11 162.83 -3.08
D1007 1.80 15.99 17.79 143.52 -3.33
D1022 1.11 10.56 11.68 172.35 -3.11
D1028 0.88 10.01 10.89 161.99 -3.57
Eccentric-1d D1006 1.29 12.27 13.55 120.72 -3.65
D1008 1.30 13.19 14.49 140.63 -2.96
D1015 1.16 7.99 9.15 143.71 -3.36
D1027 1.50 8.09 9.60 136.65 -3.45
Eccentric-3d D1012 2.05 15.52 17.57 135.25 -3.56
D1013 2.46 16.17 18.62 118.45 -3.93
D1014 1.82 12.44 14.27 120.26 -4.10
D1024 2.31 12.47 14.79 109.60 -4.41
Control D1003-L 2.45 19.91 22.36 131.02 -3.03
D1003-R 3.09 19.51 22.60 106.67 -3.26
D1009 3.16 20.54 23.71 109.09 -3.99
D1010 2.40 20.11 22.51 119.04 -3.31
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  Study Two:  Isometric Torque-Frequency (Nmm·kg-1) 
Pre1
Name
W
eight_g
W
eight_kg
Temp (˚C)
20
40
60
80
100
125
150
200
250
300
350
400
D1080
31.8
0.032
35.7
28.36
30.36
37.93
78.82
93.12
107.58
113.93
120.91
124.05
125.56
126.54
127.04
D1081
31.6
0.032
36.4
22.31
19.35
24.74
42.65
71.09
88.11
94.12
99.56
101.06
101.45
101.14
103.42
D1082
30.1
0.030
36.3
19.58
17.90
23.86
46.61
72.49
88.17
94.41
100.09
102.81
104.05
103.20
102.43
D1084
30.5
0.031
35.2
32.91
37.75
55.53
78.86
98.00
108.42
113.54
119.27
121.88
123.32
124.38
124.53
D1085
34.5
0.035
36
18.74
19.12
25.75
42.41
69.99
87.60
93.63
99.48
100.57
101.64
102.23
102.68
D1086
29.7
0.030
35.5
23.66
24.42
34.73
60.91
80.12
89.79
94.73
99.46
101.79
101.69
101.52
100.74
D1088
32
0.032
36.5
19.18
19.41
27.43
53.80
80.04
93.00
98.63
104.02
105.95
106.82
107.28
106.46
D1089
32
0.032
35.7
23.33
27.73
33.51
53.39
88.46
110.42
118.74
125.77
128.48
130.16
131.00
131.36
D1090
28.8
0.029
35.1
21.96
20.04
22.83
38.04
75.80
102.84
112.04
120.82
124.40
126.80
127.66
128.14
D1092
33.4
0.033
36.7
22.59
21.10
23.35
36.42
71.68
96.79
104.95
111.46
114.64
115.78
116.17
115.58
D1093
34.8
0.035
35
23.20
25.97
34.50
59.40
82.28
95.59
101.47
107.54
110.60
111.78
112.12
113.10
D1094
30.6
0.031
36.1
23.78
23.43
29.74
47.95
78.67
93.02
99.20
105.26
107.99
109.58
110.23
110.69
D1095
35.9
0.036
35.3
23.06
20.94
27.21
42.13
74.32
92.56
99.16
105.89
109.25
111.24
112.30
113.06
D1096
32.3
0.032
36.5
23.25
23.42
28.41
45.18
74.73
94.47
101.80
108.56
112.15
113.74
114.78
115.27
D1097
32.4
0.032
35.7
19.61
16.11
18.02
28.98
62.63
96.26
104.50
110.86
111.97
117.24
117.50
117.67
P
o
st1
N
a
m
e
2
0
4
0
6
0
8
0
1
0
0
1
2
5
1
5
0
2
0
0
2
5
0
3
0
0
3
5
0
4
0
0
D
1080
4.53
4.90
6.92
11.08
16.68
30.82
43.57
60.94
64.30
66.18
66.57
66.64
D
1081
5.06
5.36
6.67
9.77
16.60
26.59
43.47
60.11
64.28
66.05
67.25
67.01
D
1082
3.89
3.68
4.27
7.21
15.52
31.81
45.95
63.52
68.01
68.87
69.68
69.67
D
1084
6.81
7.78
9.76
13.85
21.66
37.68
51.06
68.77
73.04
75.20
75.39
74.97
D
1085
4.47
4.20
5.57
8.24
13.77
32.07
44.78
62.66
66.81
68.48
69.13
68.92
D
1086
5.64
6.19
7.85
13.07
21.33
36.24
49.91
63.68
67.08
68.19
69.39
69.05
D
1088
6.10
6.35
8.76
13.44
24.03
44.76
60.21
70.87
74.17
75.15
75.12
74.76
D
1089
6.65
6.83
8.20
12.23
20.74
42.68
62.22
82.04
88.22
89.63
90.77
89.77
D
1090
6.96
6.82
7.96
11.63
17.70
39.38
60.44
81.97
88.41
91.69
92.55
92.43
D
1092
3.61
3.98
4.96
7.35
13.10
27.54
43.24
62.82
66.25
68.45
67.31
66.36
D
1093
4.94
5.91
7.55
12.09
20.42
36.82
50.16
64.12
67.51
68.87
69.38
69.12
D
1094
4.89
5.27
8.04
12.43
19.19
37.58
50.72
61.22
63.85
64.75
65.07
64.31
D
1095
6.23
6.35
7.44
9.63
15.01
31.96
46.28
67.58
73.05
75.36
76.53
77.48
D
1096
6.64
6.86
8.76
12.08
20.27
39.79
58.30
73.09
76.63
77.61
77.98
76.41
D
1097
6.08
6.26
6.35
9.37
15.17
31.40
50.90
69.45
73.73
75.52
75.43
75.30
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Study Two:  Isometric Torque-Frequency (Nmm·kg-1)  
Pre2/14d
N
am
e
20
40
60
80
100
125
150
200
250
300
350
400
D
1080
23.76
23.28
34.55
57.52
84.47
98.43
103.83
109.65
112.49
113.74
115.10
114.57
D
1081
14.09
16.35
20.57
34.28
50.73
61.82
67.13
71.96
73.88
74.15
73.74
73.45
D
1082
23.30
22.30
29.84
53.51
77.64
94.04
100.14
105.08
107.31
110.15
109.32
108.67
D
1084
22.93
24.03
32.43
51.04
71.60
82.42
87.36
92.98
94.75
95.11
97.19
97.19
D
1085
16.68
15.95
20.42
36.30
64.54
79.27
82.86
86.21
89.68
88.74
93.25
93.32
D
1086
24.05
22.08
27.23
39.67
69.76
85.27
91.41
97.29
100.28
101.81
102.96
103.22
D
1088
15.15
14.48
19.87
40.67
63.24
75.50
79.15
83.58
85.22
86.90
87.51
87.20
D
1089
22.01
19.86
24.99
39.75
73.70
90.42
96.18
101.45
103.95
105.67
106.47
106.86
D
1090
22.44
22.87
27.76
48.40
84.53
106.38
114.14
121.28
124.44
124.44
124.43
124.97
D
1092
24.41
26.34
38.33
59.26
79.68
91.52
96.22
101.26
102.72
103.31
105.82
104.01
D
1093
19.43
21.19
32.02
51.58
73.41
89.05
94.70
100.75
103.44
104.95
105.77
106.55
D
1094
20.92
25.06
39.73
66.23
81.55
88.49
92.13
95.87
96.58
94.94
95.16
94.27
D
1095
27.60
26.13
37.19
62.02
85.40
100.20
105.90
112.02
115.04
116.61
116.94
117.53
D
1096
20.00
21.56
27.01
55.23
78.84
90.05
93.76
98.44
101.14
102.16
102.31
101.57
D
1097
21.15
19.98
26.06
51.82
79.67
91.43
97.15
102.83
106.05
108.45
106.90
107.37
P
o
st2
-0
d
N
a
m
e
2
0
4
0
6
0
8
0
1
0
0
1
2
5
1
5
0
2
0
0
2
5
0
3
0
0
3
5
0
4
0
0
D
1080
6.97
7.47
9.58
13.90
22.73
45.06
60.56
76.77
80.80
81.75
81.71
80.74
D
1081
D
1082
6.29
5.69
7.01
10.09
18.04
39.38
57.77
74.83
79.07
81.06
82.35
82.92
D
1084
D
1085
D
1086
7.50
9.01
10.28
14.59
22.33
47.00
60.59
70.12
73.60
75.09
76.12
76.29
D
1088
8.46
8.93
9.59
16.15
30.17
46.54
58.21
68.31
71.63
73.35
74.06
74.45
D
1089
5.87
5.78
6.97
11.23
23.33
51.47
69.66
83.41
87.86
89.70
90.42
90.27
D
1090
10.49
10.32
12.05
17.60
29.42
59.91
79.98
96.11
100.28
102.10
102.59
102.34
D
1092
D
1093
D
1094
4.15
4.68
7.80
13.55
23.56
41.60
53.17
61.80
63.86
65.23
65.67
65.87
D
1095
6.38
6.95
9.98
16.57
24.63
45.99
60.68
76.73
80.88
81.59
82.35
82.52
D
1096
5.57
5.31
7.69
11.69
19.08
38.96
53.90
70.32
74.29
76.26
75.99
76.25
D
1097
7.09
6.24
6.86
12.83
21.64
44.00
57.43
75.52
80.61
81.11
81.15
79.38
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Study Two:  Isometric Torque-Frequency (Nmm·kg-1) and Predicted Parameters
P
o
st2
-3
d
N
a
m
e
2
0
4
0
6
0
8
0
1
0
0
1
2
5
1
5
0
2
0
0
2
5
0
3
0
0
3
5
0
4
0
0
D
1080
27.63
33.32
49.19
75.06
93.24
101.56
105.79
109.88
109.85
110.27
110.59
111.67
D
1081
D
1082
20.96
22.65
35.54
58.93
74.54
82.78
87.81
92.27
94.79
95.65
95.57
92.93
D
1084
D
1085
D
1086
D
1088
D
1089
D
1090
D
1092
D
1093
D
1094
D
1095
D
1096
24.48
27.86
42.15
65.67
85.01
95.49
99.88
104.21
106.38
108.13
108.70
108.31
D
1097
20.58
22.69
30.60
47.84
74.02
90.32
96.09
101.86
104.66
106.10
106.94
106.88
P
re
-1
P
o
s
t-1
P
re
-2
P
o
s
t-2
P
o
s
t2
-3
d
N
a
m
e
m
in
 
m
a
x
m
in
m
a
x
m
in
m
a
x
m
in
m
a
x
m
in
m
a
x
D
1
0
8
0
2
8
.3
6
1
2
7
.0
4
4
.5
3
6
6
.6
4
2
3
.2
8
1
1
5
.1
0
6
.9
7
8
1
.7
5
2
7
.6
3
1
1
1
.6
7
D
1
0
8
1
1
9
.3
5
1
0
3
.4
2
5
.0
6
6
7
.2
5
1
4
.0
9
7
4
.1
5
D
1
0
8
2
1
7
.9
0
1
0
4
.0
5
3
.6
8
6
9
.6
8
2
2
.3
0
1
1
0
.1
5
5
.6
9
8
2
.9
2
2
0
.9
6
9
5
.6
5
D
1
0
8
4
3
2
.9
1
1
2
4
.5
3
6
.8
1
7
5
.3
9
2
2
.9
3
9
7
.1
9
D
1
0
8
5
1
8
.7
4
1
0
2
.6
8
4
.2
0
6
9
.1
3
1
5
.9
5
9
3
.3
2
D
1
0
8
6
2
3
.6
6
1
0
1
.7
9
5
.6
4
6
9
.3
9
2
2
.0
8
1
0
3
.2
2
7
.5
0
7
6
.2
9
D
1
0
8
8
1
9
.1
8
1
0
7
.2
8
6
.1
0
7
5
.1
5
1
4
.4
8
8
7
.5
1
8
.4
6
7
4
.4
5
D
1
0
8
9
2
3
.3
3
1
3
1
.3
6
6
.6
5
9
0
.7
7
1
9
.8
6
1
0
6
.8
6
5
.7
8
9
0
.4
2
D
1
0
9
0
2
0
.0
4
1
2
8
.1
4
6
.8
2
9
2
.5
5
2
2
.4
4
1
2
4
.9
7
1
0
.3
2
1
0
2
.5
9
D
1
0
9
2
2
1
.1
0
1
1
6
.1
7
3
.6
1
6
8
.4
5
2
4
.4
1
1
0
5
.8
2
D
1
0
9
3
2
3
.2
0
1
1
3
.1
0
4
.9
4
6
9
.3
8
1
9
.4
3
1
0
6
.5
5
D
1
0
9
4
2
3
.4
3
1
1
0
.6
9
4
.8
9
6
5
.0
7
2
0
.9
2
9
6
.5
8
4
.1
5
6
5
.8
7
D
1
0
9
5
2
0
.9
4
1
1
3
.0
6
6
.2
3
7
7
.4
8
2
6
.1
3
1
1
7
.5
3
6
.3
8
8
2
.5
2
D
1
0
9
6
2
3
.2
5
1
1
5
.2
7
6
.6
4
7
7
.9
8
2
0
.0
0
1
0
2
.3
1
5
.3
1
7
6
.2
6
2
4
.4
8
1
0
8
.7
0
D
1
0
9
7
1
6
.1
1
1
1
7
.6
7
6
.0
8
7
5
.5
2
1
9
.9
8
1
0
8
.4
5
6
.2
4
8
1
.1
5
2
0
.5
8
1
0
6
.9
4
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Study Two:  Isometric Specific Force-frequency (Nmm·kg+1)
Muscle Length
Fiber LengthWet Wt.
Active
Condition
Animal
L-TA
L-EDL
inches
cm
cm
Grams
10 Hz
20 Hz
40 Hz
60 Hz
80 Hz
100 Hz
125 Hz
150 Hz
200 Hz
250 Hz
300 Hz
Caffeine 50mM
14d
D1081
51.68
10.42
0.61
1.55
0.68
0.01
2.24
2.20
2.84
4.14
6.43
10.18
14.31
17.88
20.88
21.61
21.73
6.79
D1084
56.67
9.7
0.60
1.53
0.67
0.01
2.63
2.79
3.07
3.84
5.15
7.81
11.64
14.25
17.31
18.10
18.88
7.56
D1085
69.41
10.92
0.62
1.57
0.69
0.01
2.51
2.64
3.06
3.99
5.80
10.01
14.39
17.50
20.02
20.90
21.29
7.09
D1092
57.26
9.93
0.62
1.57
0.69
0.01
5.35
5.96
6.03
7.94
11.72
13.48
15.68
17.32
18.52
18.87
19.05
7.84
D1093
67.22
10.61
0.61
1.56
0.68
0.01
2.45
2.59
2.81
3.38
4.74
7.63
12.25
15.60
18.71
19.62
20.16
7.41
Bout 2 0d
D1086
56.23
10.21
0.60
1.53
0.67
0.01
1.55
1.71
1.81
2.21
2.97
4.38
6.42
8.37
11.29
12.19
12.34
6.45
D1088
73
11.74
0.60
1.51
0.67
0.01
1.68
1.84
2.11
2.54
3.39
5.07
7.65
10.11
12.40
13.44
13.63
6.28
D1089
72.06
12.6
0.63
1.60
0.70
0.01
1.73
1.80
2.19
2.85
3.80
5.44
8.01
10.52
14.36
26.48
15.11
5.89
D1090
70.22
10.83
0.61
1.54
0.68
0.01
1.74
1.86
1.95
2.29
2.80
3.66
5.18
7.14
11.36
13.38
13.34
7.08
D1094
59.13
10.69
0.61
1.56
0.68
0.01
1.80
1.84
2.08
2.56
3.64
5.51
8.50
11.22
14.76
15.40
15.63
6.64
Bout 2 3d
D1082
66.58
10.6
0.64
1.61
0.71
0.01
2.41
2.77
3.24
3.83
5.41
8.22
13.08
15.43
19.28
20.81
22.97
8.65
D1080
62.79
11.33
0.62
1.57
0.69
0.01
4.05
4.30
4.78
5.48
7.60
12.85
18.00
20.68
22.87
23.51
24.12
D1095
70.1
11.3
0.64
1.61
0.71
0.01
2.65
2.75
2.97
3.37
4.57
7.10
11.16
14.86
18.29
19.40
20.48
7.40
D1097
62.03
11.42
0.60
1.53
0.67
0.01
3.22
3.37
3.71
4.08
5.65
9.42
13.76
17.30
19.70
20.55
20.81
7.60
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Study Three:  Isometric Specific Force (N·cm-2) 
M
u
scle
 Le
n
g
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g
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P
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Study Three:  Eccentric or Isometric and Caffeine Specific Force (N·cm-2)
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Study One:  Western Blots 
 
 
 
 
 
 
 
  137 
 
Study One:  Western Blots 
 
 
 
 
 
 
 
  138 
 
  139 
 
Study Two:  Repeated Bout of Eccentric Contractions 
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Study Three:  Temperature Dependency of Muscle Injury 
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APPENDIX C 
 
WESTERN BLOT PROTOCOL 
 
Primary Antibodies 
Junctophilin 1:  Rabbit Anti-mouse JP1 (C-terminus), Invitrogen (40-5100) 
Junctophilin 2:  Rabbit Anti-mouse JP2 (C-terminus), Invitrogen (40-5300) 
Tubulin (multiple isoforms):  Rabbit Anti-mouse, Sigma (T 3526) 
 
Secondary Antibody 
Goat Anti-rabbit HRP conjugated, Invitrogen (G21234) 
 
Protocol 
 
SDS-PAGE 
- 7% 37.5:1 Acrylamide : Bis 1mm gel 
- Load 25 µg of protein (Protein estimated from Bradford Assay) 
- Run for 30 minutes at 100 V 
- Run for 45 minutes at 150 V 
 
Membrane Transfer 
- Transfer to nitrocellulose membrane for 60 minutes at 100 V (peak current 360 mV) 
- Be sure to equilibrate membrane and gel for 10 – 15 minutes in transfer buffer. 
 
Treatment of Transferred Membrane 
- Stain membrane briefly with Ponceau and scan the membrane 
- Rinse membrane with TBS-T to remove most of Ponceau staining 
- Block membrane in 5% Non-Fat Dried Milk TBS-T (0.1%) overnight at 4˚C 
- Incubate membrane in primary antibody for 2 hours at room temperature with shaking 
o JP1 & JP2 1˚ Ab; 1: 20,000 (1 µL Ab in 20 mL TBS-T) 
o Tubulin 1˚ Ab; 1: 2,500 (6 µL in 15 mL TBS-T) 
- Rinse 3 x 15 minute in TBS-T 
- Incubated membrane in secondary antibody for 1 hour at room temperature with shaking 
o 2˚; 1 : 25,000 (1µL in 25 mL of TBS-T) 
- Rinse 3 x 15 minute in TBS-T 
- Blot dry and apply chemilumiscent substrate (Thermo Scientific ECL solution) 
- Blot dry and place in plastic sheeth 
- Expose x-ray film to membrane 
o JP1 – 3 minutes 
o JP2 – 1.5 minutes 
o Tubulin – 4 minutes 
- Develop and Fix Film 
- Allow film to dry and then scan for optic densitometric analysis. 
 
 
